unique_id,Target,IndexSampleType,Rank,SampleSize,ReferenceSampleType,unique_evaluation,TestName,Manufacturer,Laboratory,SampleSubPopulation,LotNumber,Facility,Country,City,SamplePopulation,SampleSet,ReferenceMethod,Repeats,Blinding,TestType,TestFormat,UseCase,CatalogNumber,AntigenUsedforDetection,RNAExtractionKit,EstimatedLoD,LoDUnit,HigherCutoff,LowerCutoff,CtValue,DaysofSickness,TotalPositive,TotalNegative,TruePositive,TrueNegative,Sensitivity,Specificity,LinktoPublication,DOI,Comments,temp_sample_size_,manufacturer_test_isotype_index,Rapid Review: Estimates
AAZ LMB - COVID-DUO® - IgG; IgM - Whole blood,IgG; IgM,Whole blood,1,205,Nasopharyngeal swabs,1,COVID-DUO®,AAZ LMB,Centre Hospitalier Regional Orléans,Not available,Not available,Hospital,France,Orleans,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,134,71,98,71,73.1,100,https://www.medrxiv.org/content/10.1101/2020.05.27.20112888v1.full.pdf,10.1101/2020.05.27.20112888,Not available,-205,AAZ LMB - COVID-DUO® - IgG; IgM - Whole blood,
AAZ LMB - COVID-PRESTO® - IgG; IgM - Capillary blood,IgG; IgM,Capillary blood,1,222,Nasopharyngeal swabs,1,COVID-PRESTO®,AAZ LMB,Centre Hospitalier Regional Orléans,Not available,Not available,Hospital,France,Orleans,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,150,72,102,72,68,100,https://www.medrxiv.org/content/10.1101/2020.05.27.20112888v1.full.pdf,10.1101/2020.05.27.20112888,Not available,-222,AAZ LMB - COVID-PRESTO® - IgG; IgM - Capillary blood,
Abacus Pharma International - SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography) - IgG - Plasma; Serum,IgG,Plasma; Serum,1,110,Not available,1,SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography),Abacus Pharma International,Frederick National Laboratory for Cancer Research,Not available,COV1252003C,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,22,79,73.3,98.8,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3257-a001.pdf,Not available,Not available,-110,Abacus Pharma International - SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography) - IgG - Plasma; Serum,
Abacus Pharma International - SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography) - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,110,Not available,1,SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography),Abacus Pharma International,Frederick National Laboratory for Cancer Research,Not available,COV1252003C,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,23,79,76.7,98.8,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3257-a001.pdf,Not available,Not available,-110,Abacus Pharma International - SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography) - IgG; IgM - Plasma; Serum,
Abacus Pharma International - SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography) - IgM - Plasma; Serum,IgM,Plasma; Serum,1,110,Not available,1,SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography),Abacus Pharma International,Frederick National Laboratory for Cancer Research,Not available,COV1252003C,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,16,80,53.3,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3257-a001.pdf,Not available,Not available,-110,Abacus Pharma International - SARS-CoV-2 IgM/IgG AB Antibody Rapid Test (Immunochromatography) - IgM - Plasma; Serum,
Abbott Diagnostics - SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,1,160,Not available,1,SARS-CoV-2 IgG,Abbott Diagnostics,,Not available,Not available,Private Laboratory,South Africa,Cape Town,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Triplicates,Not available,Antibody,Cchemiluminescent microparticle immunoassay,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,93,67,65,67,69.9,100,Not available,Not available,I don't think it's in the public domain? Jacob,-160,Abbott Diagnostics - SARS-CoV-2 IgG - IgG - Serum,"200828_CastiglioneD'Adda_UniversitadegliStudidiMilano_overall,200828_CastiglioneD'Adda_UniversitadegliStudidiMilano_age0to19,200828_CastiglioneD'Adda_UniversitadegliStudidiMilano_age20to39,200828_CastiglioneD'Adda_UniversitadegliStudidiMilano_age40to59,200828_CastiglioneD'Adda_UniversitadegliStudidiMilano_age60+"
Abbott Diagnostics Inc. - SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,1,256,Nasopharyngeal swabs; Oropharyngeal swabs; Lower respiratory specimen,3,SARS-CoV-2 IgG,Abbott Diagnostics Inc.,Barnes Jewish Hospital Laboratory,Not available,Not available,Hospital,United States of America (USA),Saint Louis,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio >=1.4,Ratio <1.4,Not available,Overall,103,153,62,152,60.2,99.3,https://academic.oup.com/clinchem/advance-article/doi/10.1093/clinchem/hvaa120/5836557,10.1093/clinchem/hvaa120,"Controls: symptomatic but PCR negative for SARS-CoV-2; pre-pandemic controls; patients  with  other  coronaviruses confirmed  by  molecular  testing  but  PCR  negative  for  COVID-19;  patients with Influenza A or B; specimens with potentially interfering antibodies

Analysis on Abbott Architect i2000 (Abbott Diagnostics)",-256,Abbott Diagnostics Inc. - SARS-CoV-2 IgG - IgG - Serum,
Abbott Diagnostics Inc. - SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,2,856,Pharyngeal swabs,3,SARS-CoV-2 IgG,Abbott Diagnostics Inc.,Clinical Service Unit (CSU) at PHE Colindale,Not available,Not available,Public Health,Great Britain,Not available,Confirmed COVID-19 patients,Not available,RT-PCR,No replicates,Not available,Antibody,Chemiluminescent microparticle immunoassay (CMIA),Detection of current infection; Detection of past infection,16253FN00,Not available,Not available,Not available,Not available,Ratio ≥1.4,Ratio <1.4,Not available,Overall,96,760,89,758,92.7,99.7,https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/890566/Evaluation_of_Abbott_SARS_CoV_2_IgG_PHE.pdf,Not available,All testing was performed per the manufacturer’s instructions on an Abbott Architect i2000SR automated instrument.,-856,Abbott Diagnostics Inc. - SARS-CoV-2 IgG - IgG - Serum,
Abbott Diagnostics Inc. - SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,3,123,Serum,3,SARS-CoV-2 IgG,Abbott Diagnostics Inc.,"Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,82,33,78,80.5,95.1,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,"Analysis using the Architect Plus i2000sr Analyzer (Abbott, Illinois, USA)

Test cut-off 1.4 index

Days of sickness: 3 to 16 days",-123,Abbott Diagnostics Inc. - SARS-CoV-2 IgG - IgG - Serum,
Abbott Laboratories - Abbott Alinity SARS-COV-2 IgG - IgG - Serum,IgG,Serum,1,160,Not available,1,Abbott Alinity SARS-COV-2 IgG,Abbott Laboratories,PathCare N1 Reference Laboratory,Not available,Not available,Private Laboratory,South Africa,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescent microparticle immunoassay (CMIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,≥1.4,<1.4,Not available,Overall,93,67,65,67,69.9,100,Not available,Not available,"Controls: Pre-pandemic controls, EQA material",-160,Abbott Laboratories - Abbott Alinity SARS-COV-2 IgG - IgG - Serum,"200717_Hungary_SemmelweisUniversity_GenPop,200717_Hungary_SemmelweisUniversity__Age14to39,200717_Hungary_SemmelweisUniversity__Age40to64,200717_Hungary_SemmelweisUniversity__Age65+,200717_Hungary_SemmelweisUniversity__BMI<18.5,200717_Hungary_SemmelweisUniversity__BMI18.5to24.9,200717_Hungary_SemmelweisUniversity__BMI25to29.9,200717_Hungary_SemmelweisUniversity__BMI30+,200717_Hungary_SemmelweisUniversity__SmokerNever,200717_Hungary_SemmelweisUniversity__SmokerCurrent,200717_Hungary_SemmelweisUniversity__SmokerPast,200717_Hungary_SemmelweisUniversity__Hypertension,200717_Hungary_SemmelweisUniversity__HeartDisease,200717_Hungary_SemmelweisUniversity__DiabetesMellitus,200717_Hungary_SemmelweisUniversity__ChronicPulmonaryDisease,200717_Hungary_SemmelweisUniversity__ChronicRenalDisease,200717_Hungary_SemmelweisUniversity__ChronicLiverDisease,200717_Hungary_SemmelweisUniversity_CurrentMalignancy,200717_Hungary_SemmelweisUniversity_Immunodeficiency,200717_Hungary_SemmelweisUniversity__GenPop_PopAdj,200717_Hungary_SemmelweisUniversity__Male_PopAdj,200717_Hungary_SemmelweisUniversity__Female_PopAdj,200717_Hungary_SemmelweisUniversity_Age14to39_PopAdj,200717_Hungary_SemmelweisUniversity__Age40to64_PopAdj,200717_Hungary_SemmelweisUniversity__Age65+_PopAdj,200717_Hungary_SemmelweisUniversity__ActiveWorker_PopAdj,200717_Hungary_SemmelweisUniversity__Pensioner_PopAdj,200717_Hungary_SemmelweisUniversity__Student_PopAdj,200717_Hungary_SemmelweisUniversity__Housewife_PopAdj,200717_Hungary_SemmelweisUniversity_NonWorker_PopAdj,200717_Hungary_SemmelweisUniversity__ContactWithInfectedPersons_PopAdj,200717_Hungary_SemmelweisUniversity__NoContactWithInfectedPersons_PopAdj,200717_Hungary_SemmelweisUniversity__InternationalTravelAfterMarch1_PopAdj,200717_Hungary_SemmelweisUniversity__NoInternationalTravelAfterMarch1_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_Budapest_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_PestCounty_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_CentralTransdanubia_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_WesternTransdanubia_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_SouthernTransdanubia_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_NothernHungary_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_NorthernGreatPlain_PopAdj,200717_Hungary_SemmelweisUniversity__GenPop_SoutherGreatPlain_PopAdj,200717_Hungary_SemmelweisUniversity__AnyComorbidity,200717_Hungary_SemmelweisUniversity__Male,200717_Hungary_SemmelweisUniversity__Female,200717_Hungary_SemmelweisUniversity__RefusedToDiscloseContacts_PopAdj"
Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,2,126,Respiratory specimen,4,Abbott Architect SARS-CoV-2 IgG,Abbott Laboratories,"Institut für Infektionsmedizin, Christian-Albrechts-Universität und Universitätsklinikum Schleswig-Holstein",Not available,Not available,Hospital,Germany,Kiel,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescent microparticle immunoassay (CMIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Signal/cut-off value of ≥1,Signal/cut-off value of <1,Not available,Overall,26,100,25,99,96.2,99,https://www.medrxiv.org/content/10.1101/2020.06.15.20131672v1.full.pdf,10.1101/2020.06.15.20131672,"Controls: Pre-pandemic controls

Sample collection between 4 and 60 days (median 19 days) after a positive real-time RT-PCR result

 Only  sera  from  individuals  that 70 exhibited a cycle threshold (CT) ≤ 35 (median CT 26.8) in the initial real-time RT-PCR were included.",-126,Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serum,
Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,3,293,Not available,4,Abbott Architect SARS-CoV-2 IgG,Abbott Laboratories,"Virology Laboratory, Angers University Hospital",Not available,Not available,Hospital,France,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescent microparticle immunoassay (CMIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,141,152,Not available,Not available,81.8,99.3,https://reader.elsevier.com/reader/sd/pii/S1386653220302535?token=341A1A99931901504B0EDE6F1EC192695BC491A850BE5FDF9A3467E2101C4C30CA935015148BC7A4A4F45C3916735036,10.1016/j.jcv.2020.104511,"Controls: Patients with symptoms consistent with COVID-19 but with a negative RT-PCR result, pre-pandemic controls",-293,Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serum,
Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,4,110,Not available,4,Abbott Architect SARS-CoV-2 IgG,Abbott Laboratories,PathCare N1 Reference Laboratory,Not available,Not available,Private Laboratory,South Africa,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescent microparticle immunoassay (CMIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,≥1.4,<1.4,Not available,Overall,56,54,46,54,82.1,100,Not available,Not available,"Controls: Pre-pandemic controls, EQA material",-110,Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serum,
Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serumabb,IgG,Serum,1,340,Respiratory specimen,4,Abbott Architect SARS-CoV-2 IgG,Abbott Laboratories,"Department of Laboratory Medicine, National University Hospital, Singapore",Not available,Not available,Hospital,Singapore,Not available,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemiluminescent microparticle immunoassay (CMIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio ≥1.4,Ratio <1.4,Not available,Overall,177,163,73,163,41.2,100,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30334-7/fulltext#,Not available,"Control: Pre-pandemic controls

Analysis performed on the Abbott Architect i4000SR (Abbott Diagnostics, Chicago, USA)",-340,Abbott Laboratories - Abbott Architect SARS-CoV-2 IgG - IgG - Serum,"200507_Boise_UniversityofWashington_GenPop,200507_Boise_UniversityofWashington_GenPopFemales,200507_Boise_UniversityofWashington_GenPopMales,200507_Boise_UniversityofWashington_GenPopAge0-19 ,200507_Boise_UniversityofWashington_GenPopAge20-29 ,200507_Boise_UniversityofWashington_GenPopAge30-39,200507_Boise_UniversityofWashington_GenPopAge40-49,200507_Boise_UniversityofWashington_GenPopAge50-59,200507_Boise_UniversityofWashington_GenPopAge70-79,200507_Boise_UniversityofWashington_GenPopAge80+,200507_Boise_UniversityofWashington_GenPopGenderUnknown,200525_SanFrancisco_UniversityCaliforniaSanFrancisco_BloodDonors,200525_SanFrancisco_UniversityCaliforniaSanFrancisco_Patients,200821_England_PHE_SeroepiUnitPaedsSurvey_Age1to4_TestAdj_May,200821_England_PHE_SeroepiUnitPaedsSurvey_Age5to10_TestAdj_May,200821_England_PHE_SeroepiUnitPaedsSurvey_Age11to19_TestAdj_May,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_Unadj_April,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_Unadj_FebMarch,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_Unadj_May,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April,200821_England_PHE_WhatsTheStory_TestAdj_FebMarch,200821_England_PHE_WhatsTheStory_TestAdj_May,200821_England_PHE_WhatsTheStory_TestAdj_April,200821_England_PHE_WhatsTheStory_Unadj_FebMarch,200821_England_PHE_WhatsTheStory_Unadj_April,200821_England_PHE_WhatsTheStory_Unadj_May,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_GenPop,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_4-10yr,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_11-17yr,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_18-50yr,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_51-70yr,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_>70,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_White,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Black,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_HispanicLatinx,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Asian,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_>HouseholdIncome$100000,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_HouseholdIncome$50000-100000,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_HouseholdIncome<$50000,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_CensusTractResidents,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Workers,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_AdjacentCityBlocks,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Male,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Female,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_FrontlineJob,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_NonFrontlineJob,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Unemployed,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Household>5,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Household1-2,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Household3-5,200617_SanFrancisco_UniversityCaliforniaSanFrancisco_Other,200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_abbott,200807_England_PHE_RCGP_GenPop_TestPopAdj_65_69_May,200807_England_PHE_RCGP_GenPop_TestPopAdj_70_74_May,200807_England_PHE_RCGP_GenPop_TestPopAdj_75_79_May,200807_England_PHE_RCGP_GenPop_TestPopAdj_80+_May,200807_England_PHE_RCGP_GenPop_TestPopAdj_65_69_June,200807_England_PHE_RCGP_GenPop_TestPopAdj_70_74_June,200807_England_PHE_RCGP_GenPop_TestPopAdj_75_79_June,200807_England_PHE_RCGP_GenPop_TestPopAdj_80+_June,200821_England_PHE_WhatsTheStory_TestAdj_June_August,200821_England_PHE_WhatsTheStory_Unadj__June_August,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_Unadj_JuneAug,200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_JuneAug,200806_Greece_UniversityofThessaly_Overall,200806_Greece_UniversityofThessaly_March_Unadj,200806_Greece_UniversityofThessaly_March_PopAdj,200806_Greece_UniversityofThessaly_March_TestAdj,200806_Greece_UniversityofThessaly_April_Unadj,200806_Greece_UniversityofThessaly_April_PopAdj,200806_Greece_UniversityofThessaly_April_TestAdj,200806_Greece_UniversityofThessaly_Females,200806_Greece_UniversityofThessaly_Males,200806_Greece_UniversityofThessaly_0-29,200806_Greece_UniversityofThessaly_30-49,200806_Greece_UniversityofThessaly_50-69,200806_Greece_UniversityofThessaly_>70,200806_Greece_UniversityofThessaly_Urban,200806_Greece_UniversityofThessaly_Non-urban,200806_Greece_UniversityofThessaly_March_PopTestAdj,200806_Greece_UniversityofThessaly_April_PopTestAdj,200821_Oxford_OxfordUniversityHospitals_Overall_Abbott,200814_Oregon_OregonHealthAuthority_Overall_UnAdj,200814_Oregon_OregonHealthAuthority_Age0-4_UnAdj,200814_Oregon_OregonHealthAuthority_Age5-17_UnAdj,200814_Oregon_OregonHealthAuthority_Age18-49_UnAdj,200814_Oregon_OregonHealthAuthority_Age50-64_UnAdj,200814_Oregon_OregonHealthAuthority_Age65-74_UnAdj,200814_Oregon_OregonHealthAuthority_Age75-84_UnAdj,200814_Oregon_OregonHealthAuthority_Age85plus_UnAdj,200822_Turkey_UniversityofHealthSciences_HCWOverall,200822_Turkey_UniversityofHealthSciences_HCWUEAH,200822_Turkey_UniversityofHealthSciences_HCWCerrahpasa,200822_Turkey_UniversityofHealthSciences_HCWFarabi,200822_Turkey_UniversityofHealthSciences_Physicians,200822_Turkey_UniversityofHealthSciences_Nurses,200822_Turkey_UniversityofHealthSciences_WardClerkSecurity,200822_Turkey_UniversityofHealthSciences_LabRadioTech,200822_Turkey_UniversityofHealthSciences_CleaningStaff,200822_Turkey_UniversityofHealthSciences_AdminStaff,200822_Turkey_UniversityofHealthSciences_PandemicClinic,200822_Turkey_UniversityofHealthSciences_ICU,200822_Turkey_UniversityofHealthSciences_ER,200822_Turkey_UniversityofHealthSciences_CoronaLab,200822_Turkey_UniversityofHealthSciences_SwabTeam,200822_Turkey_UniversityofHealthSciences_NonPandemicClinic,200822_Turkey_UniversityofHealthSciences_AdminOffice,200822_Turkey_UniversityofHealthSciences_OnLeave,200822_Turkey_UniversityofHealthSciences_HighRisk,200822_Turkey_UniversityofHealthSciences_LowRisk,200822_Turkey_UniversityofHealthSciences_NoRisk,200818_Cambridge_CambridgeHealthAllianceAbbottInitial,200818_Cambridge_CambridgeHealthAllianceAbbottRepeat,200618_Japan_IwatePrefecturalCentralHospital_HealthCareWorkersAbbotTest_IgG,200623_AddisAbaba_KuwaitUniversity_GenPop,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Female_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Male_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_0–19_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_20–34_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_35–49_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_50–64_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_≥65_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Telecommuter_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Retail_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Transport_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Publicsafety_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Cleaning_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Healthcare_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_Nursinghome_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_NationalitySpanish_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_NationalityOther_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Activeworker_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Unemployed_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Student_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Retired_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_DisabilityLeave_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseWork_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_UnpaidSocialWork_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_OtherOccupation_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof1_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof2_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof3to5_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof6ormore_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income<5thpercentile_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income5thto24thpercentile_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income25thto49thpercentile_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income50thto74thpercentile_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income75thto94thpercentile_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income95th+percentile_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize100000+_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize20000to99999_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize5000to19999_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize<5000_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_NoContactConfirmedCase_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedHousehold_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedFriend_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedCoWorker_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedHouseStaff_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedClient_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_NoContactSymptomaticCase_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticHousehold_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticFriend_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticCoWorker_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticHouseStaff_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticClient_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_HomeCaregiver_ImmunoAssay,200706_Spain_InstituteofHealthCarlosIII_OccupationSectorOther_ImmunoAssay,200626_London_UniversityCollegeLondon_MaternityHCWOverall,200626_London_UniversityCollegeLondon_MaternityHCWAsymptomatic,200626_London_UniversityCollegeLondon_MaternityHCW_Midwives,200626_London_UniversityCollegeLondon_MaternityHCW_Anaesthesia,200626_London_UniversityCollegeLondon_HCWMaternityObstetrics,200630_Seattle_FredHutchinsonResearchCenter_Overall,200630_Seattle_FredHutchinsonResearchCenter_Female,200630_Seattle_FredHutchinsonResearchCenter_Male,200630_Seattle_FredHutchinsonResearchCenter_0-4,200630_Seattle_FredHutchinsonResearchCenter_5-9,200630_Seattle_FredHutchinsonResearchCenter_10-14,200630_Seattle_FredHutchinsonResearchCenter_>15,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age<10,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age10to19,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age20to29,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age30to39,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age40to49,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age50to59,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age60to69,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age70to79,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_AbbottCLIA_Age80+,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age<10,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age10to19,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age20to29,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age30to39,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age40to49,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age50to59,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age60to69,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age70to79,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA_Age80+,200717_Saxony_TechnischeUniversitätDresden_Overall_Test2,200717_Saxony_TechnischeUniversitätDresden_Students_Test2,200717_Saxony_TechnischeUniversitätDresden_Teachers_Test2,200720_Lahore_ChughtaiInstituteofPathology_Overall,200720_Lahore_ChughtaiInstituteofPathology_QuarantineCenters,200720_Lahore_ChughtaiInstituteofPathology_FamilyContacts,200720_Lahore_ChughtaiInstituteofPathology_NonfamilyContacts,200720_Lahore_ChughtaiInstituteofPathology_SuspectedExposure,200720_Lahore_ChughtaiInstituteofPathology_Gloves,200720_Lahore_ChughtaiInstituteofPathology_Masks,200720_Lahore_ChughtaiInstituteofPathology_Gloves+Masks,200720_Lahore_ChughtaiInstituteofPathology_FullPPE,200720_Lahore_ChughtaiInstituteofPathology_JointFamily,200720_Lahore_ChughtaiInstituteofPathology_SingleAccommodation,200720_Uppsala_UppsalaUniversity_Total,200720_Uppsala_UppsalaUniversity_Male,200720_Uppsala_UppsalaUniversity_Female,200720_Uppsala_UppsalaUniversity_WorkinginHealthCare,200720_Uppsala_UppsalaUniversity_WorkinginPrimaryHealthCare,200720_Uppsala_UppsalaUniversity_WorkingwithOutpatientCare,200720_Uppsala_UppsalaUniversity_WorkinginCovid-19specificUnit,200720_Uppsala_UppsalaUniversity_WorkinginCovid-19possibleunit,200720_Uppsala_UppsalaUniversity_NotWorkinginHealthCare,200720_Uppsala_UppsalaUniversity_NotWorkinginPrimaryHealthCare,200720_Uppsala_UppsalaUniversity_NotWorkingwithOutpatientCare,200720_Uppsala_UppsalaUniversity_NotWorkinginCovid-19specificUnit,200721_Idaho_UniversityofWashington_TotalTestAdj,200721_Idaho_UniversityofWashington_TotalCrude,200721_Idaho_UniversityofWashington_18-29yrs_TestAdj,200721_Idaho_UniversityofWashington_30-39yrs_TestAdj,200721_Idaho_UniversityofWashington_40-49yrs_TestAdj,200721_Idaho_UniversityofWashington_50-59yrs_TestAdj,200721_Idaho_UniversityofWashington_60-69yrs_TestAdj,200721_Idaho_UniversityofWashington_>=70years_TestAdj,200721_Idaho_UniversityofWashington_Male_TestAdj,200721_Idaho_UniversityofWashington_Female_TestAdj,200721_Idaho_UniversityofWashington_HispanicorLatino_TestAdj,200721_Idaho_UniversityofWashington_Non-HispanicorLatino_TestAdj,200721_Idaho_UniversityofWashington_CityofHailey_TestAdj,200721_Idaho_UniversityofWashington_CityofKetchum_TestAdj,200721_Idaho_UniversityofWashington_CityofSunValley_TestAdj,200721_Idaho_UniversityofWashington_TotalPopTestAdj,200721_Idaho_UniversityofWashington_TotalPopTestAdj_Singlehousehold,200721_Idaho_UniversityofWashington_TotalPopTestAdj_RandomWithinHouse,200721_Idaho_UniversityofWashington_Employed_TestAdj,200721_Idaho_UniversityofWashington_Unemployed_TestAdj,200721_Idaho_UniversityofWashington_EssentialEmployee_TestAdj,200721_Idaho_UniversityofWashington_NonEssentialEmployee_TestAdj,200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted,200730_Louisiana_OschnerClinicFoundation_White_PopWeighted,200730_Louisiana_OschnerClinicFoundation_Black_PopWeighted,200730_Louisiana_OschnerClinicFoundation_Asian_PopWeighted,200730_Louisiana_OschnerClinicFoundation_Indigenous_PopWeighted,200730_Louisiana_OschnerClinicFoundation_PacificIslander_PopWeighted,200730_Louisiana_OschnerClinicFoundation_Multiracialorother_PopWeighted,200730_Louisiana_OschnerClinicFoundation_Hispanic_PopWeighted,200730_Louisiana_OschnerClinicFoundation_Overall,200730_Louisiana_OschnerClinicFoundation_Asian,200730_Louisiana_OschnerClinicFoundation_Black,200730_Louisiana_OschnerClinicFoundation_Hispanic,200730_Louisiana_OschnerClinicFoundation_Indigenous ,200730_Louisiana_OschnerClinicFoundation_Multiracialorother,200730_Louisiana_OschnerClinicFoundation_PacificIslander,200730_Louisiana_OschnerClinicFoundation_White,200803_Indiana_IndianaUniversity_healthcareworkers,200803_Indiana_IndianaUniversity_Physicians,200803_Indiana_IndianaUniversity_Nurses,200803_Indiana_IndianaUniversity_RespiratoryTherapist,200803_Indiana_IndianaUniversity_Administrators,200803_Indiana_IndianaUniversity_Males,200803_Indiana_IndianaUniversity_Females,200803_Indiana_IndianaUniversity_HighRisk,200803_Indiana_IndianaUniversity_LowRisk,200803_Italy_ItalianMinistryOfHealth_Overall,200803_Italy_ItalianMinistryOfHealth_Lombardy,200803_Italy_ItalianMinistryOfHealth_ValleD'Aosta,200803_Italy_ItalianMinistryOfHealth_Bolzano,200803_Italy_ItalianMinistryOfHealth_Trento,200803_Italy_ItalianMinistryOfHealth_Liguria,200803_Italy_ItalianMinistryOfHealth_Piemonte,200803_Italy_ItalianMinistryOfHealth_Emilia-Romagna,200803_Italy_ItalianMinistryOfHealth_Marche,200803_Italy_ItalianMinistryOfHealth_Veneto,200803_Italy_ItalianMinistryOfHealth_Abruzzo,200803_Italy_ItalianMinistryOfHealth_Lazio,200803_Italy_ItalianMinistryOfHealth_Tuscany,200803_Italy_ItalianMinistryOfHealth_Friuli-VeneziaGiulia,200803_Italy_ItalianMinistryOfHealth_Puglia,200803_Italy_ItalianMinistryOfHealth_Umbria,200803_Italy_ItalianMinistryOfHealth_Basilicata,200803_Italy_ItalianMinistryOfHealth_Campania,200803_Italy_ItalianMinistryOfHealth_Molise,200803_Italy_ItalianMinistryOfHealth_Calabria,200803_Italy_ItalianMinistryOfHealth_Sardegna,200803_Italy_ItalianMinistryOfHealth_Sicily,200803_Italy_ItalianMinistryOfHealth_Bergamo,200803_Italy_ItalianMinistryOfHealth_Cremona,200803_Italy_ItalianMinistryOfHealth_HCWsinAreasWithHigherSeroprevalence,200803_Italy_ItalianMinistryOfHealth_HCWsinAreasWithIntermediateSeroprevalence,200803_Italy_ItalianMinistryOfHealth_HCWsinSouthernItaly,200808_UK_PortlandHospitalforWomenandChildren_HCW,200810_London_UniversityCollegeLondon_Total,200810_London_UniversityCollegeLondon_Midwives,200810_London_UniversityCollegeLondon_Anaesthetists,200810_London_UniversityCollegeLondon_Obstetrics,200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients,200815_Bolinas_UniversityofCaliforniaSanFrancisco_AbbottTest,200815_Bolinas_UniversityofCaliforniaSanFrancisto_AbbottBolinasResidents,200817_Ireland_HPSC_genpop_Dublin,200817_Ireland_HPSC_genpop_females_Dublin,200817_Ireland_HPSC_genpop_males_Dublin,200817_Ireland_HPSC_genpop_12-19_Dublin,200817_Ireland_HPSC_genpop_Sligo,200817_Ireland_HPSC_genpop_females_Sligo,200817_Ireland_HPSC_genpop_males_Sligo,200817_Ireland_HPSC_genpop_20-29_Dublin,200817_Ireland_HPSC_genpop_30-39_Dublin,200817_Ireland_HPSC_genpop_40-49_Dublin,200817_Ireland_HPSC_genpop_50-59_Dublin,200817_Ireland_HPSC_genpop_60-69_Dublin,200817_Ireland_HPSC_genpop_12-39_Sligo,200817_Ireland_HPSC_genpop_40-69_Sligo,200817_Ireland_HPSC_genpop_12-19,200817_Ireland_HPSC_genpop_20-29,200817_Ireland_HPSC_genpop_30-39,200817_Ireland_HPSC_genpop_40-49,200817_Ireland_HPSC_genpop_50-59,200817_Ireland_HPSC_genpop_60-69,200817_Ireland_HPSC_genpop_popadj,200817_Ireland_HPSC_genpop_unadj,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_CensusTractPopulation,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_CensusTractWorkers,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_AdjacentCityBlockResidents,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_Male,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_Female,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_4-10yrs,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_11-17yrs,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_18-50yrs,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_51-70yrs,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_>70yrs,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_White/Caucasian,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_Hispanic/Latinx,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_Black/AfricanAmerican,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_Asian/PacificIslander,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_OtherEthnicity,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_Frontlinejob,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_NonFrontlinejob,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_Unemployed,200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_PastMedicalHistory,""200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_>$100,000"",""200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_$50-100,000"",""200818_SanFrancisco_UniversityofCaliforniaSanFrancisco_<$50,000"",200819_Canada_CBS_BloodDonors_Overall,200819_Canada_CBS_BloodDonors_Overall_Adjusted,200819_Canada_CBS_BloodDonors_Male_Adjusted,200819_Canada_CBS_BloodDonors_Male,200819_Canada_CBS_BloodDonors_Female_Adjusted,200819_Canada_CBS_BloodDonors_Female,200819_Canada_CBS_BloodDonors_17-24_Adjusted,200819_Canada_CBS_BloodDonors_17-24,200819_Canada_CBS_BloodDonors_25-39_Adjusted,200819_Canada_CBS_BloodDonors_25-39,200819_Canada_CBS_BloodDonors_40-59_Adjusted,200819_Canada_CBS_BloodDonors_40-59,200819_Canada_CBS_BloodDonors_60+_Adjusted,200819_Canada_CBS_BloodDonors_60+,200819_Canada_CBS_BloodDonors_BC_Adjusted,200819_Canada_CBS_BloodDonors_BC,200819_Canada_CBS_BloodDonors_Alberta_Adjusted,200819_Canada_CBS_BloodDonors_Alberta,200819_Canada_CBS_BloodDonors_Saskatchewan_Adjusted,200819_Canada_CBS_BloodDonors_Saskatchewan,200819_Canada_CBS_BloodDonors_Manitoba_Adjusted,200819_Canada_CBS_BloodDonors_Manitoba,200819_Canada_CBS_BloodDonors_Ontario_Adjusted,200819_Canada_CBS_BloodDonors_Ontario,200819_Canada_CBS_BloodDonors_NewBrunswick_Adjusted,200819_Canada_CBS_BloodDonors_NewBrunswick,200819_Canada_CBS_BloodDonors_NovaScotia_Adjusted,200819_Canada_CBS_BloodDonors_NovaScotia,200819_Canada_CBS_BloodDonors_PEI,200819_Canada_CBS_BloodDonors_N&L_Adjusted,200819_Canada_CBS_BloodDonors_N&L,200819_Canada_CBS_BloodDonors_Vancouver_Adjusted,200819_Canada_CBS_BloodDonors_Vancouver,200819_Canada_CBS_BloodDonors_Calgary_Adjusted,200819_Canada_CBS_BloodDonors_Calgary,200819_Canada_CBS_BloodDonors_Edmonton_Adjusted,200819_Canada_CBS_BloodDonors_Edmonton,200819_Canada_CBS_BloodDonors_Ottawa_Adjusted,200819_Canada_CBS_BloodDonors_Ottawa,200819_Canada_CBS_BloodDonors_Toronto_Adjusted,200819_Canada_CBS_BloodDonors_Toronto,200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers,200826_NewYorkCity_JacobiMedicalCenter_AmbulatoryCare,200826_NewYorkCity_JacobiMedicalCenter_Behavioral/Psychiatry,200826_NewYorkCity_JacobiMedicalCenter_CriticalCare/ICU,200826_NewYorkCity_JacobiMedicalCenter_EmergencyDepartment,200826_NewYorkCity_JacobiMedicalCenter_Inpatient,200826_NewYorkCity_JacobiMedicalCenter_NA,200826_NewYorkCity_JacobiMedicalCenter_OBGyn,200826_NewYorkCity_JacobiMedicalCenter_OtherHealthcareWorker,200826_NewYorkCity_JacobiMedicalCenter_TraumaService,200826_NewYorkCity_JacobiMedicalCenter_Asymptomatic,200826_NewYorkCity_JacobiMedicalCenter_SymptomaticNegPCR,200826_NewYorkCity_JacobiMedicalCenter_Symptomatic,200901_Mumbai_UChicago_Slums_Matunga,200901_Mumbai_UChicago_NonSlums_Matunga,200901_Mumbai_UChicago_Slums_TestAdjusted,200901_Mumbai_UChicago_NonSlums,200901_Mumbai_UChicago_Slums,200901_Mumbai_UChicago_Slums_Matunga_TestAdjusted,200901_Mumbai_UChicago_NonSlums_TestAdjusted,200901_Mumbai_UChicago_NonSlums_Matunga_TestAdjusted,200901_Mumbai_UChicago_Slums_ChemburWest,200901_Mumbai_UChicago_Slums_ChemburWest_TestAdjusted,200901_Mumbai_UChicago_NonSlums_ChemburWest,200901_Mumbai_UChicago_NonSlums_ChemburWest_TestAdjusted,200901_Mumbai_UChicago_Slums_Dahisar,200901_Mumbai_UChicago_Slums_Dahisar_TestAdjusted,200901_Mumbai_UChicago_NonSlums_Dahisar,200901_Mumbai_UChicago_NonSlums_Dahisar_TestAdjusted,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_AbbottCLIA,200817_Ireland_HPSC_genpop_12-19_Dublin_adj,200817_Ireland_HPSC_genpop_12-39_Sligo_adj,200817_Ireland_HPSC_genpop_20-29_Dublin_adj,200817_Ireland_HPSC_genpop_30-39_Dublin_adj,200817_Ireland_HPSC_genpop_40-49_Dublin_adj,200817_Ireland_HPSC_genpop_40-69_Sligo_adj,200817_Ireland_HPSC_genpop_50-59_Dublin_adj,200817_Ireland_HPSC_genpop_60-69_Dublin_adj,200817_Ireland_HPSC_genpop_females,200817_Ireland_HPSC_genpop_females_Sligo_adj,200817_Ireland_HPSC_genpop_females_Sligo_adj,200817_Ireland_HPSC_genpop_males,200817_Ireland_HPSC_genpop_males_Dublin_adj,200817_Ireland_HPSC_genpop_males_Sligo_adj,200507_Boise_UniversityofWashington_GenPopAge60-69"
Abbott Laboratories - SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,1,140,Not reported,2,SARS-CoV-2 IgG,Abbott Laboratories,,Not available,Not available,Hospital,Italy,Rome,Confirmed COVID-19 cases and negative controls (unclear if all symptomatic),Retrospective set,RT-PCR,Not available,Not available,Antibody,Indirect immunoassay,Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,140,Not available,Not available,Not available,66.7,100,https://reader.elsevier.com/reader/sd/pii/S138665322030281X?token=8DE4DDC88C125E6C74C5CD5D0AC38D87455F12400FF43F726A324662A163581A854D2D4CED41E5341237058FF51CA748,10.1016/j.jcv.2020.104539,Not available,,Abbott Laboratories - SARS-CoV-2 IgG - IgG - Serum,
Abbott Laboratories - SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,2,92,Not reported,2,SARS-CoV-2 IgG,Abbott Laboratories,,Not available,Not available,Hospital,Canada,Not available,Confirmed COVID-19 cases and pre-pandemic controls,Retrospective set,RT-PCR,Not available,Not available,Antibody,CMIA/CLIA,Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,42,50,34,49,81,98,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,Sensitivity available for multiple groups according to time since symptom onset but categories do not match ours.,-92,Abbott Laboratories - SARS-CoV-2 IgG - IgG - Serum,
AccuBioTech Co. Ltd - Accu-Tell COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma,IgG,Plasma,1,58,Plasma,1,Accu-Tell COVID-19 IgG/IgM Rapid Test Cassette,AccuBioTech Co. Ltd,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,84.6,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,AccuBioTech Co. Ltd - Accu-Tell COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma,
AccuBioTech Co. Ltd - Accu-Tell COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma,IgM,Plasma,1,58,Plasma,1,Accu-Tell COVID-19 IgG/IgM Rapid Test Cassette,AccuBioTech Co. Ltd,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,91.7,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,AccuBioTech Co. Ltd - Accu-Tell COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma,
"Acro Biotech Inc, Rancho Cucamonga, CA, USA - Not available - IgG; IgM - Whole blood",IgG; IgM,Whole blood,1,486,Nasopharyngeal swabs,1,Not available,"Acro Biotech Inc, Rancho Cucamonga, CA, USA",,Not available,Not available,Hospital,Italy,Arezzo,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,membrane-based quanlitative immunoassay,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,73,413,27,387,37,93.7,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371578/pdf/main.pdf,https://doi.org/10.1016/j.clinbiochem.2020.07.002,Not available,-486,"Acro Biotech Inc, Rancho Cucamonga, CA, USA - Not available - IgG; IgM - Whole blood","200721_Arezzo_OspedaleSanDonato_Total,200728_Prato_SantoStefanoHospital_Overall,200728_Prato_SantoStefanoHospital_IgGIgM"
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Plasma,IgG,Plasma,1,58,Plasma,1,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,84.6,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Plasma,
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Serum,IgG,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,2,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,16,25,69.6,100,Not available,Not available,Not available,-48,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Serum,
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Serum,IgG,Serum,2,123,Serum,2,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,"Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,82,23,61,56.1,74.4,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,Days of sickness: 3 to 16 days,-123,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Serum,
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Whole blood,IgG,Whole blood,1,49,Upper respiratory specimen,1,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,17,92,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgG - Whole blood,200728_Prato_SantoStefanoHospital_IgG
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Plasma,IgM,Plasma,1,58,Plasma,1,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,76.9,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Plasma,
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Serum,IgM,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,2,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,12,25,52.2,100,Not available,Not available,Not available,-48,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Serum,
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Serum,IgM,Serum,2,123,Serum,2,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,"Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,82,19,57,46.3,69.5,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,Days of sickness: 3 to 16 days,-123,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Serum,
ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Whole blood,IgM,Whole blood,1,49,Upper respiratory specimen,1,Acro Biotech COVID-19 Rapid POC test,ACRO Biotech Inc.,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,35,85,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,ACRO Biotech Inc. - Acro Biotech COVID-19 Rapid POC test - IgM - Whole blood,"200721_Arezzo_OspedaleSanDonato_AsymptomaticCohort,200721_Arezzo_OspedaleSanDonato_Total_IgG,200721_Arezzo_OspedaleSanDonato_Total_IgM,200728_Prato_SantoStefanoHospital_IgM"
"Anhui Deep Blue Medical Technology Co., Ltd - Not available - IgG; IgM - Serum",IgG; IgM,Serum,1,625,Not available,1,Not available,"Anhui Deep Blue Medical Technology Co., Ltd",Institute of Laboratory Medicine - Semmelweis University,Not available,Not available,Hospital,Hungary,Budapest,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,21,604,7,440,33.3,72.8,https://akjournals.com/view/journals/650/161/20/article-p807.xml,10.1556/650.2020.31859,Not available,-625,"Anhui Deep Blue Medical Technology Co., Ltd - Not available - IgG; IgM - Serum",
"Anhui Deep Blue Medical Technology Co., Ltd - SARS-CoV-2 IgG Ab Rapid Test - IgG - Serum",IgG,Serum,1,90,Not available,1,SARS-CoV-2 IgG Ab Rapid Test,"Anhui Deep Blue Medical Technology Co., Ltd",,Not available,Not available,Hospital,Canada,Not available,Not available,Not available,Not available,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,21,50,52.5,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,"Anhui Deep Blue Medical Technology Co., Ltd - SARS-CoV-2 IgG Ab Rapid Test - IgG - Serum",
"Anhui Deep Blue Medical Technology Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgM - Serum",IgM,Serum,1,90,Not reported,1,SARS-CoV-2 IgM/IgG Ab Rapid Test,"Anhui Deep Blue Medical Technology Co., Ltd",,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,27,49,67.5,98,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,"Anhui Deep Blue Medical Technology Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgM - Serum",
Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgG - Serum,IgG,Serum,1,187,Nasopharyngeal swabs,1,One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test,Artron Laboratories Inc.,Department of Clinical Laboratory - Saitama Medical University,Not available,Not available,Hospital,Japan,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,A03-51-322,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,139,48,20,48,14.4,100,https://www.medrxiv.org/content/10.1101/2020.04.22.20075564v1.full.pdf,10.1101/2020.04.22.20075564,Specificity was calculated using stored serum samples collected in early 2019,-187,Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgG - Serum,"200721_Egypt_CairoUniversity_TotalHCW_IgG,200721_Egypt_CairoUniversity_Physician_IgG,200721_Egypt_CairoUniversity_Nurse_IgG,200721_Egypt_CairoUniversity_TransporterCleaner_IgG,200721_Egypt_CairoUniversity_Admin_IgG"
Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,47,Respiratory specimen,1,One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test,Artron Laboratories Inc.,"Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut",Not available,Not available,Public Health,Denmark,Copenhagen,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,A03-51-322,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,17,25,17,83.3,100,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf,10.1101/2020.04.09.20056325,"Weak signals for IgM and IgG, together or separate, was considered positive.",-47,Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgG; IgM - Plasma; Serum,
Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgG; IgM - Serum,IgG; IgM,Serum,1,187,Nasopharyngeal swabs,1,One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test,Artron Laboratories Inc.,Department of Clinical Laboratory - Saitama Medical University,Not available,Not available,Hospital,Japan,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,A03-51-322,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,139,48,60,48,43.2,100,https://www.medrxiv.org/content/10.1101/2020.04.22.20075564v1.full.pdf,10.1101/2020.04.22.20075564,Specificity was calculated using stored serum samples collected in early 2019,-187,Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgG; IgM - Serum,"200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers,200526_AlzintanCity_Al-ZintanUniversity_GenPopulation,200526_AlzintanCity_Al-ZintanUniversity_HealthCare_Age40orUnder,200526_AlzintanCity_Al-ZintanUniversity_HealthCare_AgeOver40,200526_AlzintanCity_Al-ZintanUniversity_HealthCare_Female,200526_AlzintanCity_Al-ZintanUniversity_HealthCare_Male,200526_AlzintanCity_Al-ZintanUniversity_GenPop_Female,200526_AlzintanCity_Al-ZintanUniversity_GenPop_Male,200526_AlzintanCity_Al-ZintanUniversity_GenPop_Age40orUnder,200526_AlzintanCity_Al-ZintanUniversity_GenPop_AgeOver40,200526_AlzintanCity_Al-ZintanUniversity_GenPopulation_LocalResidents,200526_AlzintanCity_Al-ZintanUniversity_GenPopulation_InternationalWorkers,200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers_Obsgyn,200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers_Surgery,200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers_PrivateClinic,200721_Egypt_CairoUniversity_TotalHCW_IgGIgM,200721_Egypt_CairoUniversity_PhysicianI_IgGIgM,200721_Egypt_CairoUniversity_Nurse_IgGIgM,200721_Egypt_CairoUniversity_TransporterCleaner_IgGIgM,200721_Egypt_CairoUniversity_Admin_IgGIgM,200721_Egypt_CairoUniversity_TotalHCW_Overall,200721_Egypt_CairoUniversity_Physician_Overall,200721_Egypt_CairoUniversity_Admin_Overall,200721_Egypt_CairoUniversity_TransporterCleaner_Overall,200721_Egypt_CairoUniversity_Nurse_Overall"
Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgM - Serum,IgM,Serum,1,187,Nasopharyngeal swabs,1,One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test,Artron Laboratories Inc.,Department of Clinical Laboratory - Saitama Medical University,Not available,Not available,Hospital,Japan,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,A03-51-322,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,139,48,60,47,43.2,97.9,https://www.medrxiv.org/content/10.1101/2020.04.22.20075564v1.full.pdf,10.1101/2020.04.22.20075564,Specificity was calculated using stored serum samples collected in early 2019,-187,Artron Laboratories Inc. - One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test - IgM - Serum,"200721_Egypt_CairoUniversity_TotalHCWIgM,200721_Egypt_CairoUniversity_Physician_IgM,200721_Egypt_CairoUniversity_Nurse_IgM,200721_Egypt_CairoUniversity_TransporterCleaner_IgM,200721_Egypt_CairoUniversity_Admin_IgM"
"Assure Tech. (Hangzhou) Co., Ltd - COVID-19 IgG/IgM Rapid Test Device - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,45,Not available,1,COVID-19 IgG/IgM Rapid Test Device,"Assure Tech. (Hangzhou) Co., Ltd","Institute for Medical Virology, University Hospital, Goethe University",Moderate; Severe,Not available,Hospital,Germany,Frankfurt,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,COV-W32M,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,32,13,25,13,78.1,100,https://www.biorxiv.org/content/biorxiv/early/2020/05/10/2020.05.08.085506.full.pdf,10.1101/2020.05.08.085506,Control: samples of individuals with selected PCR- or serologically-confirmed infections,-45,"Assure Tech. (Hangzhou) Co., Ltd - COVID-19 IgG/IgM Rapid Test Device - IgG; IgM - Plasma; Serum",
Augurix diagnostic - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody - IgG - Plasma; Serum,IgG,Plasma; Serum,1,172,Not available,1,One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody,Augurix diagnostic,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,CG2057,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,105,67,Not available,Not available,67,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-172,Augurix diagnostic - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody - IgG - Plasma; Serum,
Augurix diagnostic - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody - IgM - Plasma; Serum,IgM,Plasma; Serum,1,172,Not available,1,One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody,Augurix diagnostic,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,CG2057,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,105,67,Not available,Not available,67,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-172,Augurix diagnostic - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody - IgM - Plasma; Serum,
Aurora Biomed Inc - COVID-19 IgG/IgM Rapid Test - IgG - Plasma; Serum,IgG,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test,Aurora Biomed Inc,Frederick National Laboratory for Cancer Research,Not available,COVID20200424,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,23,80,76.7,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3258-a001.pdf,Not available,Not available,-110,Aurora Biomed Inc - COVID-19 IgG/IgM Rapid Test - IgG - Plasma; Serum,
Aurora Biomed Inc - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test,Aurora Biomed Inc,Frederick National Laboratory for Cancer Research,Not available,COVID20200424,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,23,80,76.7,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3258-a001.pdf,Not available,Not available,-110,Aurora Biomed Inc - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Plasma; Serum,
Aurora Biomed Inc - COVID-19 IgG/IgM Rapid Test - IgM - Plasma; Serum,IgM,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test,Aurora Biomed Inc,Frederick National Laboratory for Cancer Research,Not available,COVID20200424,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,20,80,66.7,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3258-a001.pdf,Not available,Not available,-110,Aurora Biomed Inc - COVID-19 IgG/IgM Rapid Test - IgM - Plasma; Serum,
AutoBio Diagnostics - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum,IgG; IgM,Serum,1,497,Nasopharyngeal swabs,1,2019-nCoV IgG/IgM Rapid Test Cassette,AutoBio Diagnostics,Bacteriology and Hygiene Bicetre Laboratory Hospital,Mild; Moderate; Severe; Critical,21C22-J01,Hospital,France,Kremlin-Bicêtre,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection,RTA0202,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,249,248,184,233,73.9,94,Not available,Not available,Not available,-497,AutoBio Diagnostics - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum,
AutoBio Diagnostics - Anti-SARS-CoV-2 Rapid Test - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,62,Respiratory specimen,1,Anti-SARS-CoV-2 Rapid Test,AutoBio Diagnostics,"Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut",Not available,Not available,Public Health,Denmark,Copenhagen,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,RTA0204,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,32,28,32,93.3,100,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf,10.1101/2020.04.09.20056325,"Weak signals for IgM and IgG, together or separate, was considered positive.",-62,AutoBio Diagnostics - Anti-SARS-CoV-2 Rapid Test - IgG; IgM - Plasma; Serum,
"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgG - Serum",IgG,Serum,1,200,Not available,1,Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold),"Avioq Bio-Tech Co., Ltd",Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,88,69,68.8,95.8,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgG - Serum",
"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgG; IgM - Serum",IgG; IgM,Serum,1,482,Nasopharyngeal swabs,2,Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold),"Avioq Bio-Tech Co., Ltd",Bacteriology and Hygiene Bicetre Laboratory Hospital,Mild; Moderate; Severe; Critical,20200201,Hospital,France,Kremlin-Bicêtre,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,244,238,166,225,68,94.5,Not available,Not available,Not available,-482,"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgG; IgM - Serum",
"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgG; IgM - Serum",IgG; IgM,Serum,2,200,Not available,2,Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold),"Avioq Bio-Tech Co., Ltd",Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,88,69,68.8,95.8,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgG; IgM - Serum",
"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgM - Serum",IgM,Serum,1,200,Not available,1,Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold),"Avioq Bio-Tech Co., Ltd",Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,88,69,68.8,95.8,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,"Avioq Bio-Tech Co., Ltd - Novel Coronavirus (2019-nCov)Antibody IgG/IgM Assay Kit (Colloidal Gold) - IgM - Serum",
"Beijing Diagreat Biotechnologies Co., Ltd - 2019-nCoV IgG/IgM Rapid Testing Kit - IgG; IgM - Whole blood",IgG; IgM,Whole blood,1,37,Nasopharyngeal swabs; Bronchial aspirate,1,2019-nCoV IgG/IgM Rapid Testing Kit,"Beijing Diagreat Biotechnologies Co., Ltd","Dipartimento di Medicina Clinica e Sperimentale, University of Catania,",Not available,Not available,Public Health,Italy,Catania,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,14,19,13,82.6,92.9,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177053/pdf/main.pdf,10.1016/j.jinf.2020.04.022,The time from symptoms onset to antibody testing ranged from 3 to 34 days.,-37,"Beijing Diagreat Biotechnologies Co., Ltd - 2019-nCoV IgG/IgM Rapid Testing Kit - IgG; IgM - Whole blood",
"Beijing Hotgen Biotech Co., Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum",IgG,Serum,1,314,Nasopharyngeal swabs,1,2019-nCoV IgG/IgM Antibody Detection Kit,"Beijing Hotgen Biotech Co., Ltd",General Hospital of the Central Theater Command of the People’s Liberation Army (PLA),Not available,Not available,Hospital,China,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Triplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,214,100,159,100,74.3,100,https://jcm.asm.org/content/jcm/early/2020/03/27/JCM.00461-20.full.pdf,10.1128/jcm.00461-20,"A median of 15 d.p.o. (range, 0–55 days)",-314,"Beijing Hotgen Biotech Co., Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum",
"Beijing Hotgen Biotech Co., Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum",IgG; IgM,Serum,1,314,Nasopharyngeal swabs,1,2019-nCoV IgG/IgM Antibody Detection Kit,"Beijing Hotgen Biotech Co., Ltd",General Hospital of the Central Theater Command of the People’s Liberation Army (PLA),Not available,Not available,Hospital,China,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Triplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,214,100,176,100,82.2,100,https://jcm.asm.org/content/jcm/early/2020/03/27/JCM.00461-20.full.pdf,10.1128/jcm.00461-20,"A median of 15 d.p.o. (range, 0–55 days)",-314,"Beijing Hotgen Biotech Co., Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum",
"Beijing Hotgen Biotech Co., Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum",IgM,Serum,1,314,Nasopharyngeal swabs,1,2019-nCoV IgG/IgM Antibody Detection Kit,"Beijing Hotgen Biotech Co., Ltd",General Hospital of the Central Theater Command of the People’s Liberation Army (PLA),Not available,Not available,Hospital,China,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Triplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,214,100,165,100,77.1,100,https://jcm.asm.org/content/jcm/early/2020/03/27/JCM.00461-20.full.pdf,10.1128/jcm.00461-20,"A median of 15 d.p.o. (range, 0–55 days)",-314,"Beijing Hotgen Biotech Co., Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - IgM - Not available",IgM,Not available,1,331,Not available,1,Wantai SARS-CoV-2 Ab ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",,Not available,Not available,Public Health,Netherlands,Rotterdam,Asymptomatic individuals,Not available,Immunoassay; PRNT,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,185,146,167,144,90.3,98.6,https://www.nature.com/articles/s41467-020-17317-y.pdf,https://doi.org/10.1038/s41467-020-17317-y,Not available,-331,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - IgM - Not available",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma",Total Ig,Plasma,1,386,Respiratory specimen,2,Wantai SARS-CoV-2 Ab ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Shenzhen Third People’s Hospital,Critical; Not available,Not available,Hospital,China,Shenzhen,Confirmed COVID-19 patients,Prospectively collected set,Clinical examination; Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,173,213,161,211,93.1,99.1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184337/pdf/ciaa344.pdf,10.1093/cid/ciaa344,Not available,-386,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma","200609_Milan_uniMilan_TotalAb,200714_Shijiazhuang_PekingUnionMedicalCollege_BloodDonors,200714_Shenzhen_PekingUnionMedicalCollege_BloodDonors,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Male,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Female,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Age18-25,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Age26-35,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Age36-45,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Age46-55,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Age>55,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_BloodTypeA,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_BloodTypeB,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_BloodTypeO,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_BloodTypeAB,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_RH(D)BloodType+,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_RH(D)BloodType-,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_EthnicityHan,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_EthnicityNonHan,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationHCW,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationCivilWorker,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationTeacher,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationStudent,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationOfficeWorker,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationWorker,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationMilitary,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationFarmer,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_OccupationOther,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_EducationMaster/Doctorate,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_EducationBachelor,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_EducationCollege,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_EducationHighSchool,200714_Wuhan_PekingUnionMedicalCollege_BloodDonors_Education<HighSchool,200812_CentralDenmark_AarhusUniversityHospital_HCW_PopAdjTestAdj,200812_CentralDenmark_AarhusUniversityHospital_HCW,200812_CentralDenmark_AarhusUniversityHospital_HCW_<29,200812_CentralDenmark_AarhusUniversityHospital_HCW_30-39,200812_CentralDenmark_AarhusUniversityHospital_HCW_40-49,200812_CentralDenmark_AarhusUniversityHospital_HCW_50-59,200812_CentralDenmark_AarhusUniversityHospital_HCW_>60,200812_CentralDenmark_AarhusUniversityHospital_HCW_Male,200812_CentralDenmark_AarhusUniversityHospital_HCW_Female,200812_CentralDenmark_AarhusUniversityHospital_HCW_<29_PopAdjTestAdj,200812_CentralDenmark_AarhusUniversityHospital_HCW_>60PopAdjTestAdj,200812_CentralDenmark_AarhusUniversityHospital_HCW_30-39_PopAdjTestAdj,200812_CentralDenmark_AarhusUniversityHospital_HCW_40-49_PopAdjTestAdj,200812_CentralDenmark_AarhusUniversityHospital_HCW_50-59_PopAdjTestAdj,200812_CentralDenmark_AarhusUniversityHospital_HCW_Female_PopAdjTestAdj,200812_CentralDenmark_AarhusUniversityHospital_HCW_Male_PopAdjTestAdj,200812_WestCentralDenmark_AarhusUniversityHospital_BloodDonors,200812_EastCentralDenmark_AarhusUniversityHospital_BloodDonors"
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma",Total Ig,Plasma,2,380,Not available,2,Wantai SARS-CoV-2 Ab ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangshou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,300,78,300,97.5,100,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-380,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma; Serum",Total Ig,Plasma; Serum,1,177,Respiratory specimen,2,Wantai SARS-CoV-2 Ab ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Kaiser-Franz-Josef Hospital,Mild; Moderate; Severe,Not available,Hospital,Austria,Vienna,Symptomatic patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio >1.1,Ratio <0.9,Not available,Overall,77,100,56,97,72.7,97,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa305/5849070,10.1093/infdis/jiaa305,Not available,-177,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma; Serum","201112_Netherlands_AmsterdamUMC_GenPop_SeroconvertedTrue,201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test,201112_Netherlands_AmsterdamUMC_GenPop_60to72,201112_Netherlands_AmsterdamUMC_GenPop_51to60,201112_Netherlands_AmsterdamUMC_GenPop_41to50,201112_Netherlands_AmsterdamUMC_GenPop_31to40,201112_Netherlands_AmsterdamUMC_GenPop_18to30,201112_Netherlands_AmsterdamUMC_GenPop_Men,201112_Netherlands_AmsterdamUMC_GenPop_Women,201112_Netherlands_AmsterdamUMC_GenPop_SeroconvertedAssumed"
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma; Serum",Total Ig,Plasma; Serum,2,112,Respiratory specimen,2,Wantai SARS-CoV-2 Ab ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd","Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut",Not available,Not available,Public Health,Denmark,Copenhagen,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,WS-1096,Not available,Not available,Not available,Not available,As per manufacturer's instructions,As per manufacturer's instructions,Not available,Overall,30,82,28,82,93.3,100,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf,10.1101/2020.04.09.20056325,Not available,-112,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Plasma; Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Serum",Total Ig,Serum,1,223,Nasopharyngeal swabs; Oropharyngeal swabs; Sputum,2,Wantai SARS-CoV-2 Ab ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Department of Medical Microbiology and Infection Control,Not available,Not available,Hospital,Netherlands,Rotterdam,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,95,128,59,125,62.1,97.7,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30305-0/pdf,10.1016/j.cmi.2020.05.028,Median time from symptom onset to sample collection: 7 days (IQR 4-14 days),-223,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Serum",Total Ig,Serum,2,226,Plasma; Serum; Not available,2,Wantai SARS-CoV-2 Ab ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd","Department of Viroscience, Erasmus Medical Centre",Not available,Not available,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,76,150,75,149,98.7,99.3,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-226,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab ELISA - Total Ig - Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Plasma",Total Ig,Plasma,1,289,Not available,1,Wantai SARS-CoV-2 Ab Rapid Test,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangshou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,209,78,199,97.5,95.2,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-289,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Plasma",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Plasma; Serum",Total Ig,Plasma; Serum,1,177,Respiratory specimen,1,Wantai SARS-CoV-2 Ab Rapid Test,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Kaiser-Franz-Josef Hospital,Mild; Moderate; Severe,Not available,Hospital,Austria,Vienna,Symptomatic patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,77,100,48,98,62.3,98,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa305/5849070,10.1093/infdis/jiaa305,Not available,-177,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Plasma; Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Serum",Total Ig,Serum,1,25,Nasopharyngeal swabs; Oropharyngeal swabs; Sputum,1,Wantai SARS-CoV-2 Ab Rapid Test,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Department of Medical Microbiology and Infection Control,Not available,Not available,Hospital,Netherlands,Rotterdam,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,20,5,10,5,50,100,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30305-0/pdf,10.1016/j.cmi.2020.05.028,Not available,-25,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Whole blood",Total Ig,Whole blood,1,49,Upper respiratory specimen,1,Wantai SARS-CoV-2 Ab Rapid Test,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,4,96,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 Ab Rapid Test - Total Ig - Whole blood",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgG ELISA - IgG - Plasma",IgG,Plasma,1,370,Respiratory specimen,2,Wantai SARS-CoV-2 IgG ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Shenzhen Third People’s Hospital,Critical; Not available,Not available,Hospital,China,Shenzhen,Confirmed COVID-19 patients,Prospectively collected set,Clinical examination; Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,173,197,112,195,64.7,99,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184337/pdf/ciaa344.pdf,10.1093/cid/ciaa344,Not available,-370,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgG ELISA - IgG - Plasma",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgG ELISA - IgG - Plasma",IgG,Plasma,2,180,Not available,2,Wantai SARS-CoV-2 IgG ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangshou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,100,71,100,88.8,100,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-180,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgG ELISA - IgG - Plasma",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgG Rapid Test - IgG - Plasma",IgG,Plasma,1,289,Not available,1,Wantai SARS-CoV-2 IgG Rapid Test,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangshou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,209,69,208,86.2,99.5,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-289,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgG Rapid Test - IgG - Plasma",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Plasma",IgM,Plasma,1,386,Respiratory specimen,2,Wantai SARS-CoV-2 IgM ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Shenzhen Third People’s Hospital,Critical; Not available,Not available,Hospital,China,Shenzhen,Confirmed COVID-19 patients,Prospectively collected set,Clinical examination; Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,173,213,143,210,82.7,98.6,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184337/pdf/ciaa344.pdf,10.1093/cid/ciaa344,Not available,-386,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Plasma","200609_Milan_uniMilan_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_>/=2ChronicDiseases_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_0-1ChronicDiseases_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Açores_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age1-9_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age10-19_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age20-39_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age40-59_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_AgeOver60_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Alentejo_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Algarve_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Central_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Female_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_HighSchool_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_LisboaeValedoTejo_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Madeira_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Male_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_NoEducationorFirstCycleofEducation_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_North_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Overall_Popadj_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Secondorthirdcycleofbasiceducation_IgM,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_UniversityEducation_IgM"
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Plasma",IgM,Plasma,2,380,Not available,2,Wantai SARS-CoV-2 IgM ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangshou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,300,74,300,92.5,100,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-380,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Plasma",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Plasma; Serum",IgM,Plasma; Serum,1,177,Respiratory specimen,1,Wantai SARS-CoV-2 IgM ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",Kaiser-Franz-Josef Hospital,Mild; Moderate; Severe,Not available,Hospital,Austria,Vienna,Symptomatic patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio >1.1,Ratio <0.9,Not available,Overall,77,100,53,97,68.8,97,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa305/5849070,10.1093/infdis/jiaa305,Not available,-177,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Plasma; Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Serum",IgM,Serum,1,226,Plasma; Serum; Not available,1,Wantai SARS-CoV-2 IgM ELISA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd","Department of Viroscience, Erasmus Medical Centre",Not available,Not available,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,76,150,68,148,89.5,98.7,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-226,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM ELISA - IgM - Serum",
"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM Rapid Test - IgM - Plasma",IgM,Plasma,1,289,Not available,1,Wantai SARS-CoV-2 IgM Rapid Test,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangshou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,209,71,205,88.8,98.1,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-289,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd - Wantai SARS-CoV-2 IgM Rapid Test - IgM - Plasma",
Bio Marketing Diagnostics (or Akiva) - 2019-n-CoV IgG/IgM rapid test cassette (LaboOn Time) - IgG - Serum,IgG,Serum,1,200,Not available,1,2019-n-CoV IgG/IgM rapid test cassette (LaboOn Time),Bio Marketing Diagnostics (or Akiva),Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,86,72,67.2,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,Bio Marketing Diagnostics (or Akiva) - 2019-n-CoV IgG/IgM rapid test cassette (LaboOn Time) - IgG - Serum,
Bio Marketing Diagnostics (or Akiva) - 2019-n-CoV IgG/IgM rapid test cassette (LaboOn Time) - IgM - Serum,IgM,Serum,1,200,Not available,1,2019-n-CoV IgG/IgM rapid test cassette (LaboOn Time),Bio Marketing Diagnostics (or Akiva),Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,62,72,48.4,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,Bio Marketing Diagnostics (or Akiva) - 2019-n-CoV IgG/IgM rapid test cassette (LaboOn Time) - IgM - Serum,
Biolidics Ltd - 2019 nCoV IgM/IgG Detection Kit - IgG - Serum,IgG,Serum,1,90,Not reported,1,2019 nCoV IgM/IgG Detection Kit,Biolidics Ltd,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,31,50,77.5,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,Biolidics Ltd - 2019 nCoV IgM/IgG Detection Kit - IgG - Serum,
Biolidics Ltd - 2019 nCoV IgM/IgG detection kit - IgM - Serum,IgM,Serum,1,90,Not available,1,2019 nCoV IgM/IgG detection kit,Biolidics Ltd,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,7,48,17.5,96,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,Biolidics Ltd - 2019 nCoV IgM/IgG detection kit - IgM - Serum,
"BioMedomics, Inc. - COVID-19 IgM-IgG Dual Antibody Rapid Test - IgG - Plasma; Serum",IgG,Plasma; Serum,1,235,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 IgM-IgG Dual Antibody Rapid Test,"BioMedomics, Inc.",University of California,Not available,2020032103,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,51-002-20,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,107,71,103,55.5,96.3,https://covidtestingproject.org/,Not available,Some control band inconsistency,-235,"BioMedomics, Inc. - COVID-19 IgM-IgG Dual Antibody Rapid Test - IgG - Plasma; Serum","200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_IgGOnly_UnAdj,200715_Massachusetts_HarvardMedicalSchool_Overall_IgG,200715_Massachusetts_HarvardMedicalSchool_Residents_IgG,200715_Massachusetts_HarvardMedicalSchool_Staff_IgG,200729_Milan_UniversitadegliStudidiMilano_Overall_IgG,200729_Milan_UniversitadegliStudidiMilano_Male_IgG,200729_Milan_UniversitadegliStudidiMilano_Female_IgG,200729_Milan_UniversitadegliStudidiMilano_20_29_IgG,200729_Milan_UniversitadegliStudidiMilano_30_39_IgG,200729_Milan_UniversitadegliStudidiMilano_40_49_IgG,200729_Milan_UniversitadegliStudidiMilano_50_59_IgG,200729_Milan_UniversitadegliStudidiMilano_60_69_IgG,200729_Milan_UniversitadegliStudidiMilano_Contact_IgG,200729_Milan_UniversitadegliStudidiMilano_NoContact_IgG,200729_Milan_UniversitadegliStudidiMilano_Physician_IgG,200729_Milan_UniversitadegliStudidiMilano_Nurse_IgG,200729_Milan_UniversitadegliStudidiMilano_OtherStaff_IgG"
"BioMedomics, Inc. - COVID-19 IgM-IgG Dual Antibody Rapid Test - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,235,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 IgM-IgG Dual Antibody Rapid Test,"BioMedomics, Inc.",University of California,Not available,2020032103,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,51-002-20,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,107,83,93,64.8,86.9,https://covidtestingproject.org/,Not available,Some control band inconsistency,-235,"BioMedomics, Inc. - COVID-19 IgM-IgG Dual Antibody Rapid Test - IgG; IgM - Plasma; Serum","200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_IgGANDIgM_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Age21-30_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Age31-40_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Age41-50_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_AgeOlder51_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Male_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Female_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_White_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Black_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Mixed_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Other_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_EthnicityHispanic_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_EthnicityNonHispanic_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_NormalBMI_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_OverweightBMI_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_ObeseBMI_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_HighSchoolGED_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_SomeCollege_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_CollegeGrad_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_CurrentSmoker_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_FormerSmoker_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_NonSmoker_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_Firefighter/paramedic/EMT_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_Driver/Operator_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_Inspector/FireInvestigator_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_Lieutenant_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_Captain_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_Battalion/deputy/divisionChief_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_Asymptomatic_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_CovidContactYes_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_CovidContactNo_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_CovidContactNotSure_UnAdj,2000806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_TimeSpentCovidCase5-30min_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_TimeSpentCovidCase>30min_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_TimeSpentCovidCase_YesPPE_UnAdj,200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_TimeSpentCovidCase_NoPPE_UnAdj,200715_Massachusetts_HarvardMedicalSchool_Residents_IgG/IgM,200715_Massachusetts_HarvardMedicalSchool_Staff_IgG/IgM,200715_Massachusetts_HarvardMedicalSchool_Overall_IgG/IgM,200715_Massachusetts_HarvardMedicalSchool_Overall_IgG+IgM,200715_Massachusetts_HarvardMedicalSchool_Staff_IgG+IgM,200715_Massachusetts_HarvardMedicalSchool_Residents_IgG+IgM"
"BioMedomics, Inc. - COVID-19 IgM-IgG Dual Antibody Rapid Test - IgM - Plasma; Serum",IgM,Plasma; Serum,1,235,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 IgM-IgG Dual Antibody Rapid Test,"BioMedomics, Inc.",University of California,Not available,2020032103,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,51-002-20,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,107,79,94,61.7,87.9,https://covidtestingproject.org/,Not available,Some control band inconsistency,-235,"BioMedomics, Inc. - COVID-19 IgM-IgG Dual Antibody Rapid Test - IgM - Plasma; Serum","200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_IgMOnly_UnAdj,200715_Massachusetts_HarvardMedicalSchool_Overall_IgM,200715_Massachusetts_HarvardMedicalSchool_Residents_IgM,200715_Massachusetts_HarvardMedicalSchool_Staff_IgM,200729_Milan_UniversitadegliStudidiMilano_Overall_IgM,200729_Milan_UniversitadegliStudidiMilano_Male_IgM,200729_Milan_UniversitadegliStudidiMilano_Female_IgM,200729_Milan_UniversitadegliStudidiMilano_20_29_IgM,200729_Milan_UniversitadegliStudidiMilano_30_39_IgM,200729_Milan_UniversitadegliStudidiMilano_40_49_IgM,200729_Milan_UniversitadegliStudidiMilano_50_59_IgM,200729_Milan_UniversitadegliStudidiMilano_60_69_IgM,200729_Milan_UniversitadegliStudidiMilano_Contact_IgM,200729_Milan_UniversitadegliStudidiMilano_NoContact_IgM,200729_Milan_UniversitadegliStudidiMilano_Physician_IgM,200729_Milan_UniversitadegliStudidiMilano_Nurse_IgM,200729_Milan_UniversitadegliStudidiMilano_OtherStaff_IgM"
"BioMedomics, Inc. - COVID-19 IgM-IgG Rapid Test kit - IgG - Plasma; Serum",IgG,Plasma; Serum,1,100,Not available,1,COVID-19 IgM-IgG Rapid Test kit,"BioMedomics, Inc.",Frederick National Laboratory for Cancer Research,Not available,51-200404,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,22,70,73.3,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3248-a001.pdf,Not available,Not available,-100,"BioMedomics, Inc. - COVID-19 IgM-IgG Rapid Test kit - IgG - Plasma; Serum",
"BioMedomics, Inc. - COVID-19 IgM-IgG Rapid Test kit - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,100,Not available,1,COVID-19 IgM-IgG Rapid Test kit,"BioMedomics, Inc.",Frederick National Laboratory for Cancer Research,Not available,51-200404,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,29,68,96.7,97.1,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3248-a001.pdf,Not available,Not available,-100,"BioMedomics, Inc. - COVID-19 IgM-IgG Rapid Test kit - IgG; IgM - Plasma; Serum",
"BioMedomics, Inc. - COVID-19 IgM-IgG Rapid Test kit - IgM - Plasma; Serum",IgM,Plasma; Serum,1,100,Not available,1,COVID-19 IgM-IgG Rapid Test kit,"BioMedomics, Inc.",Frederick National Laboratory for Cancer Research,Not available,51-200404,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,26,68,86.7,97.1,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3248-a001.pdf,Not available,Not available,-100,"BioMedomics, Inc. - COVID-19 IgM-IgG Rapid Test kit - IgM - Plasma; Serum",
Biomerica Inc - Covid-19 IgG/IgM Antibody Test - IgG - Serum,IgG,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,1,Covid-19 IgG/IgM Antibody Test,Biomerica Inc,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,16,25,69.6,100,Not available,Not available,Not available,-48,Biomerica Inc - Covid-19 IgG/IgM Antibody Test - IgG - Serum,
Biomerica Inc - Covid-19 IgG/IgM Antibody Test - IgM - Serum,IgM,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,1,Covid-19 IgG/IgM Antibody Test,Biomerica Inc,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,4,25,17.4,100,Not available,Not available,Not available,-48,Biomerica Inc - Covid-19 IgG/IgM Antibody Test - IgM - Serum,
Boson Biotech - Rapid 2019-nCoV IgG/IgM Combo Test Card - IgG; IgM - Serum,IgG; IgM,Serum,1,25,Nasopharyngeal swabs; Oropharyngeal swabs; Sputum,1,Rapid 2019-nCoV IgG/IgM Combo Test Card,Boson Biotech,Department of Medical Microbiology and Infection Control,Not available,Not available,Hospital,Netherlands,Rotterdam,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,20,5,10,5,50,100,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30305-0/pdf,10.1016/j.cmi.2020.05.028,Not available,-25,Boson Biotech - Rapid 2019-nCoV IgG/IgM Combo Test Card - IgG; IgM - Serum,
BTNX Inc. - Rapid Response COVID-19 IgG/IgM Test Cassette (Whole Blood/Serum/Plasma) - IgG - Serum; Whole blood,IgG,Serum; Whole blood,1,90,not reported,1,Rapid Response COVID-19 IgG/IgM Test Cassette (Whole Blood/Serum/Plasma),BTNX Inc.,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,27,50,67.5,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,BTNX Inc. - Rapid Response COVID-19 IgG/IgM Test Cassette (Whole Blood/Serum/Plasma) - IgG - Serum; Whole blood,
BTNX Inc. - Rapid Response COVID-19 IgG/IgM Test Cassette (Whole Blood/Serum/Plasma) - IgM - Serum; Whole blood,IgM,Serum; Whole blood,1,90,not reported,1,Rapid Response COVID-19 IgG/IgM Test Cassette (Whole Blood/Serum/Plasma),BTNX Inc.,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,20,50,50,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,BTNX Inc. - Rapid Response COVID-19 IgG/IgM Test Cassette (Whole Blood/Serum/Plasma) - IgM - Serum; Whole blood,
Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG - Serum,IgG,Serum,1,38,Nasopharyngeal swabs; Oropharyngeal swabs,2,Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test,Cellex Inc.,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,25,13,15,12,60,92.3,Not available,Not available,Not available,-38,Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG - Serum,
Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG - Serum,IgG,Serum,2,137,Plasma; Serum; Not available,2,Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test,Cellex Inc.,"Department of Viroscience, Erasmus Medical Centre",Not available,0200311WI5513C-3,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,93,44,Not available,Not available,84.4,85,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-137,Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG - Serum,
Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG; IgM - Serum,IgG; IgM,Serum,1,25,Nasopharyngeal swabs; Oropharyngeal swabs; Sputum,2,Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test,Cellex Inc.,Department of Medical Microbiology and Infection Control,Not available,Not available,Hospital,Netherlands,Rotterdam,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,20,5,4,5,20,100,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30305-0/pdf,10.1016/j.cmi.2020.05.028,Not available,-25,Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG; IgM - Serum,
Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG; IgM - Serum,IgG; IgM,Serum,2,195,Serum,2,Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test,Cellex Inc.,Viroscience Erasmus MC,Mild; Moderate; Severe,20200311WI5513C-3,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,96,99,76,98,79.2,99,Not available,Not available,Each sample was tested by one test and interpreted by two operators in parallel from Erasmus MC.,-195,Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgG; IgM - Serum,
Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgM - Serum,IgM,Serum,1,38,Nasopharyngeal swabs; Oropharyngeal swabs,3,Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test,Cellex Inc.,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,25,13,16,12,64,92.3,Not available,Not available,Not available,-38,Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgM - Serum,
Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgM - Serum,IgM,Serum,2,195,Serum,3,Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test,Cellex Inc.,Viroscience Erasmus MC,Mild; Moderate; Severe,20200311WI5513C-3,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,96,99,37,99,38.5,100,Not available,Not available,Each sample was tested by one test and interpreted by two operators in parallel from Erasmus MC.,-195,Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgM - Serum,
Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgM - Serum,IgM,Serum,3,137,Plasma; Serum; Not available,3,Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test,Cellex Inc.,"Department of Viroscience, Erasmus Medical Centre",Not available,0200311WI5513C-3,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,93,44,Not available,Not available,87.4,81,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-137,Cellex Inc. - Cellex qSARS-CoV-2 IgGIgM Cassette Rapid Test - IgM - Serum,
Cellex Inc. - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Not available,IgG; IgM,Not available,1,297,Not available,1,COVID-19 IgG/IgM Rapid Test Cassette,Cellex Inc.,,Not available,Not available,Public Health,Netherlands,Not available,Asymptomatic individuals,Not available,Immunoassay; PRNT,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,165,132,134,119,81.2,90.2,https://www.nature.com/articles/s41467-020-17317-y.pdf,Not available,Not available,-297,Cellex Inc. - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Not available,
ChemBio - DPP COVID-19 IgM/IgG System - IgG - Plasma; Serum,IgG,Plasma; Serum,1,108,Not available,1,DPP COVID-19 IgM/IgG System,ChemBio,Frederick National Laboratory for Cancer Research,Not available,204IG001Z,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,28,80,22,73,78.6,91.2,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3265-a001.pdf,Not available,Not available,-108,ChemBio - DPP COVID-19 IgM/IgG System - IgG - Plasma; Serum,
ChemBio - DPP COVID-19 IgM/IgG System - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,108,Not available,1,DPP COVID-19 IgM/IgG System,ChemBio,Frederick National Laboratory for Cancer Research,Not available,204IG001Z,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,28,80,23,65,82.1,81.2,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3265-a001.pdf,Not available,Not available,-108,ChemBio - DPP COVID-19 IgM/IgG System - IgG; IgM - Plasma; Serum,
ChemBio - DPP COVID-19 IgM/IgG System - IgM - Plasma; Serum,IgM,Plasma; Serum,1,108,Not available,1,DPP COVID-19 IgM/IgG System,ChemBio,Frederick National Laboratory for Cancer Research,Not available,204IG001Z,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,28,80,16,69,57.1,86.2,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3265-a001.pdf,Not available,Not available,-108,ChemBio - DPP COVID-19 IgM/IgG System - IgM - Plasma; Serum,
"Chongqing iSIA BIO-Technology Co., Ltd. - 2019-nCoV IgM/IgG Diagnostic Test Kit - IgG - Plasma",IgG,Plasma,1,58,Plasma,1,2019-nCoV IgM/IgG Diagnostic Test Kit,"Chongqing iSIA BIO-Technology Co., Ltd.",Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,80,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,"Chongqing iSIA BIO-Technology Co., Ltd. - 2019-nCoV IgM/IgG Diagnostic Test Kit - IgG - Plasma",
"Chongqing iSIA BIO-Technology Co., Ltd. - 2019-nCoV IgM/IgG Diagnostic Test Kit - IgM - Plasma",IgM,Plasma,1,58,Plasma,1,2019-nCoV IgM/IgG Diagnostic Test Kit,"Chongqing iSIA BIO-Technology Co., Ltd.",Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,93.3,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,"Chongqing iSIA BIO-Technology Co., Ltd. - 2019-nCoV IgM/IgG Diagnostic Test Kit - IgM - Plasma",
Creative Diagnostics - SARS-CoV-2 IgG ELISA Kit - IgG - Plasma; Serum,IgG,Plasma; Serum,1,182,Not available,1,SARS-CoV-2 IgG ELISA Kit,Creative Diagnostics,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,DEIASL019,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,113,69,Not available,Not available,65,99,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-182,Creative Diagnostics - SARS-CoV-2 IgG ELISA Kit - IgG - Plasma; Serum,
Creative Diagnostics - SARS-CoV-2 IgM ELISA Kit - IgM - Plasma; Serum,IgM,Plasma; Serum,1,182,Not available,1,SARS-CoV-2 IgM ELISA Kit,Creative Diagnostics,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,DEIASL020,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,113,69,Not available,Not available,83,36,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-182,Creative Diagnostics - SARS-CoV-2 IgM ELISA Kit - IgM - Plasma; Serum,
"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG - Serum",IgG,Serum,1,229,Respiratory specimen,1,OnSite COVID-19 IgG/IgM Rapid Test,"CTK Biotech, Inc.",Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,Triplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,64,Not available,46.7,98.9,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-229,"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG - Serum",
"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG - Whole blood",IgG,Whole blood,1,49,Upper respiratory specimen,1,OnSite COVID-19 IgG/IgM Rapid Test,"CTK Biotech, Inc.","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,4,100,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG - Whole blood",
"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,62,Respiratory specimen,1,OnSite COVID-19 IgG/IgM Rapid Test,"CTK Biotech, Inc.","Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut",Not available,Not available,Public Health,Denmark,Copenhagen,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,R0180C,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,32,27,32,90,100,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf,10.1101/2020.04.09.20056325,"Weak signals for IgM and IgG, together or separate, was considered positive.",-62,"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG; IgM - Plasma; Serum",
"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,1,229,Respiratory specimen,1,OnSite COVID-19 IgG/IgM Rapid Test,"CTK Biotech, Inc.",Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,Triplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,78,Not available,56.9,95.6,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-229,"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum","200520_Jersey_JerseyStatistics_Round2_GenPop_TestAdj,200520_Jersey_JerseyStatistics_Round2_GenPop_TestUnAdjPopAdj,200520_Jersey_JerseyStatistics_Round2_16-34,200520_Jersey_JerseyStatistics_Round2_35-44,200520_Jersey_JerseyStatistics_Round2_45-54,200520_Jersey_JerseyStatistics_Round2_55-64,200520_Jersey_JerseyStatistics_Round2_65+,200520_Jersey_JerseyStatistics_Round2_Females,200520_Jersey_JerseyStatistics_Round2_Males,200520_Jersey_JerseyStatistics_Round2_Urban,200520_Jersey_JerseyStatistics_Round2_Semi-urban,200520_Jersey_JerseyStatistics_Round2_Rural,200520_Jersey_JerseyStatistics_Round2_GenPop_PopUnadjTestUnadj"
"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgM - Serum",IgM,Serum,1,229,Respiratory specimen,1,OnSite COVID-19 IgG/IgM Rapid Test,"CTK Biotech, Inc.",Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,Triplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,68,Not available,49.6,96.7,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-229,"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgM - Serum",
"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgM - Whole blood",IgM,Whole blood,1,49,Upper respiratory specimen,1,OnSite COVID-19 IgG/IgM Rapid Test,"CTK Biotech, Inc.","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,22,92,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,"CTK Biotech, Inc. - OnSite COVID-19 IgG/IgM Rapid Test - IgM - Whole blood",
Decombio Biotechnology Co Ltd. - Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette - IgG - Plasma; Serum,IgG,Plasma; Serum,1,233,Nasopharyngeal swabs; Oropharyngeal swabs,1,Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette,Decombio Biotechnology Co Ltd.,University of California,Not available,Not available,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,126,107,84,98,66.7,91.6,https://covidtestingproject.org/,Not available,Some control band inconsistency,-233,Decombio Biotechnology Co Ltd. - Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette - IgG - Plasma; Serum,
Decombio Biotechnology Co Ltd. - Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,233,Nasopharyngeal swabs; Oropharyngeal swabs,1,Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette,Decombio Biotechnology Co Ltd.,University of California,Not available,Not available,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,126,107,85,96,67.5,89.7,https://covidtestingproject.org/,Not available,Some control band inconsistency,-233,Decombio Biotechnology Co Ltd. - Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette - IgG; IgM - Plasma; Serum,
Decombio Biotechnology Co Ltd. - Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette - IgM - Plasma; Serum,IgM,Plasma; Serum,1,233,Nasopharyngeal swabs; Oropharyngeal swabs,1,Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette,Decombio Biotechnology Co Ltd.,University of California,Not available,Not available,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,126,107,85,97,67.5,90.7,https://covidtestingproject.org/,Not available,Some control band inconsistency,-233,Decombio Biotechnology Co Ltd. - Novel Coronavirus (SARSCoV-2) IgM/IgG Combo Rapid Test-Cassette - IgM - Plasma; Serum,
DeepBlue Medical Technology Co Ltd. - COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold) - IgG - Plasma; Serum,IgG,Plasma; Serum,1,238,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold),DeepBlue Medical Technology Co Ltd.,University of California,Not available,20200305,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,108,69,107,53.1,99.1,https://covidtestingproject.org/,Not available,"Extra diluent necessary,
Some control band inconsistency",-238,DeepBlue Medical Technology Co Ltd. - COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold) - IgG - Plasma; Serum,
DeepBlue Medical Technology Co Ltd. - COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold) - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,238,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold),DeepBlue Medical Technology Co Ltd.,University of California,Not available,20200305,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,108,95,91,73.1,84.3,https://covidtestingproject.org/,Not available,"Extra diluent necessary,
Some control band inconsistency",-238,DeepBlue Medical Technology Co Ltd. - COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold) - IgG; IgM - Plasma; Serum,
DeepBlue Medical Technology Co Ltd. - COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold) - IgM - Plasma; Serum,IgM,Plasma; Serum,1,238,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold),DeepBlue Medical Technology Co Ltd.,University of California,Not available,20200305,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,108,94,91,72.3,84.3,https://covidtestingproject.org/,Not available,"Extra diluent necessary,
Some control band inconsistency",-238,DeepBlue Medical Technology Co Ltd. - COVID-19 (SARS-CoV-2) IgG/IgM Antibody Test Kit (Colloidal Gold) - IgM - Plasma; Serum,
DiaSorin SpA - ISON® SARS-CoV-2 IgG kit - IgG - Plasma; Serum,IgG,Plasma; Serum,1,584,Not available,2,ISON® SARS-CoV-2 IgG kit,DiaSorin SpA,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,311450,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,175,409,Not available,Not available,65,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-584,DiaSorin SpA - ISON® SARS-CoV-2 IgG kit - IgG - Plasma; Serum,"200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents,200808_Italy_UniversityofTurin_CLLPatients_CLIA"
DiaSorin SpA - ISON® SARS-CoV-2 IgG kit - IgG - Plasma; Serum,IgG,Plasma; Serum,2,174,Not available,2,ISON® SARS-CoV-2 IgG kit,DiaSorin SpA,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,311450,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,107,67,Not available,Not available,53,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-174,DiaSorin SpA - ISON® SARS-CoV-2 IgG kit - IgG - Plasma; Serum,
DiaSorin SpA - LIAISON® SARS-CoV-2 S1/S2 IgG - IgG - Serum,IgG,Serum,1,126,Respiratory specimen,3,LIAISON® SARS-CoV-2 S1/S2 IgG,DiaSorin SpA,"Institut für Infektionsmedizin, Christian-Albrechts-Universität und Universitätsklinikum Schleswig-Holstein",Not available,Not available,Hospital,Germany,Kiel,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Signal/cut-off value of ≥1,Signal/cut-off value of <1,Not available,Overall,26,100,Not available,Not available,80.8,96,https://www.medrxiv.org/content/10.1101/2020.06.15.20131672v1.full.pdf,10.1101/2020.06.15.20131672,"Controls: Pre-pandemic controls

Sample collection between 4 and 60 days (median 19 days) after a positive real-time RT-PCR result

 Only  sera  from  individuals  that 70 exhibited a cycle threshold (CT) ≤ 35 (median CT 26.8) in the initial real-time RT-PCR were included.",-126,DiaSorin SpA - LIAISON® SARS-CoV-2 S1/S2 IgG - IgG - Serum,"200526_Lombardy_HumanitasClinicalandResearchCenter_HealthCareWorkers,200526_Lombardy_HumanitasClinicalandResearchCenter_Male,200526_Lombardy_HumanitasClinicalandResearchCenter_Female,200526_Lombardy_HumanitasClinicalandResearchCenter_Age>60yrs,200526_Lombardy_HumanitasClinicalandResearchCenter_Age<60yrs,200730_Belgium_IrisHospitalsSouth_HCW_Exposed_UnAdj,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj,200730_Belgium_IrisHospitalsSouth_HCW_Unexposed_UnAdj,200730_Belgium_IrisHospitalsSouth_HCWImageTechEtAl_UnAdj,200730_Belgium_IrisHospitalsSouth_HCWMaintenanceEtAl_UnAdj,200730_Belgium_IrisHospitalsSouth_HCWNurseEtAl_UnAdj,200730_Belgium_IrisHospitalsSouth_HCWOtherEtAl_UnAdj,200730_Belgium_IrisHospitalsSouth_HCWPharmacistEtAl_UnAdj,200730_Belgium_IrisHospitalsSouth_HCWUnspecifiedOccupation_UnAdj,200730_Belgium_IrisHospitalsSouth_HCWDoctorEtAl_UnAdj,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_Covidinpatientunit,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_ICU,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_Covidemergencies,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_noncovidemergencies,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj__noncovideinpatientunit,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_serviceswithnocontact,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_bronchoscopes,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_intubations,200730_Belgium_IrisHospitalsSouth_HCW_UnAdj_riskyprocedures,200818_Brescia_UniversityofBrescia_Overall,200626_Barcelona_InstitutCatala_HCW-Asymptomatic,200626_Barcelona_InstitutCatala_HCWOverall,200626_Barcelona_InstitutCatala_HCWMales,200626_Barcelona_InstitutCatala_HCWFemales,200626_Barcelona_InstitutCatala_18-34,200626_Barcelona_InstitutCatala_35-54,200626_Barcelona_InstitutCatala_>55,200707_Turin_University of Turin_PregnantWomen_IgGonlyNeutralizing,200717_Saxony_TechnischeUniversitätDresden_Overall_Test1,200717_Saxony_TechnischeUniversitätDresden_Students_Test1,200717_Saxony_TechnischeUniversitätDresden_Teachers_Test1,200717_Switzerland_UniversityofLausanne_Contacts_DiasorinAssay,200717_Switzerland_UniversityofLausanne_GenPop_DiasorinAssay,200721_NewYork_ShermanAbramsLaboratory_Male,200721_NewYork_ShermanAbramsLaboratory_Female,200721_NewYork_ShermanAbramsLaboratory_Overall,200818_Cambridge_CambridgeHealthAllianceLiaison"
DiaSorin SpA - LIAISON® SARS-CoV-2 S1/S2 IgG - IgG - Serum,IgG,Serum,2,122,Plasma; Serum; Not available,3,LIAISON® SARS-CoV-2 S1/S2 IgG,DiaSorin SpA,"Department of Viroscience, Erasmus Medical Centre",Not available,Not available,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,53,69,39,68,73.6,98.6,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-122,DiaSorin SpA - LIAISON® SARS-CoV-2 S1/S2 IgG - IgG - Serum,
DiaSorin SpA - LIAISON® SARS-CoV-2 S1/S2 IgG - IgG - Serum,IgG,Serum,3,111,Serum,3,LIAISON® SARS-CoV-2 S1/S2 IgG,DiaSorin SpA,"Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,32,79,14,75,43.8,94.9,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,"Analysis using Diasorin Liaison® XL (DiaSorin, Saluggia, Italy)

Test cut-off 15 AU/ml

Days of sickness: 3 to 16 days",-111,DiaSorin SpA - LIAISON® SARS-CoV-2 S1/S2 IgG - IgG - Serum,
"DiaSorin SpA; Saluggia, Italy - Not available - Total Ig - Not available",Total Ig,Not available,1,297,Not available,1,Not available,"DiaSorin SpA; Saluggia, Italy",,Not available,Not available,Public Health,Canada,Rotterdam,Asymptomatic individuals,Not available,Immunoassay; PRNT,Not available,Not available,Antibody,CLIA,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,165,132,134,119,81.2,90.2,https://www.nature.com/articles/s41467-020-17317-y.pdf,Not available,Not available,-297,"DiaSorin SpA; Saluggia, Italy - Not available - Total Ig - Not available",
"DiaSorin, Saluggia, Italy - Liaison SARS-CoV-2 S1/S2 IgG - IgG - Not available",IgG,Not available,1,228,Not available,1,Liaison SARS-CoV-2 S1/S2 IgG,"DiaSorin, Saluggia, Italy",,Not available,Not available,Hospital,United States of America (USA),Not available,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,54,174,31,172,57.4,98.9,https://watermark.silverchair.com/jfaa125.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArcwggKzBgkqhkiG9w0BBwagggKkMIICoAIBADCCApkGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMWUyyJY3q8FSj5r0-AgEQgIICatSpktZ-MpfjSPc97hw3LFVqVWs7Bo7RQmlyphFFf7Rttw3,Not available,Not available,-228,"DiaSorin, Saluggia, Italy - Liaison SARS-CoV-2 S1/S2 IgG - IgG - Not available",
"DiaSorin, Stillwater, MN, USA - SARS-CoV-2 S1/S2 IgG - IgG - Serum",IgG,Serum,1,92,Not available,1,SARS-CoV-2 S1/S2 IgG,"DiaSorin, Stillwater, MN, USA",,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,CLIA,Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,42,50,26,48,61.9,96,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-92,"DiaSorin, Stillwater, MN, USA - SARS-CoV-2 S1/S2 IgG - IgG - Serum",
Diesse Diagnostica Senese SpA - ENZY-WELL SARS-CoV-2 IgA - IgA - Serum,IgA,Serum,1,533,Serum,1,ENZY-WELL SARS-CoV-2 IgA,Diesse Diagnostica Senese SpA,"National Institute for Infectious Diseases (INMI) ""L. Spallanzani” IRCCS",Not available,Not available,Hospital,Italy,Rome,Symptomatic patients,Retrospective set,Immunoassay,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,91402,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,65,468,Not available,Not available,93.6,97.9,https://www.medrxiv.org/content/10.1101/2020.05.24.20111682v1.full.pdf,10.1101/2020.05.24.20111682,"Cases: Samples from suspected and confirmed cases

Controls: Samples from suspected and pre-pandemic patients",-533,Diesse Diagnostica Senese SpA - ENZY-WELL SARS-CoV-2 IgA - IgA - Serum,
Diesse Diagnostica Senese SpA - ENZY-WELL SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,1,533,Serum,1,ENZY-WELL SARS-CoV-2 IgG,Diesse Diagnostica Senese SpA,"National Institute for Infectious Diseases (INMI) ""L. Spallanzani” IRCCS",Not available,Not available,Hospital,Italy,Rome,Symptomatic patients,Retrospective set,Immunoassay,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,91400,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,65,468,Not available,Not available,92.5,91.7,https://www.medrxiv.org/content/10.1101/2020.05.24.20111682v1.full.pdf,10.1101/2020.05.24.20111682,"Cases: Samples from suspected and confirmed cases

Controls: Samples from suspected and pre-pandemic patients",-533,Diesse Diagnostica Senese SpA - ENZY-WELL SARS-CoV-2 IgG - IgG - Serum,
Diesse Diagnostica Senese SpA - ENZY-WELL SARS-CoV-2 IgM - IgM - Serum,IgM,Serum,1,533,Serum,1,ENZY-WELL SARS-CoV-2 IgM,Diesse Diagnostica Senese SpA,"National Institute for Infectious Diseases (INMI) ""L. Spallanzani” IRCCS",Not available,Not available,Hospital,Italy,Rome,Symptomatic patients,Retrospective set,Immunoassay,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,91401,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,65,468,Not available,Not available,87.7,88,https://www.medrxiv.org/content/10.1101/2020.05.24.20111682v1.full.pdf,10.1101/2020.05.24.20111682,"Cases: Samples from suspected and confirmed cases

Controls: Samples from suspected and pre-pandemic patients",-533,Diesse Diagnostica Senese SpA - ENZY-WELL SARS-CoV-2 IgM - IgM - Serum,
"DRG International, Inc. - Novel Coronavirus COVID-19 IgG - IgG - SerumSerum",IgG,Serum,1,92,not reported,1,Novel Coronavirus COVID-19 IgG,"DRG International, Inc.",,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,42,50,35,50,83.3,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-92,"DRG International, Inc. - Novel Coronavirus COVID-19 IgG - IgG - Serum","200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_HCW,200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_MedicalDoctors,200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_NurseMedicalClerk,200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_DeptInfectiousDisease,200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_RespDiseaseWard,200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_OtolaryngologyWard,200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_EmergeMedWard"
"DRG International, Inc. - Novel Coronavirus COVID-19 IgM - IgM - Serum",IgM,Serum,1,92,not reported,1,Novel Coronavirus COVID-19 IgM,"DRG International, Inc.",,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,42,50,23,49,54.8,98,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-92,"DRG International, Inc. - Novel Coronavirus COVID-19 IgM - IgM - Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG - Serum",IgG,Serum,1,256,Nasopharyngeal swabs,2,2019 nCOV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,200301,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,61.4,99,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG - Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG - Serum",IgG,Serum,2,38,Nasopharyngeal swabs; Oropharyngeal swabs,2,2019 nCOV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.",RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,25,13,14,12,56,92.3,Not available,Not available,Not available,-38,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG - Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,62,Respiratory specimen,1,2019 nCOV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut",Not available,Not available,Public Health,Denmark,Copenhagen,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,DNK-1419-1,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,32,27,32,90,100,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf,10.1101/2020.04.09.20056325,"Weak signals for IgM and IgG, together or separate, was considered positive.",-62,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG; IgM - Plasma; Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,1,256,Nasopharyngeal swabs,1,2019 nCOV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,200301,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,69.3,95.2,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgG; IgM - Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgM - Serum",IgM,Serum,1,256,Nasopharyngeal swabs,2,2019 nCOV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,200301,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,69.3,95.1,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgM - Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgM - Serum",IgM,Serum,2,38,Nasopharyngeal swabs; Oropharyngeal swabs,2,2019 nCOV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.",RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,25,13,15,12,60,92.3,Not available,Not available,Not available,-38,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019 nCOV IgG/IgM Rapid Test - IgM - Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgG - Plasma; Serum",IgG,Plasma; Serum,1,582,Not available,2,2019-nCoV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,DNK-1419-1,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,179,403,Not available,Not available,75,98,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-582,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgG - Plasma; Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgG - Plasma; Serum",IgG,Plasma; Serum,2,180,Not available,2,2019-nCoV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,DNK-1419-1,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,111,69,Not available,Not available,66,99,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-180,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgG - Plasma; Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,1,25,Nasopharyngeal swabs; Oropharyngeal swabs; Sputum,1,2019-nCoV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.",Department of Medical Microbiology and Infection Control,Not available,Not available,Hospital,Netherlands,Rotterdam,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,20,5,2,5,10,100,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30305-0/pdf,10.1016/j.cmi.2020.05.028,Not available,-25,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgG; IgM - Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgM - Plasma; Serum",IgM,Plasma; Serum,1,577,Not available,2,2019-nCoV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,DNK-1419-1,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,176,401,Not available,Not available,79,96,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-577,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgM - Plasma; Serum",
"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgM - Plasma; Serum",IgM,Plasma; Serum,2,177,Not available,2,2019-nCoV IgG/IgM Rapid Test,"Dynamiker Biotechnology (Tianjin) Co., Ltd.","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,DNK-1419-1,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,108,69,Not available,Not available,70,93,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-177,"Dynamiker Biotechnology (Tianjin) Co., Ltd. - 2019-nCoV IgG/IgM Rapid Test - IgM - Plasma; Serum",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma",IgG,Plasma,1,560,Respiratory specimen,1,EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.","Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern",Not available,Not available,Hospital,Austria,Linz,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,0.1,O.D.,Not available,Not available,Not available,Overall,104,456,36,450,34.6,98.7,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278646/pdf/main.pdf,10.1016/j.cca.2020.05.047,Controls: Pre-pandemic controls,-560,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma; Serum",IgG,Plasma; Serum,1,238,Nasopharyngeal swabs; Oropharyngeal swabs,3,EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.",University of California,Not available,P637U,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,KT-1033,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,108,96,98,73.8,90.7,https://covidtestingproject.org/,Not available,Not available,-238,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma; Serum",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma; Serum",IgG,Plasma; Serum,2,569,Not available,3,EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,KT-1032,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,178,391,Not available,Not available,82,98,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-569,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma; Serum",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma; Serum",IgG,Plasma; Serum,3,175,Not available,3,EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,KT-1032,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,110,65,Not available,Not available,75,98,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-175,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Plasma; Serum",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Serum",IgG,Serum,1,126,Respiratory specimen,1,EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.","Institut für Infektionsmedizin, Christian-Albrechts-Universität und Universitätsklinikum Schleswig-Holstein",Not available,Not available,Hospital,Germany,Kiel,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Signal/cut-off value of ≥1,Signal/cut-off value of <1,Not available,Overall,26,100,Not available,Not available,80.8,100,https://www.medrxiv.org/content/10.1101/2020.06.15.20131672v1.full.pdf,10.1101/2020.06.15.20131672,"Controls: Pre-pandemic controls

Sample collection between 4 and 60 days (median 19 days) after a positive real-time RT-PCR result

 Only  sera  from  individuals  that 70 exhibited a cycle threshold (CT) ≤ 35 (median CT 26.8) in the initial real-time RT-PCR were included.",-126,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG - Serum","200614_Ohio_OhioStateUniversity_Period1,200614_Ohio_OhioStateUniversity_Period 2,200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgG,200717_Switzerland_UniversityofLausanne_Contacts_EpitopeAssay,200717_Switzerland_UniversityofLausanne_GenPop_EpitopeAssay,200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine,200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall,200824_Jena_UniversitätsklinikumJena_Pregnantwomen_withchildren,200824_Jena_UniversitätsklinikumJena_Pregnantwomen_withoutchildren"
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgM - Plasma; Serum",IgM,Plasma; Serum,1,165,Not available,1,EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,KT-1033,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,101,64,Not available,Not available,42,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-165,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgM - Plasma; Serum",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgG - Serum",IgG,Serum,1,87,Not available,1,EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit,"Epitope Diagnostics, Inc.",,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,47,27,47,67.5,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,Sensitivity available for multiple groups according to time since symptom onset but categories do not match ours.,-87,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgG - Serum",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgM - Plasma",IgM,Plasma,1,560,Respiratory specimen,1,EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit,"Epitope Diagnostics, Inc.","Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern",Not available,Not available,Hospital,Austria,Linz,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,0.1,O.D.,Not available,Not available,Not available,Overall,104,456,36,447,34.6,98,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278646/pdf/main.pdf,10.1016/j.cca.2020.05.047,Controls: Pre-pandemic controls,-560,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgM - Plasma",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgM - Plasma; Serum",IgM,Plasma; Serum,1,238,Nasopharyngeal swabs; Oropharyngeal swabs,1,EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit,"Epitope Diagnostics, Inc.",University of California,Not available,P630C,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,KT-1032,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,108,74,105,56.9,97.2,https://covidtestingproject.org/,Not available,Not available,-238,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgM - Plasma; Serum",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgM - Serum",IgM,Serum,1,87,not reported,1,EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit,"Epitope Diagnostics, Inc.",,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,47,35,47,87.5,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-87,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit - IgM - Serum",200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgM
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit; EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG; IgM - Plasma",IgG; IgM,Plasma,1,560,Respiratory specimen,1,EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit; EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.","Department of Laboratory Medicine, Konventhospital Barmherzige Brueder Linz and Ordensklinikum Linz Barmherzige Schwestern",Not available,Not available,Hospital,Austria,Linz,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,104,456,36,441,34.6,96.7,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278646/pdf/main.pdf,10.1016/j.cca.2020.05.047,Controls: Pre-pandemic controls,-560,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit; EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG; IgM - Plasma",
"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit; EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,238,Nasopharyngeal swabs; Oropharyngeal swabs,1,EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit; EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit,"Epitope Diagnostics, Inc.",University of California,Not available,P630C; P637U,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,KT-1032; KT-1033,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,108,98,97,75.4,89.8,https://covidtestingproject.org/,Not available,Not available,-238,"Epitope Diagnostics, Inc. - EDI™ Novel Coronavirus COVID-19 IgM ELISA Kit; EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit - IgG; IgM - Plasma; Serum",200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM
ET Healthcare - Pylon COVID-19 IgG/IgM assay - IgG - Serum,IgG,Serum,1,440,Nasopharyngeal swabs,1,Pylon COVID-19 IgG/IgM assay,ET Healthcare,"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine",Not available,Not available,Hospital,United States of America (USA),New York,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Cyclic enhanced fluorescence assay (CEFA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Index value ≥ 1,Not available,Not available,Overall,120,320,71,Not available,59.2,98.8,https://reader.elsevier.com/reader/sd/pii/S0009898120302680?token=71A28DA0252D168AED57399149A4E40B0E5F035E8C6BD2CFC9F35D4737A3A1A64A35EAEDCD2CD84C974C941DECC01472,10.1016/j.cca.2020.06.004,Controls: Pre-pandemic controls,-440,ET Healthcare - Pylon COVID-19 IgG/IgM assay - IgG - Serum,
ET Healthcare - Pylon COVID-19 IgG/IgM assay - IgG; IgM - Serum,IgG; IgM,Serum,1,440,Nasopharyngeal swabs,1,Pylon COVID-19 IgG/IgM assay,ET Healthcare,"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine",Not available,Not available,Hospital,United States of America (USA),New York,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Cyclic enhanced fluorescence assay (CEFA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Index value ≥ 1,Not available,Not available,Overall,120,320,74,Not available,61.7,98.8,https://reader.elsevier.com/reader/sd/pii/S0009898120302680?token=71A28DA0252D168AED57399149A4E40B0E5F035E8C6BD2CFC9F35D4737A3A1A64A35EAEDCD2CD84C974C941DECC01472,10.1016/j.cca.2020.06.004,Controls: Pre-pandemic controls,-440,ET Healthcare - Pylon COVID-19 IgG/IgM assay - IgG; IgM - Serum,
ET Healthcare - Pylon COVID-19 IgG/IgM assay - IgM - Serum,IgM,Serum,1,440,Nasopharyngeal swabs,1,Pylon COVID-19 IgG/IgM assay,ET Healthcare,"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine",Not available,Not available,Hospital,United States of America (USA),New York,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Cyclic enhanced fluorescence assay (CEFA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Index value ≥ 1,Not available,Not available,Overall,120,320,61,Not available,50.8,99.4,https://reader.elsevier.com/reader/sd/pii/S0009898120302680?token=71A28DA0252D168AED57399149A4E40B0E5F035E8C6BD2CFC9F35D4737A3A1A64A35EAEDCD2CD84C974C941DECC01472,10.1016/j.cca.2020.06.004,Controls: Pre-pandemic controls,-440,ET Healthcare - Pylon COVID-19 IgG/IgM assay - IgM - Serum,
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Not available",IgA,Not available,1,168,Nasopharyngeal swabs; Nasal mid-turbinate swabs,1,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,The University of Chicago Medicine,Not available,Not available,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio ≥ 1.1,Ratio < 0.8,Not available,Overall,82,86,68,76,82.9,88.4,https://www.sciencedirect.com/science/article/pii/S1386653220302109#!,10.1016/j.jcv.2020.104468,"Of samples collected ≥4 days after positive PCR, 38 of 42 (90.5% agreement, 95% CI: 77.9–96.2) were positive for IgA.",-168,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Not available",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma",IgA,Plasma,1,58,Plasma,1,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,1.1,0.8,Not available,Overall,38,20,Not available,Not available,86.7,80,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma","200602_Gangelt_UniversityofBonn_ GenPopUnadj_TestUnadj_IgA,200602_Gangelt_UniversityofBonn_ GenPopUnadj_TestAdj_IgA"
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma; Serum",IgA,Plasma; Serum,1,177,Respiratory specimen,3,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,Kaiser-Franz-Josef Hospital,Mild; Moderate; Severe,Not available,Hospital,Austria,Vienna,Symptomatic patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio >1.1,Ratio <0.8,Not available,Overall,77,100,52,83,67.5,83,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa305/5849070,10.1093/infdis/jiaa305,Not available,-177,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma; Serum","200514_Saalfeld_ThuringiaClinic_IgA,200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgA,200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgA"
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma; Serum",IgA,Plasma; Serum,2,112,Respiratory specimen,3,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,"Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut",Not available,Not available,Public Health,Denmark,Copenhagen,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,EI 2606-9601,Not available,Not available,Not available,Ratio between the extinction of the sample and calibrator on each plate,> =1.1,<0.8,Not available,Overall,30,82,28,76,93.3,92.7,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf,10.1101/2020.04.09.20056325,Borderline data were considered negative.,-112,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma; Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma; Serum",IgA,Plasma; Serum,3,169,Not available,3,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,EI 2606-9601 A,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,105,64,Not available,Not available,80,88,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-169,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Plasma; Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",IgA,Serum,1,76,Nasopharyngeal swabs,7,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,"University of Helsinki and Helsinki University Hospital, Helsinki, Finland",Mild; Moderate; Severe,Not available,Not available,Finland,Helsinki,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Ratio ≥ 1.1,Ratio <0.8,Not available,Overall,39,37,24,27,61.5,73,https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.18.2000603,10.2807/1560-7917.ES.2020.25.18.2000603,Control: Pre-pandemic controls,-76,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum","200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgA,200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgAPopAdj,200629_Fulda_UniversitätsmedizinMarburg_retailemployees_IgA,200629_Fulda_UniversitätsmedizinMarburg_nonhcw_IgA,200629_Fulda_UniversitätsmedizinMarburg_hcw_IgA,200629_Fulda_UniversitätsmedizinMarburg_professionals_IgA,200629_Fulda_UniversitätsmedizinMarburg_entirecohort_IgA,200622_Rostock_UniversitätsmedizinRostock_Mothers_IgA"
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",IgA,Serum,2,123,Serum,7,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,"Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,82,36,56,87.8,68.3,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,"Analysis using EUROLabworkstation (Euroimmun, Lübeck, Germany)

Test cut-off 1.1 ratio

Days of sickness: 3 to 16 days",-123,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",IgA,Serum,3,237,Plasma; Serum; Not available,7,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,"Department of Viroscience, Erasmus Medical Centre",Not available,Not available,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,76,161,74,151,97.4,93.8,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-237,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",IgA,Serum,4,362,Not available,7,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,"Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva",Mild; Moderate; Severe,Not available,Hospital,Switzerland,Geneva,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,2606-9601,Not available,Not available,Not available,Not available,Ratio ≥1.1,Ratio <0.8,Not available,Overall,181,181,164,157,90.6,86.7,https://www.medrxiv.org/content/10.1101/2020.05.02.20080879v1.full.pdf,10.1101/2020.05.02.20080879,"Controls: Pre-pandemic controls

Analysis on Dynex Agility 158 (Ruwag, Switzerland)",-362,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",IgA,Serum,5,293,Not available,7,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,"Virology Laboratory, Angers University Hospital",Not available,Not available,Hospital,France,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,141,152,Not available,Not available,86.7,82.7,https://reader.elsevier.com/reader/sd/pii/S1386653220302535?token=341A1A99931901504B0EDE6F1EC192695BC491A850BE5FDF9A3467E2101C4C30CA935015148BC7A4A4F45C3916735036,10.1016/j.jcv.2020.104511,"Controls: Patients with symptoms consistent with COVID-19 but with a negative RT-PCR result, pre-pandemic controls",-293,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",IgA,Serum,6,200,Not reported,7,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Ratio  ≥ 1.1,Ratio < 0.8,Not available,Overall,128,72,107,62,83.6,86.1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",IgA,Serum,7,90,not reported,7,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,30,46,75,92,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgG - Not available",IgG,Not available,1,168,Nasopharyngeal swabs; Nasal mid-turbinate swabs,1,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)",EUROIMMUN AG,The University of Chicago Medicine,Not available,Not available,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio ≥ 1.1,Ratio < 0.8,Not available,Overall,82,86,55,84,67.1,97.7,https://www.sciencedirect.com/science/article/pii/S1386653220302109#!,10.1016/j.jcv.2020.104468,"Of samples collected ≥4 days after positive PCR, 42 of 42 (100% agreement, 95% CI: 91.6–100) were positive for IgG.",-168,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgG - Not available",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated); Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgA; IgG - Serum",IgA; IgG,Serum,1,293,Not available,1,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated); Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Virology Laboratory, Angers University Hospital",Not available,Not available,Hospital,France,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,141,152,Not available,Not available,87.4,82,https://reader.elsevier.com/reader/sd/pii/S1386653220302535?token=341A1A99931901504B0EDE6F1EC192695BC491A850BE5FDF9A3467E2101C4C30CA935015148BC7A4A4F45C3916735036,10.1016/j.jcv.2020.104511,"Controls: Patients with symptoms consistent with COVID-19 but with a negative RT-PCR result, pre-pandemic controls",-293,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated); Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgA; IgG - Serum",200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma",IgG,Plasma,1,58,Plasma,2,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,1.1,0.8,Not available,Overall,38,20,Not available,Not available,86.7,85,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma","200602_Gangelt_UniversityofBonn_ GenPopUnadj_TestUnadj_IgG,200602_Gangelt_UniversityofBonn_ GenPopUnadj_TestAdj_IgG,200609_Milan_uniMilan_IgG,200717_Saxony_TechnischeUniversitätDresden_Overall_Test3,200717_Saxony_TechnischeUniversitätDresden_Students_Test3,200717_Saxony_TechnischeUniversitätDresden_Teachers_Test3"
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma",IgG,Plasma,2,91,Not available,2,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,,Not available,Not available,Hospital,Switzerland,Geneva,Confirmed COVID-19 cases and asymptomatic blood donors,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,50,37,49,90.2,98,https://www.mdpi.com/2077-0383/9/8/2369/htm,10.3390/jcm9082369,Not available,-91,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",IgG,Plasma; Serum,1,177,Respiratory specimen,5,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,Kaiser-Franz-Josef Hospital,Mild; Moderate; Severe,Not available,Hospital,Austria,Vienna,Symptomatic patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio >1.1,Ratio <0.8,Not available,Overall,77,100,33,98,42.9,98,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa305/5849070,10.1093/infdis/jiaa305,Not available,-177,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum","200514_Saalfeld_Thuringia_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_>/=2ChronicDiseases_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_0-1ChronicDiseases_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Açores_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age1-9_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age10-19_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age20-39_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Age40-59_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_AgeOver60_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Alentejo_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Algarve_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Central_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_FemaleIgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_HighSchool_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_LisboaeValedoTejo_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Madeira_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_MaleIgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_NoEducationorFirstCycleofEducation_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_North_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Overall_Popadj_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Secondorthirdcycleofbasiceducation_IgG,200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_UniversityEducation_IgG,200818_Cambridge_CambridgeHealthAllianceEuroimmun,200625_Brussels_UniversitéLibredeBruxelles_OverallHCW,200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG,200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG,200807_Bavaria_UniversityHospitalMunich,200807_Bavaria_UniversityHospitalMunich_Females,200807_Bavaria_UniversityHospitalMunich_Males,200807_Bavaria_UniversityHospitalMunich_Symptoms"
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",IgG,Plasma; Serum,2,112,Respiratory specimen,5,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Department of Virus & Microbiological Special Diagnostics, Statens Serum Institut",Not available,Not available,Public Health,Denmark,Copenhagen,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,EI 2668-9601,Not available,Not available,Not available,Ratio between the extinction of the sample and calibrator on each plate,> =1.1,<0.8,Not available,Overall,30,82,20,79,66.7,96.3,https://www.medrxiv.org/content/10.1101/2020.04.09.20056325v1.full.pdf,10.1101/2020.04.09.20056325,Borderline data were considered negative.,-112,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",IgG,Plasma; Serum,3,173,Not available,5,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,EI 2606-9601 G,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,105,68,Not available,Not available,67,97,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-173,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",IgG,Plasma; Serum,4,110,Not available,5,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,Frederick National Laboratory for Cancer Research,Not available,E200330DT,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,27,80,90,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3246-a001.pdf,Not available,Not available,-110,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",IgG,Plasma; Serum,5,59,Not available,5,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Institute for Medical Virology, University Hospital, Goethe University",Moderate; Severe,Not available,Hospital,Germany,Frankfurt,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Ratio >=1.1,Ratio <0.8,Not available,Overall,33,26,25,25,75.8,96.2,https://www.biorxiv.org/content/biorxiv/early/2020/05/10/2020.05.08.085506.full.pdf,10.1101/2020.05.08.085506,Control: samples of individuals with selected PCR- or serologically-confirmed infections,-59,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Plasma; Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,1,126,Respiratory specimen,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Institut für Infektionsmedizin, Christian-Albrechts-Universität und Universitätsklinikum Schleswig-Holstein",Not available,Not available,Hospital,Germany,Kiel,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Signal/cut-off value of ≥1,Signal/cut-off value of <1,Not available,Overall,26,100,Not available,Not available,76.9,97,https://www.medrxiv.org/content/10.1101/2020.06.15.20131672v1.full.pdf,10.1101/2020.06.15.20131672,"Controls: Pre-pandemic controls

Sample collection between 4 and 60 days (median 19 days) after a positive real-time RT-PCR result

 Only  sera  from  individuals  that 70 exhibited a cycle threshold (CT) ≤ 35 (median CT 26.8) in the initial real-time RT-PCR were included.",-126,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum","200513_Germany_UniversityHospitalEssen_HCW,200513_Germany_UniversityHospitalEssenCOVIDHCWs,200513_Germany_UniversityHospitalEssen_non-COVIDHCW,200513_Germany_UniversityHospitalEssen_HCWnopatientcontact,200503_SaltLakeCity_UniversityofUtah_HCW,200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgG,200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj,200611_Geneva_UniversityofLausanne_5-9,200611_Geneva_UniversityofLausanne_10-19,200611_Geneva_UniversityofLausanne_20-49,200611_Geneva_UniversityofLausanne_>=65,200611_Geneva_UniversityofLausanne_genpop,200611_Geneva_UniversityofLausanne_50-64,200611_Geneva_UniversityofLausanne_females,200611_Geneva_UniversityofLausanne_males,200611_Geneva_UniversityofLausanne_Week1_Unadj,200611_Geneva_UniversityofLausanne_Week2_Unadj,200611_Geneva_UniversityofLausanne_Week3_Unadj,200611_Geneva_UniversityofLausanne_Week4_Unadj,200611_Geneva_UniversityofLausanne_Week 5_Unadj,200611_Geneva_UniversityofLausanne_Week1_TestPopAdj,200611_Geneva_UniversityofLausanne_Week2_TestPopAdj,200611_Geneva_UniversityofLausanne_Week3_TestPopAdj,200611_Geneva_UniversityofLausanne_Week4_TestPopAdj,200611_Geneva_UniversityofLausanne_Week 5_TestPopAdj,200615_Germany_UniversityofHannover_hcw,200615_Germany_UniversityofHannover_18-29,200615_Germany_UniversityofHannover_30-49,200615_Germany_UniversityofHannover_50-64,200615_Germany_UniversityofHannover_65,200615_Germany_UniversityofHannover_male,200615_Germany_UniversityofHannover_female,200615_Germany_UniversityofHannover_nurse,200615_Germany_UniversityofHannover_doctor,200615_Germany_UniversityofHannover_therapist,200615_Germany_UniversityofHannover_otherhcw,200615_Germany_UniversityofHannover_cvd,200615_Germany_UniversityofHannover_respiratorydisease,200615_Germany_UniversityofHannover_immunecompromised,200615_Germany_UniversityofHannover_diabetes,200615_Germany_UniversityofHannover_cancer,200615_Germany_UniversityofHannover_hepaticdisease,200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16,200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17,200603_England_PHE_BloodDonor_Male_TestPopAdj_Week18to21,200603_England_PHE_BloodDonor_Female_TestPopAdj_Week18to21,200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South,200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week21,0610_England_PHE_BloodDonor_GenPop_Southeast_TestPopAdj_Week18,200610_England_PHE_BloodDonor_GenPop_Southeast_TestPopAdj_Week22,200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14,200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid,200624_England_PHE_BloodDonor_GenPop_Midlands_PopAdj_Week24to25,200624_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week20,200702_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week24,200702_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week22to26,200702_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week18to21,200702_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week25to26,200702_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week20,200702_England_PHE_BloodDonor_GenPop_East_TestPopAdj_Week19,200702_England_PHE_BloodDonor_GenPop_Age17to29_TestPopAdj_Week22to26,0702_England_PHE_BloodDonor_GenPop_Age30to39_TestPopAdj_Week22to26,200702_England_PHE_BloodDonor_GenPop_Age40to49_TestPopAdj_Week22to26,200702_England_PHE_BloodDonor_Age50to59_TestPopAdj_Week22to26,200702_England_PHE_BloodDonor_Age60to69_TestPopAdj_Week22to26,200702_England_PHE_BloodDonor_GenPop_Age17to29_TestPopAdj_Week18to21,200702_England_PHE_BloodDonor_GenPop_Age30to39_TestPopAdj_Week18to21,200702_England_PHE_BloodDonor_Age50to59_TestPopAdj_Week18to21,200702_England_PHE_BloodDonor_Age60to69_TestPopAdj_Week18to21,200702_England_PHE_BloodDonor_GenPop_Age40to49_TestPopAdj_Week18to21,200702_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week28,200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27,200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22,200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16,200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week18,200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week21,200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week23to24,200709_England_PHE_BloodDonor_GenPop_Southeast_TestPopAdj_Week22to27,200709_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week23,200709_England_PHE_BloodDonor_GenPop_Age17to29_TestPopAdj_Week19to22,200709_England_PHE_BloodDonor_GenPop_Age30to39_TestPopAdj_Week19to22,200709_England_PHE_BloodDonor_GenPop_Age40to49_TestPopAdj_Week19to22,200709_England_PHE_BloodDonor_Age50to59_TestPopAdj_Week19to22,200709_England_PHE_BloodDonor_Age60to69_TestPopAdj_Week19to22,200709_England_PHE_BloodDonor_GenPop_Age17to29_TestPopAdj_Week23to27,200709_England_PHE_BloodDonor_GenPop_Age30to39_TestPopAdj_Week23to27,200709_England_PHE_BloodDonor_GenPop_Age40to49_TestPopAdj_Week23to27,200709_England_PHE_BloodDonor_Age50to59_TestPopAdj_Week23to27,200709_England_PHE_BloodDonor_Age60to69_TestPopAdj_Week23to27,200717_England_PHE_BloodDonor_GenPop_East_TestPopAdj_Week22,200717_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week24to28,200717_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week20to23,200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13,200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week25to26,200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week27to28,200717_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week19,200717_England_PHE_BloodDonor_GenPop_Southeast_TestPopAdj_Week26to27,200717_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week27,200717_England_PHE_BloodDonor_GenPop_East_TestPopAdj_Week27,200717_England_PHE_BloodDonor_GenPop_Midlands_PopAdj_Week28to29,200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun,200717_England_PHE_BloodDonor_GenPop_East_TestPopAdj_Week30_31,200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week29to30,200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week31,200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week33,200821_England_PHE_BloodDonor_GenPop_Midlands_PopAdj_Week32,200821_England_PHE_BloodDonor_GenPop_Northeast_PopAdj_Week32,200717_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week31,200702_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week29to30,200702_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week33,200717_England_PHE_BloodDonor_GenPop_Southeast_TestPopAdj_Week30,200723_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week30,200723_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week21to24,200731_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week26to30,200731_England_PHE_BloodDonor_GenPop_Age17to29_PopAdj_Week26to30,200731_England_PHE_BloodDonor_GenPop_Age30to39_PopAdj_Week26to30,200731_England_PHE_BloodDonor_GenPop_Age40to49_PopAdj_Week26to30,200731_England_PHE_BloodDonor_GenPop_Age50to59_PopAdj_Week26to30,200731_England_PHE_BloodDonor_GenPop_Age60to69_PopAdj_Week26to30,200731_England_PHE_BloodDonor_GenPop_Age70to84_PopAdj_Week26to30,200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31,200807_England_PHE_BloodDonor_GenPop_Age17to29_PopAdj_Week27to31,200807_England_PHE_BloodDonor_GenPop_Age30to39_PopAdj_Week27to31,200807_England_PHE_BloodDonor_GenPop_Age40to49_PopAdj_Week27to31,200807_England_PHE_BloodDonor_GenPop_Age50to59_PopAdj_Week27to31,200807_England_PHE_BloodDonor_GenPop_Age60to69_PopAdj_Week27to31,200807_England_PHE_BloodDonor_GenPop_Age70to84_PopAdj_Week27to31,200814_England_PHE_BloodDonor_GenPop_Age17to29_PopAdj_Week28to31,200814_England_PHE_BloodDonor_GenPop_Age30to39_PopAdj_Week28to31,200814_England_PHE_BloodDonor_GenPop_Age40to49_PopAdj_Week28to31,200814_England_PHE_BloodDonor_GenPop_Age50to59_PopAdj_Week28to31,200814_England_PHE_BloodDonor_GenPop_Age60to69_PopAdj_Week28to31,200814_England_PHE_BloodDonor_GenPop_Age70to84_PopAdj_Week28to31,200821_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week29to32,200821_England_PHE_BloodDonor_GenPop_Age17to29_PopAdj_Week29to32,200821_England_PHE_BloodDonor_GenPop_Age30to39_PopAdj_Week29to32,200821_England_PHE_BloodDonor_GenPop_Age40to49_PopAdj_Week29to32,200821_England_PHE_BloodDonor_GenPop_Age50to59_PopAdj_Week29to32,200821_England_PHE_BloodDonor_GenPop_Age60to69_PopAdj_Week29to32,200821_England_PHE_BloodDonor_GenPop_Age70to84_PopAdj_Week29to32,200828_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week30to33,200904_England_PHE_BloodDonor_GenPop_Age17to29_PopAdj_Week30to33,200904_England_PHE_BloodDonor_GenPop_Age30to39_PopAdj_Week30to33,200904_England_PHE_BloodDonor_GenPop_Age40to49_PopAdj_Week30to33,200904_England_PHE_BloodDonor_GenPop_Age50to59_PopAdj_Week30to33,200904_England_PHE_BloodDonor_GenPop_Age60to69_PopAdj_Week30to33,200904_England_PHE_BloodDonor_GenPop_Age70to84_PopAdj_Week30to33,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Male,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Female,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age0to10,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age10to20,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age30to40,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age50to60,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age40to50,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age60to70,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age70to80,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age80to90,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age90+,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1_Age20to30,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age0to10,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age0to10,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age0to10,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age10to20 ,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age10to20,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age10to20,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age10to20,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age30to40,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age30to40,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age30to40,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age30to40,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age50to60,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age50to60,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age50to60,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age50to60,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age0to10,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age20to30,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age20to30,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age20to30,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age20to30,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age40to50,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age40to50,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age40to50,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age40to50 ,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age60to70,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age60to70,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age60to70,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age70to80,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age70to80,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age70to80,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age70to80,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age80to90,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age80to90,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age80to90,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age80to90,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Age90+,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Age90+,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age90+,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Age90+,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Female,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Female,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Female,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Female,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2_Male,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3_Male,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4_Male,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Male,200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5_Age60to70,200629_Fulda_UniversitätsmedizinMarburg_hcw_IgG,200629_Fulda_UniversitätsmedizinMarburg_nonhcw_IgG,200629_Fulda_UniversitätsmedizinMarburg_retailemployees_IgG,200629_Fulda_UniversitätsmedizinMarburg_professionals_IgG,200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG,200806_Milan_UniversityofMilan_Overall,200806_Milan_UniversityofMilan_Physician,200806_Milan_UniversityofMilan_Nurse,200806_Milan_UniversityofMilan_OtherHealthTechnicians,200806_Milan_UniversityofMilan_HCW_ContactCovidPatients,200806_Milan_UniversityofMilan_HCW_NoContactCovidPatients,200806_Milan_UniversityofMilan_Female,200806_Milan_UniversityofMilan_Male,200806_Milan_UniversityofMilan_HCW,200806_Milan_UniversityofMilan_Non-HCW,200806_Milan_UniversityofMilan_SpecialistOutpatientServces,200806_Milan_UniversityofMilan_Surgery,200806_Milan_UniversityofMilan_Pediatric,200806_Milan_UniversityofMilan_PediatricEmerge,200806_Milan_UniversityofMilan_NeonatalIntensiveCare,200806_Milan_UniversityofMilan_PediatricIntensiveCare,200806_Milan_UniversityofMilan_PreandPostNatal,200806_Milan_UniversityofMilan_Administration/Pharmacy/Laboratory,200806_Milan_UniversityofMilan_Others,200622_Rostock_UniversitätsmedizinRostock_Mothers_IgG,200714_CzechRepublic_ResearchCenterIBD_HCW,200717_Switzerland_UniversityofLausanne_Contacts_EuroImmunAssay,200717_Switzerland_UniversityofLausanne_GenPop_EuroImmunAssay,200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG,200904_England_PHE_BloodDonors_East_TestPopAdj_Week34to35,200904_England_PHE_BloodDonors_SouthEast_TestPopAdj_Week33,200717_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week35,200911_England_PHE_BloodDonor_GenPop_Age17to29_PopAdj_Week31to35,200911_England_PHE_BloodDonor_GenPop_Age30to39_PopAdj_Week31to35,200911_England_PHE_BloodDonor_GenPop_Age40to49_PopAdj_Week31to35,200911_England_PHE_BloodDonor_GenPop_Age50to59_PopAdj_Week31to35,200911_England_PHE_BloodDonor_GenPop_Age60to69_PopAdj_Week31to35,200911_England_PHE_BloodDonor_GenPop_Age70to84_PopAdj_Week31to35,200918_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week35to36,200918_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week36,200918_England_PHE_BloodDonors_SouthEast_TestPopAdj_Week34,200918_England_PHE_BloodDonor_GenPop_Age17to29_PopAdj_Week33to36,200918_England_PHE_BloodDonor_GenPop_Age30to39_PopAdj_Week33to36,200918_England_PHE_BloodDonor_GenPop_Age40to49_PopAdj_Week33to36,200918_England_PHE_BloodDonor_GenPop_Age50to59_PopAdj_Week33to36,200918_England_PHE_BloodDonor_GenPop_Age60to69_PopAdj_Week33to36,200918_England_PHE_BloodDonor_GenPop_Age70to84_PopAdj_Week33to36,200925_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week37,200918_England_PHE_BloodDonors_SouthEast_TestPopAdj_Week38,0814_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week28to31"
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,2,592,Nasopharyngeal swabs,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,Public Health England,Not available,Not available,Public Health,Great Britain,London,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of past infection,Not available,Not available,Not available,Not available,Au/mL,1.1,0.8,Not available,Overall,93,499,67,493,72,98.8,https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/893433/Evaluation_of_Euroimmun_SARS_CoV_2_ELISA_IgG__1_.pdf,Not available,"Breakdown of day period for positives is as follows:
   early: =< 10 days
   intermediate: 11-20 days
   late: >= 21 days",-592,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,3,256,Nasopharyngeal swabs,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,Not available,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,55.6,96.1,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,4,76,Nasopharyngeal swabs,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"University of Helsinki and Helsinki University Hospital, Helsinki, Finland",Mild; Moderate; Severe,Not available,Not available,Finland,Helsinki,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Ratio ≥ 1.1,Ratio <0.8,Not available,Overall,39,37,13,34,33.3,91.9,https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.18.2000603,10.2807/1560-7917.ES.2020.25.18.2000603,Control: Pre-pandemic controls,-76,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,5,123,Serum,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,82,29,71,70.7,86.6,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,"Analysis using EUROLabworkstation (Euroimmun, Lübeck, Germany)

Test cut-off 1.1 ratio

Days of sickness: 3 to 16 days",-123,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,6,237,Plasma; Serum; Not available,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Department of Viroscience, Erasmus Medical Centre",Not available,Not available,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,76,161,62,160,81.6,99.4,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-237,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,7,357,Not available,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva",Mild; Moderate; Severe,Not available,Hospital,Switzerland,Geneva,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,2606-9601,Not available,Not available,Not available,Not available,Ratio ≥1.1,Ratio <0.8,Not available,Overall,181,176,154,171,85.1,97.2,https://www.medrxiv.org/content/10.1101/2020.05.02.20080879v1.full.pdf,10.1101/2020.05.02.20080879,"Controls: Pre-pandemic controls

Analysis on Dynex Agility 158 (Ruwag, Switzerland)",-357,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,8,293,Not available,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,"Virology Laboratory, Angers University Hospital",Not available,Not available,Hospital,France,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,141,152,Not available,Not available,78.3,96.7,https://reader.elsevier.com/reader/sd/pii/S1386653220302535?token=341A1A99931901504B0EDE6F1EC192695BC491A850BE5FDF9A3467E2101C4C30CA935015148BC7A4A4F45C3916735036,10.1016/j.jcv.2020.104511,"Controls: Patients with symptoms consistent with COVID-19 but with a negative RT-PCR result, pre-pandemic controls",-293,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,9,200,Not available,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Ratio  ≥ 1.1,Ratio < 0.8,Not available,Overall,128,72,79,71,61.7,98.6,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,10,90,Not available,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,25,50,62.5,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",IgG,Serum,11,73,Not available,11,"Anti-SARS-CoV-2 ELISA (IgG) (manual, automated)",EUROIMMUN AG,PathCare N1 Reference Laboratory,Not available,Not available,Private Laboratory,South Africa,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,≥1.1,<0.8,Not available,Overall,39,34,29,34,74.4,100,Not available,Not available,"Controls: Pre-pandemic controls, healthy controls",-73,"EUROIMMUN AG - Anti-SARS-CoV-2 ELISA (IgG) (manual, automated) - IgG - Serum",
EUROIMMUN AG - EI SARS-Cov-2 IgG assay - IgG - Serum,IgG,Serum,1,256,Nasopharyngeal swabs; Oropharyngeal swabs; Lower respiratory specimen,1,EI SARS-Cov-2 IgG assay,EUROIMMUN AG,Barnes Jewish Hospital Laboratory,Not available,Not available,Hospital,United States of America (USA),Saint Louis,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio >=1.1,Ratio <0.8,Not available,Overall,103,153,64,145,62.1,94.8,https://academic.oup.com/clinchem/advance-article/doi/10.1093/clinchem/hvaa120/5836557,10.1093/clinchem/hvaa120,"Controls: symptomatic but PCR negative for SARS-CoV-2; pre-pandemic controls; patients  with  other  coronaviruses confirmed  by  molecular  testing  but  PCR  negative  for  COVID-19;  patients with Influenza A or B; specimens with potentially interfering antibodies

Analysis on an automated Inova QUANTA-Lyser 240 (Inova Diagnostics Inc.)",-256,EUROIMMUN AG - EI SARS-Cov-2 IgG assay - IgG - Serum,
EUROIMMUN AG - Euroimmun - IgG - Plasma,IgG,Plasma,1,232,Not available,1,Euroimmun,EUROIMMUN AG,,Not available,Not available,Public Health,Netherlands,Rotterdam,Asymptomatic individuals,Not available,Immunoassay; PRNT,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,75,157,61,156,81.3,99.4,https://www.nature.com/articles/s41467-020-17317-y.pdf,https://doi.org/10.1038/s41467-020-17317-y,Not available,-232,EUROIMMUN AG - Euroimmun - IgG - Plasma,
EUROIMMUN AG - EUROIMMUN EIA - IgA - Serum,IgA,Serum,1,208,Respiratory specimen,1,EUROIMMUN EIA,EUROIMMUN AG,Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,116,92,76,67,65.5,72.8,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-208,EUROIMMUN AG - EUROIMMUN EIA - IgA - Serum,
EUROIMMUN AG - EUROIMMUN EIA - IgA; IgG - Serum,IgA; IgG,Serum,1,208,Respiratory specimen,1,EUROIMMUN EIA,EUROIMMUN AG,Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,116,92,79,67,68.1,72.8,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-208,EUROIMMUN AG - EUROIMMUN EIA - IgA; IgG - Serum,
EUROIMMUN AG - EUROIMMUN EIA - IgG - Serum,IgG,Serum,1,208,Respiratory specimen,1,EUROIMMUN EIA,EUROIMMUN AG,Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,116,92,67,90,57.8,97.8,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-208,EUROIMMUN AG - EUROIMMUN EIA - IgG - Serum,
EUROIMMUN AG - Euroimmun IgA - IgA - Plasma,IgA,Plasma,1,232,Not available,1,Euroimmun IgA,EUROIMMUN AG,,Not available,Not available,Public Health,Netherlands,Rotterdam,Asymptomatic individuals,Not available,Immunoassay; PRNT,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,75,157,73,147,97.3,93.6,https://www.nature.com/articles/s41467-020-17317-y.pdf,Not available,Not available,-232,EUROIMMUN AG - Euroimmun IgA - IgA - Plasma,
Genrui Biotech - Novel Coronavirus IgG/IgM test kit - IgM - Serum,IgM,Serum,1,90,Not available,1,Novel Coronavirus IgG/IgM test kit,Genrui Biotech,,Not available,Not available,Hospital,Canada,Not available,Not available,Not available,Not available,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,32,48,80,96,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,Genrui Biotech - Novel Coronavirus IgG/IgM test kit - IgM - Serum,
Genrui Biotech. - Novel Coronavirus IgG/IgM test kit - IgG - Serum,IgG,Serum,1,90,Not available,1,Novel Coronavirus IgG/IgM test kit,Genrui Biotech.,,Not available,Not available,Hospital,Canada,Not available,Not available,Not available,Not available,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,26,50,65,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,Genrui Biotech. - Novel Coronavirus IgG/IgM test kit - IgG - Serum,
GenScript - IgG indirect ELISA assay - IgG - Serum,IgG,Serum,1,96,Not available,2,IgG indirect ELISA assay,GenScript,Emory University Nell Hodgson Woodruff School of Nursing,Mild; Moderate; Severe,Not available,Hospital,United States of America (USA),Atlanta,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,18,78,Not available,Not available,88.9,92.3,https://www.medrxiv.org/content/10.1101/2020.05.10.20097535v1.full.pdf,10.1101/2020.05.10.20097535,"Cases:hospitalized and actively symptomatic

Controls:pre-2020 healthy adult control participants

A cut-off of 0.89 OD",-96,GenScript - IgG indirect ELISA assay - IgG - Serum,
GenScript - IgG indirect ELISA assay - IgG - Serum,IgG,Serum,2,92,Not available,2,IgG indirect ELISA assay,GenScript,Emory University Nell Hodgson Woodruff School of Nursing,Mild,Not available,Hospital,United States of America (USA),Atlanta,Recovered COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,14,78,4,Not available,28.6,92.3,https://www.medrxiv.org/content/10.1101/2020.05.10.20097535v1.full.pdf,10.1101/2020.05.10.20097535,"Cases:recovered mild cases

Controls:pre-2020 healthy adult control participants

A cut-off of 0.89 OD",-92,GenScript - IgG indirect ELISA assay - IgG - Serum,
"Getein Biotech, Inc. - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody (Colloidal Gold) - IgG - Serum",IgG,Serum,1,89,Not available,1,One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody (Colloidal Gold),"Getein Biotech, Inc.",,Not available,Not available,Hospital,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,39,50,25,50,64.1,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-89,"Getein Biotech, Inc. - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody (Colloidal Gold) - IgG - Serum",
"Getein Biotech, Inc. - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody (Colloidal Gold) - IgM - Serum",IgM,Serum,1,89,Not available,1,One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody (Colloidal Gold),"Getein Biotech, Inc.",,Not available,Not available,Hospital,Canada,Not available,Not available,Not available,Not available,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,39,50,1,50,2.6,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-89,"Getein Biotech, Inc. - One Step Test for Novel Coronavirus (2019-nCoV) IgM/IgG Antibody (Colloidal Gold) - IgM - Serum",
GritOverseas Pte. Ltd - DiagnoSure COVID-19 IgG/IgM rapid test cassette - IgG - Serum,IgG,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,1,DiagnoSure COVID-19 IgG/IgM rapid test cassette,GritOverseas Pte. Ltd,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,8,25,34.8,100,Not available,Not available,Not available,-48,GritOverseas Pte. Ltd - DiagnoSure COVID-19 IgG/IgM rapid test cassette - IgG - Serum,
GritOverseas Pte. Ltd - DiagnoSure COVID-19 IgG/IgM rapid test cassette - IgM - Serum,IgM,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,1,DiagnoSure COVID-19 IgG/IgM rapid test cassette,GritOverseas Pte. Ltd,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,12,25,52.2,100,Not available,Not available,Not available,-48,GritOverseas Pte. Ltd - DiagnoSure COVID-19 IgG/IgM rapid test cassette - IgM - Serum,
"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgG Antibody Detection Kit (ELISA Method) - IgG - Serum",IgG,Serum,1,129,Respiratory specimen,2,2019 Novel Coronavirus (2019-nCoV) IgG Antibody Detection Kit (ELISA Method),"Guangzhou Darui Biotechnology Co.,Ltd",Guangdong Provincial Key Laboratory of Regional Immunity and Disease,Not available,Not available,Public Health,China,Shenzhen,Confirmed COVID-19 patients,Prospectively collected set,Clinical examination; Epidemiologic criteria; RT-PCR,No replicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,65,64,15,64,23.1,100,https://www.medrxiv.org/content/10.1101/2020.03.27.20045153v1.full.pdf,10.1101/2020.03.27.20045153,Not available,-129,"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgG Antibody Detection Kit (ELISA Method) - IgG - Serum",
"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgG Antibody Detection Kit (ELISA Method) - IgG - Serum",IgG,Serum,2,129,Nasopharyngeal swabs; Oropharyngeal swabs,2,2019 Novel Coronavirus (2019-nCoV) IgG Antibody Detection Kit (ELISA Method),"Guangzhou Darui Biotechnology Co.,Ltd",Guangdong Provincial Key Laboratory of Regional Immunity and Disease,Moderate,Not available,Public Health,China,Shenzhen,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,As per manufactures instructions,As per manufactures instructions,Not available,Overall,65,64,15,64,23.1,100,https://www.medrxiv.org/content/10.1101/2020.03.27.20045153v1.full.pdf,10.1101/2020.03.27.20045153,Not available,-129,"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgG Antibody Detection Kit (ELISA Method) - IgG - Serum",
"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgM Antibody Detection Kit (ELISA Method) - IgM - Serum",IgM,Serum,1,129,Respiratory specimen,2,2019 Novel Coronavirus (2019-nCoV) IgM Antibody Detection Kit (ELISA Method),"Guangzhou Darui Biotechnology Co.,Ltd",Guangdong Provincial Key Laboratory of Regional Immunity and Disease,Not available,Not available,Public Health,China,Shenzhen,Confirmed COVID-19 patients,Prospectively collected set,Clinical examination; Epidemiologic criteria; RT-PCR,No replicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,65,64,30,50,46.2,78.1,https://www.medrxiv.org/content/10.1101/2020.03.27.20045153v1.full.pdf,10.1101/2020.03.27.20045153,Not available,-129,"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgM Antibody Detection Kit (ELISA Method) - IgM - Serum",
"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgM Antibody Detection Kit (ELISA Method) - IgM - Serum",IgM,Serum,2,129,Nasopharyngeal swabs; Oropharyngeal swabs,2,2019 Novel Coronavirus (2019-nCoV) IgM Antibody Detection Kit (ELISA Method),"Guangzhou Darui Biotechnology Co.,Ltd",Guangdong Provincial Key Laboratory of Regional Immunity and Disease,Moderate,Not available,Public Health,China,Shenzhen,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,As per manufactures instructions,As per manufactures instructions,Not available,Overall,65,64,30,50,46.2,78.1,https://www.medrxiv.org/content/10.1101/2020.03.27.20045153v1.full.pdf,10.1101/2020.03.27.20045153,Not available,-129,"Guangzhou Darui Biotechnology Co.,Ltd - 2019 Novel Coronavirus (2019-nCoV) IgM Antibody Detection Kit (ELISA Method) - IgM - Serum",
"Guangzhou Wondfo Biotech Co., Ltd - Finecare SARS-CoV-2 Antibody test - Total Ig - Serum",Total Ig,Serum,1,497,Nasopharyngeal swabs,1,Finecare SARS-CoV-2 Antibody test,"Guangzhou Wondfo Biotech Co., Ltd",Bacteriology and Hygiene Bicetre Laboratory Hospital,Mild; Moderate; Severe; Critical,F27614309AD,Hospital,France,Kremlin-Bicêtre,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT) with reader,Detection of current infection,W276,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,249,248,195,244,78.3,98.4,Not available,Not available,Not available,-497,"Guangzhou Wondfo Biotech Co., Ltd - Finecare SARS-CoV-2 Antibody test - Total Ig - Serum","200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round1_GenPop,200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round2_GenPop,200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round3_GenPop"
"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,232,Nasopharyngeal swabs; Oropharyngeal swabs,1,Wondfo SARS-CoV-2 Antibody Test (lateral flow method),"Guangzhou Wondfo Biotech Co., Ltd",University of California,Not available,W19500318,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,W195,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,126,106,87,105,69,99.1,https://covidtestingproject.org/,Not available,Some band smearing,-232,"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Plasma; Serum","200530_Brazil_UniversidadeFederaldePelotas_GenPop,200530_Brazil_UniversidadeFederaldePelotas_Northeast,200530_Brazil_UniversidadeFederaldePelotas_North,200530_Brazil_UniversidadeFederaldePelotas_Central-west,200530_Brazil_UniversidadeFederaldePelotas_Southeast,200530_Brazil_UniversidadeFederaldePelotas_South,200530_Brazil_UniversidadeFederaldePelotas_Female,200530_Brazil_UniversidadeFederaldePelotas_MaleAdj,200530_Brazil_UniversidadeFederaldePelotas_0-4yrs,200530_Brazil_UniversidadeFederaldePelotas_5-9yrs,200530_Brazil_UniversidadeFederaldePelotas_10-19yrs,200530_Brazil_UniversidadeFederaldePelotas_20-29yrs,200530_Brazil_UniversidadeFederaldePelotas_30-39yrs,200530_Brazil_UniversidadeFederaldePelotas_40-49yrs,200530_Brazil_UniversidadeFederaldePelotas_50-59yrs,200530_Brazil_UniversidadeFederaldePelotas_60-69yrs,200530_Brazil_UniversidadeFederaldePelotas_70-79yrs,200530_Brazil_UniversidadeFederaldePelotas_80+yrs,200530_Brazil_UniversidadeFederaldePelotas_White,200530_Brazil_UniversidadeFederaldePelotas_Brown,200530_Brazil_UniversidadeFederaldePelotas_Black,200530_Brazil_UniversidadeFederaldePelotas_Asian,200530_Brazil_UniversidadeFederaldePelotas_Indigenous,200530_Brazil_UniversidadeFederaldePelotas_NortheastAdj,200530_Brazil_UniversidadeFederaldePelotas_NorthAdj,200530_Brazil_UniversidadeFederaldePelotas_Central-westAdj,200530_Brazil_UniversidadeFederaldePelotas_SoutheastAdj,200530_Brazil_UniversidadeFederaldePelotas_SouthAdj,200530_Brazil_UniversidadeFederaldePelotas_FemaleAdj,200530_Brazil_UniversidadeFederaldePelotas_Male,200530_Brazil_UniversidadeFederaldePelotas_0-4yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_5-9yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_10-19yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_20-29yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_30-39yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_40-49yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_50-59yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_60-69yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_70-79yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_80+yrsAdj,200530_Brazil_UniversidadeFederaldePelotas_WhiteAdj,200530_Brazil_UniversidadeFederaldePelotas_BrownAdj,200530_Brazil_UniversidadeFederaldePelotas_BlackAdj,200530_Brazil_UniversidadeFederaldePelotas_AsianAdj,200530_Brazil_UniversidadeFederaldePelotas_IndigenousAdj,200812_Brazil_UniversidadeFederaldePelotas_Overall,200702_Brazil_UniversidadeFederaldePelotas_Round2,200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19,200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26,200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3,200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10,200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17,200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24,200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31"
"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Serum",IgG; IgM,Serum,1,229,Respiratory specimen,3,Wondfo SARS-CoV-2 Antibody Test (lateral flow method),"Guangzhou Wondfo Biotech Co., Ltd",Royal Melbourne Hospital and Victorian Infectious Diseases Reference Laboratory,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Duplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,94,Not available,68.6,97.8,https://www.health.gov.au/sites/default/files/documents/2020/06/post-market-validation-of-serological-assays-for-covid-19-updated-report_0.pdf,Not available,"Controls: Patients  with  respiratory  viral  infections, patients  with  other  acute  infections, pre-pandemic controls",-229,"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Serum",
"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Serum",IgG; IgM,Serum,2,497,Nasopharyngeal swabs,3,Wondfo SARS-CoV-2 Antibody Test (lateral flow method),"Guangzhou Wondfo Biotech Co., Ltd",Bacteriology and Hygiene Bicetre Laboratory Hospital,Mild; Moderate; Severe; Critical,W1900329,Hospital,France,Kremlin-Bicêtre,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection,W195,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,249,248,193,239,77.5,96.4,Not available,Not available,Not available,-497,"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Serum",
"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Serum",IgG; IgM,Serum,3,412,Nasopharyngeal swabs; Oropharyngeal swabs,3,Wondfo SARS-CoV-2 Antibody Test (lateral flow method),"Guangzhou Wondfo Biotech Co., Ltd","Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA",Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,12,400,10,400,83.3,100,https://www.medrxiv.org/content/10.1101/2020.05.05.20092551v1.full.pdf,10.1101/2020.05.05.20092551.t,Analysis on an ACCRE 6 system,-412,"Guangzhou Wondfo Biotech Co., Ltd - Wondfo SARS-CoV-2 Antibody Test (lateral flow method) - IgG; IgM - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum",IgG,Plasma; Serum,1,177,Respiratory specimen,1,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Kaiser-Franz-Josef Hospital,Mild; Moderate; Severe,Not available,Hospital,Austria,Vienna,Symptomatic patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,77,100,38,100,49.4,100,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa305/5849070,10.1093/infdis/jiaa305,Not available,-177,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Serum",IgG,Serum,1,229,Respiratory specimen,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Royal Melbourne Hospital and Victorian Infectious Diseases Reference Laboratory,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,82,92,59.9,100,https://www.health.gov.au/sites/default/files/documents/2020/06/post-market-validation-of-serological-assays-for-covid-19-updated-report_0.pdf,Not available,"Controls: Patients  with  respiratory  viral  infections, patients  with  other  acute  infections, pre-pandemic controls",-229,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Serum","200826_Japan_KanenokumaHospital_Overall_April,200826_Japan_KanenokumaHospital_Overall_June,200826_Japan_KanenokumaHospital_Residents_April,200826_Japan_KanenokumaHospital_Staff_April,200826_Japan_KanenokumaHospital_Residents_June,200826_Japan_KanenokumaHospital_Staff_June"
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Serum",IgG,Serum,2,163,Plasma; Serum; Whole blood,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Hospital Universitario Príncipe de Asturias,Not available,Not available,Hospital,Spain,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,55,108,23,52,41.8,48.1,https://www.medrxiv.org/content/10.1101/2020.04.11.20062158v2.full.pdf,10.1101/2020.04.11.20062158,Not available,-163,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Serum",IgG,Serum,3,190,Not available,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd","Departamento De Microbiología Clínica, Hospital Universitario Príncipe De Asturia",Not available,Not available,Hospital,Spain,Madrid,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,90,100,54,100,60,100,https://reader.elsevier.com/reader/sd/pii/S1386653220302158?token=D8C24BD16AC19ABEC68D008F9DCA1559D99195ACFE27798F168CF05937AC72B59E4F1E501842625F2E56992C7C19EB27,10.1016/j.jcv.2020.104473,Controls: Pre-pandemic controls,-190,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",IgG; IgM,Serum,1,229,Respiratory specimen,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Royal Melbourne Hospital and Victorian Infectious Diseases Reference Laboratory,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,83,Not available,60.6,96.7,https://www.health.gov.au/sites/default/files/documents/2020/06/post-market-validation-of-serological-assays-for-covid-19-updated-report_0.pdf,Not available,"Controls: Patients  with  respiratory  viral  infections, patients  with  other  acute  infections, pre-pandemic controls",-229,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",IgG; IgM,Serum,2,163,Plasma; Serum; Whole blood,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Hospital Universitario Príncipe de Asturias,Not available,Not available,Hospital,Spain,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,55,108,26,52,47.3,48.1,https://www.medrxiv.org/content/10.1101/2020.04.11.20062158v2.full.pdf,10.1101/2020.04.11.20062158,Not available,-163,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",IgG; IgM,Serum,3,190,Not available,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd","Departamento De Microbiología Clínica, Hospital Universitario Príncipe De Asturia",Not available,Not available,Hospital,Spain,Madrid,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,90,100,58,100,64.4,100,https://reader.elsevier.com/reader/sd/pii/S1386653220302158?token=D8C24BD16AC19ABEC68D008F9DCA1559D99195ACFE27798F168CF05937AC72B59E4F1E501842625F2E56992C7C19EB27,10.1016/j.jcv.2020.104473,Controls: Pre-pandemic controls,-190,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum",IgM,Plasma; Serum,1,177,Respiratory specimen,1,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Kaiser-Franz-Josef Hospital,Mild; Moderate; Severe,Not available,Hospital,Austria,Vienna,Symptomatic patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,77,100,21,99,27.3,99,https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaa305/5849070,10.1093/infdis/jiaa305,Not available,-177,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Serum",IgM,Serum,1,229,Respiratory specimen,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Royal Melbourne Hospital and Victorian Infectious Diseases Reference Laboratory,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,18,89,13.1,96.7,https://www.health.gov.au/sites/default/files/documents/2020/06/post-market-validation-of-serological-assays-for-covid-19-updated-report_0.pdf,Not available,"Controls: Patients  with  respiratory  viral  infections, patients  with  other  acute  infections, pre-pandemic controls",-229,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Serum",IgM,Serum,2,163,Plasma; Serum; Whole blood,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd",Hospital Universitario Príncipe de Asturias,Not available,Not available,Hospital,Spain,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,55,108,12,83,21.8,76.9,https://www.medrxiv.org/content/10.1101/2020.04.11.20062158v2.full.pdf,10.1101/2020.04.11.20062158,Not available,-163,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Serum",
"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Serum",IgM,Serum,3,190,Not available,3,2019-nCoV IgG/IgM Rapid Test Cassette,"Hanghzhou AllTest Biotech Co., Ltd","Departamento De Microbiología Clínica, Hospital Universitario Príncipe De Asturia",Not available,Not available,Hospital,Spain,Madrid,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,90,100,26,100,28.9,100,https://reader.elsevier.com/reader/sd/pii/S1386653220302158?token=D8C24BD16AC19ABEC68D008F9DCA1559D99195ACFE27798F168CF05937AC72B59E4F1E501842625F2E56992C7C19EB27,10.1016/j.jcv.2020.104473,Controls: Pre-pandemic controls,-190,"Hanghzhou AllTest Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test Cassette - IgM - Serum",
"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum",IgG,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test Cassette,"Hangzhou Biotest Biotech Co., Ltd",Frederick National Laboratory for Cancer Research,Not available,COV20030071,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,28,80,93.3,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3252-a001.pdf,Not available,Not available,-110,"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum",
"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test Cassette,"Hangzhou Biotest Biotech Co., Ltd",Frederick National Laboratory for Cancer Research,Not available,COV20030071,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,30,80,100,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3252-a001.pdf,Not available,Not available,-110,"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Plasma; Serum","200606_Leon_UniversidadedeLeon_HCWs,200606_Leon_UniversidadedeLeon_HCWsMale,200606_Leon_UniversidadedeLeon_HCWsFemale,200606_Leon_UniversidadedeLeon_GPs,200606_Leon_UniversidadedeLeon_Nurses,200606_Leon_UniversidadedeLeon_HCWsLowExposure,200606_Leon_UniversidadedeLeon_HCWsHighExposure,200606_Leon_UniversidadedeLeon_HCWsLowPrevention,200606_Leon_UniversidadedeLeon_HCWsHighPrevention,200606_Leon_UniversidadedeLeon_HCWsIsolation,200606_Leon_UniversidadedeLeon_HCWsNotIsolation,200606_Leon_UniversidadedeLeon_HCWsNursingHome,200606_Leon_UniversidadedeLeon_HCWsHealthCentre,200606_Leon_UniversidadedeLeon_HCWsAsymptomatic/NoCOVID,200606_Leon_UniversidadedeLeon_HCWs_TestAdj1,200606_Leon_UniversidadedeLeon_HCWs_TestAdj2"
"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum",IgM,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test Cassette,"Hangzhou Biotest Biotech Co., Ltd",Frederick National Laboratory for Cancer Research,Not available,COV20030071,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,30,80,100,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3252-a001.pdf,Not available,Not available,-110,"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum",
"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) - IgG - Whole blood",IgG,Whole blood,1,49,Upper respiratory specimen,1,COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma),"Hangzhou Biotest Biotech Co., Ltd","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,4,100,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) - IgG - Whole blood",
"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) - IgM - Whole blood",IgM,Whole blood,1,49,Upper respiratory specimen,1,COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma),"Hangzhou Biotest Biotech Co., Ltd","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,30,88,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,"Hangzhou Biotest Biotech Co., Ltd - COVID-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) - IgM - Whole blood",
"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgG - Serum",IgG,Serum,1,256,Nasopharyngeal swabs,1,2019-nCoV IgG/IgM Rapid Test,"Hangzhou Clongene Biotech Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2020030098; 2020030093,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,62.1,98.1,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgG - Serum","200807_Lome_UniversiteDeLome_AirTransport_IgG,200807_Lome_UniversiteDeLome_Overall_IgG,200807_Lome_UniversiteDeLome_Police_IgG,200807_Lome_UniversiteDeLome_InformalSector_IgG,200807_Lome_UniversiteDeLome_HealthSector_IgG,200807_Lome_UniversiteDeLome_RoadTransport_IgG"
"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,1,256,Nasopharyngeal swabs,2,2019-nCoV IgG/IgM Rapid Test,"Hangzhou Clongene Biotech Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2020030098; 2020030093,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,65.4,90.3,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgG; IgM - Serum",200807_Lome_UniversiteDeLome_Overall
"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,2,1029,Not available,2,2019-nCoV IgG/IgM Rapid Test,"Hangzhou Clongene Biotech Co., Ltd",Institute of Laboratory Medicine - Semmelweis University,Not available,Not available,Hospital,Hungary,Budapest,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,31,998,11,840,35.5,84.2,https://akjournals.com/view/journals/650/161/20/article-p807.xml,10.1556/650.2020.31859,Not available,-1029,"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgG; IgM - Serum",
"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgM - Serum",IgM,Serum,1,256,Nasopharyngeal swabs,1,2019-nCoV IgG/IgM Rapid Test,"Hangzhou Clongene Biotech Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2020030098; 2020030093,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,39.2,91.3,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Hangzhou Clongene Biotech Co., Ltd - 2019-nCoV IgG/IgM Rapid Test - IgM - Serum","200807_Lome_UniversiteDeLome_AirTransport_IgM,200807_Lome_UniversiteDeLome_Overall_IgM,200807_Lome_UniversiteDeLome_Police_IgM,200807_Lome_UniversiteDeLome_InformalSector_IgM,200807_Lome_UniversiteDeLome_HealthSector_IgM,200807_Lome_UniversiteDeLome_RoadTransport_IgM"
"Hangzhou Laihe Biotech Co., Ltd - LYHER Novel Coronavirus(2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold) - IgG - Whole blood",IgG,Whole blood,1,49,Upper respiratory specimen,1,LYHER Novel Coronavirus(2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold),"Hangzhou Laihe Biotech Co., Ltd","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,4,100,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,"Hangzhou Laihe Biotech Co., Ltd - LYHER Novel Coronavirus(2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold) - IgG - Whole blood",
"Hangzhou Laihe Biotech Co., Ltd - LYHER Novel Coronavirus(2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold) - IgM - Whole blood",IgM,Whole blood,1,49,Upper respiratory specimen,1,LYHER Novel Coronavirus(2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold),"Hangzhou Laihe Biotech Co., Ltd","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,48,88,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,"Hangzhou Laihe Biotech Co., Ltd - LYHER Novel Coronavirus(2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold) - IgM - Whole blood",
Healgen - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum,IgG,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test Cassette,Healgen,Frederick National Laboratory for Cancer Research,Not available,2003292,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,29,78,96.7,97.5,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3247-a001.pdf,Not available,Not available,-110,Healgen - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum,200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1
Healgen - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test Cassette,Healgen,Frederick National Laboratory for Cancer Research,Not available,2003292,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,30,78,100,97.5,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3247-a001.pdf,Not available,Not available,-110,Healgen - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Plasma; Serum,200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgGIgM_T1
Healgen - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum,IgM,Plasma; Serum,1,110,Not available,1,COVID-19 IgG/IgM Rapid Test Cassette,Healgen,Frederick National Laboratory for Cancer Research,Not available,2003292,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,30,80,100,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3247-a001.pdf,Not available,Not available,-110,Healgen - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum,200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgM_T1
"Hecin Scientific, Inc. - COVID-19 IgM Antibody Rapid Test Kit - IgM - Plasma",IgM,Plasma,1,58,Plasma,1,COVID-19 IgM Antibody Rapid Test Kit,"Hecin Scientific, Inc.",Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,86.7,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,"Hecin Scientific, Inc. - COVID-19 IgM Antibody Rapid Test Kit - IgM - Plasma",
ID.Vet - ID Screen SARS-COV-2-N IgG indirect - IgG - Plasma,IgG,Plasma,1,58,Plasma,1,ID Screen SARS-COV-2-N IgG indirect,ID.Vet,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,70%,60%,Not available,Overall,38,20,Not available,Not available,86.7,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,ID.Vet - ID Screen SARS-COV-2-N IgG indirect - IgG - Plasma,
ImmunoDiagnostics limited - SARS-CoV-2 NP IgG ELISA Kit - IgG - Plasma; Serum,IgG,Plasma; Serum,1,180,Not available,1,SARS-CoV-2 NP IgG ELISA Kit,ImmunoDiagnostics limited,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,41A222,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,114,66,Not available,Not available,76,48,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-180,ImmunoDiagnostics limited - SARS-CoV-2 NP IgG ELISA Kit - IgG - Plasma; Serum,200726_Vienna_MedicalUniversityofVienna_hcw_IgG
ImmunoDiagnostics limited - SARS-CoV-2 NP IgM ELISA Kit - IgM - Plasma; Serum,IgM,Plasma; Serum,1,182,Not available,1,SARS-CoV-2 NP IgM ELISA Kit,ImmunoDiagnostics limited,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,41A224,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,115,67,Not available,Not available,79,70,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-182,ImmunoDiagnostics limited - SARS-CoV-2 NP IgM ELISA Kit - IgM - Plasma; Serum,200726_Vienna_MedicalUniversityofVienna_hcw_IgM
Innovita Biological Technology Co. Ltd - 2019 nCoV Ab test - IgG - Serum,IgG,Serum,1,90,Not available,1,2019 nCoV Ab test,Innovita Biological Technology Co. Ltd,,Not available,Not available,Hospital,Canada,Not available,Not available,Not available,Not available,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,16,50,40,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,Innovita Biological Technology Co. Ltd - 2019 nCoV Ab test - IgG - Serum,"200723_Wuhan_HubeiProvincialHospital_Genpop_IgG_Adj,200723_Wuhan_HubeiProvincialHospital_GenPop_IgG_TestAdj,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG,200723_Wuhan_HubeiProvincialHospital_MaleUnadj_IgG,200723_Wuhan_HubeiProvincialHospital_Male_TestAdj_IgG,200723_Wuhan_HubeiProvincialHospital_Male_PopAdj_IgG,200723_Wuhan_HubeiProvincialHospital_Female_UnadjIgG,200723_Wuhan_HubeiProvincialHospital_Female_PopAdj_IgG,200723_Wuhan_HubeiProvincialHospital_Female_TestAdj_IgG,200723_Wuhan_HubeiProvincialHospital_HCW,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Jiangan,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Caidian+Others,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Jianghan,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Huangpi,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Hanyang,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Qiaokou,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Wuchang,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Hongshan,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_Dongxihu,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkPrimaryMedicalCare,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkWaterandGas,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkRealEstate,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkGovernmentInstitution,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkAirport,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkBankSecuritiesInsurance,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkTelecommunications,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkHighwaymanagementAutoRepair,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkLawFirms,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkRehab,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkServiceIndustry,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgG_WorkPersonal"
Innovita Biological Technology Co. Ltd - 2019 nCoV Ab test - IgM - Serum,IgM,Serum,1,90,Not available,1,2019 nCoV Ab test,Innovita Biological Technology Co. Ltd,,Not available,Not available,Hospital,Canada,Not available,Not available,Not available,Not available,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,40,50,8,50,20,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-90,Innovita Biological Technology Co. Ltd - 2019 nCoV Ab test - IgM - Serum,"200723_Wuhan_HubeiProvincialHospital_Male_UnadjIgM,200723_Wuhan_HubeiProvincialHospital_Male_PopAdj_IgM,200723_Wuhan_HubeiProvincialHospital_Female_IgM_Unadj,200619_Wuhan_HubeiProvincialHospital_Female_PopAdj_IgM,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkPrimaryMedicalCare,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkWaterandGas,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkRealEstate,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkGovernmentInstitution,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkAirport,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkBankSecuritiesInsurance,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkTelecommunications,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkHighwaymanagementAutoRepair,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkLawFirms,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkRehab,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkServiceIndustry,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_WorkPersonal,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Jiangan,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Caidian+Others,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Jianghan,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Huangpi,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Hanyang,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Qiaokou,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Wuchang,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Hongshan,200723_Wuhan_HubeiProvincialHospital_GenpopUnadjIgM_Dongxihu"
Innovita Biological Technology Co. Ltd - 2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo) - IgG - Plasma; Serum,IgG,Plasma; Serum,1,224,Nasopharyngeal swabs; Oropharyngeal swabs,1,2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo),Innovita Biological Technology Co. Ltd,University of California,Not available,20200304,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,116,108,62,108,53.4,100,https://covidtestingproject.org/,Not available,Some band smearing,-224,Innovita Biological Technology Co. Ltd - 2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo) - IgG - Plasma; Serum,"200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG+ ,200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG+only"
Innovita Biological Technology Co. Ltd - 2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo) - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,224,Nasopharyngeal swabs; Oropharyngeal swabs,1,2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo),Innovita Biological Technology Co. Ltd,University of California,Not available,20200304,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,116,108,66,104,56.9,96.3,https://covidtestingproject.org/,Not available,Some band smearing,-224,Innovita Biological Technology Co. Ltd - 2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo) - IgG; IgM - Plasma; Serum,"200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM,200720_Wuhan_GuangzhouMedicalUniversity_OverallIgM+IgG,200720_Wuhan_GuangzhouMedicalUniversity_Male ,200720_Wuhan_GuangzhouMedicalUniversity_Female ,200720_Wuhan_GuangzhouMedicalUniversity_Age0-9 ,200720_Wuhan_GuangzhouMedicalUniversity_Age10-19 ,200720_Wuhan_GuangzhouMedicalUniversity_Age20-29 ,200720_Wuhan_GuangzhouMedicalUniversity_Age30-39,200720_Wuhan_GuangzhouMedicalUniversity_Age40-49 ,200720_Wuhan_GuangzhouMedicalUniversity_Age50-59 ,200720_Wuhan_GuangzhouMedicalUniversity_Age60-69,200720_Wuhan_GuangzhouMedicalUniversity_Age70-79,200720_Wuhan_GuangzhouMedicalUniversity_Age80-89 ,200723_Wuhan_HubeiProvincialHospital_GenpopUnadj,200723_Wuhan_HubeiProvincialHospital_GenpopPopAdj,200723_Wuhan_HubeiProvincialHospital_Genpop_TestAdj,200723_Wuhan_HubeiProvincialHospital_Male_Unadj,200723_Wuhan_HubeiProvincialHospital_Male_PopAdj,200723_Wuhan_HubeiProvincialHospital_Male_TestAdj,200723_Wuhan_HubeiProvincialHospital_Female_Unadj,200723_Wuhan_HubeiProvincialHospital_Females_PopAdj,200723_Wuhan_HubeiProvincialHospital_Female_TestAdj"
Innovita Biological Technology Co. Ltd - 2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo) - IgM - Plasma; Serum,IgM,Plasma; Serum,1,223,Nasopharyngeal swabs; Oropharyngeal swabs,1,2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo),Innovita Biological Technology Co. Ltd,University of California,Not available,20200304,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,115,108,33,104,28.7,96.3,https://covidtestingproject.org/,Not available,Some band smearing,-223,Innovita Biological Technology Co. Ltd - 2019-nCoV Ab Test (Colloidal Gold) (IgM/IgG Whole Blood/Serum/Plasma Combo) - IgM - Plasma; Serum,
Innovita Biological Technology Co. Ltd - SARS-CoV-2 IgG Ab Rapid Test - IgM - Whole blood,IgM,Whole blood,1,91,Not available,1,SARS-CoV-2 IgG Ab Rapid Test,Innovita Biological Technology Co. Ltd,,Not available,Not available,Hospital,Switzerland,Geneva,Confirmed COVID-19 cases and asymptomatic blood donors,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,50,6,50,14.6,100,https://www.mdpi.com/2077-0383/9/8/2369/htm,10.3390/jcm9082369,Not available,-91,Innovita Biological Technology Co. Ltd - SARS-CoV-2 IgG Ab Rapid Test - IgM - Whole blood,"200720_Wuhan_GuangzhouMedicalUniversity_OverallIgM+,200720_Wuhan_GuangzhouMedicalUniversity_OverallIgM+only"
"InTec Products, Inc. - Covid-19 IgG/IgM Antibody Test - IgG; IgM - Not available",IgG; IgM,Not available,1,211,Not available,1,Covid-19 IgG/IgM Antibody Test,"InTec Products, Inc.",,Not available,Not available,Public Health,Netherlands,Rotterdam,Asymptomatic individuals,Not available,Immunoassay; PRNT,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,113,98,102,83,90.3,84.7,https://www.nature.com/articles/s41467-020-17317-y.pdf,Not available,Not available,-211,"InTec Products, Inc. - Covid-19 IgG/IgM Antibody Test - IgG; IgM - Not available",
"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG - Serum",IgG,Serum,1,38,Nasopharyngeal swabs; Oropharyngeal swabs,3,Rapid SARS-CoV-2 Antibody (IgM/IgG),"InTec Products, Inc.",RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,25,13,18,12,72,92.3,Not available,Not available,Not available,-38,"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG - Serum",
"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG - Serum",IgG,Serum,2,99,Serum,3,Rapid SARS-CoV-2 Antibody (IgM/IgG),"InTec Products, Inc.",Viroscience Erasmus MC,Mild; Moderate; Severe,S2020021505.,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,99,Not available,95,Not available,96,96,Not available,Not available,Each sample was tested by one test and interpreted by two operators in parallel from Erasmus MC.,,"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG - Serum",
"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG - Serum",IgG,Serum,3,157,Plasma; Serum; Not available,3,Rapid SARS-CoV-2 Antibody (IgM/IgG),"InTec Products, Inc.","Department of Viroscience, Erasmus Medical Centre",Not available,S2020021505,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,93,64,Not available,Not available,95,77.3,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-157,"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG - Serum",
"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG; IgM - Serum",IgG; IgM,Serum,1,198,Serum,1,Rapid SARS-CoV-2 Antibody (IgM/IgG),"InTec Products, Inc.",Viroscience Erasmus MC,Mild; Moderate; Severe,S2020021505.,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,99,99,89,84,89.9,84.8,Not available,Not available,Each sample was tested by one test and interpreted by two operators in parallel from Erasmus MC.,-198,"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgG; IgM - Serum",
"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgM - Serum",IgM,Serum,1,38,Nasopharyngeal swabs; Oropharyngeal swabs,3,Rapid SARS-CoV-2 Antibody (IgM/IgG),"InTec Products, Inc.",RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,25,13,19,12,76,92.3,Not available,Not available,Not available,-38,"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgM - Serum",
"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgM - Serum",IgM,Serum,2,198,Serum,3,Rapid SARS-CoV-2 Antibody (IgM/IgG),"InTec Products, Inc.",Viroscience Erasmus MC,Mild; Moderate; Severe,S2020021505.,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,99,99,77,86,77.8,86.9,Not available,Not available,Each sample was tested by one test and interpreted by two operators in parallel from Erasmus MC.,-198,"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgM - Serum",
"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgM - Serum",IgM,Serum,3,157,Plasma; Serum; Not available,3,Rapid SARS-CoV-2 Antibody (IgM/IgG),"InTec Products, Inc.","Department of Viroscience, Erasmus Medical Centre",Not available,S2020021505,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,93,64,Not available,Not available,88.4,73.9,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-157,"InTec Products, Inc. - Rapid SARS-CoV-2 Antibody (IgM/IgG) - IgM - Serum",
Jiangsu Bioperfectus Technologies Co. Ltd - PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit - IgG - Plasma; Serum,IgG,Plasma; Serum,1,232,Nasopharyngeal swabs; Oropharyngeal swabs,1,PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit,Jiangsu Bioperfectus Technologies Co. Ltd,University of California,Not available,"20200313, 20200313, 20210312",Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,SC30201W,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,104,80,102,62.5,98.1,https://covidtestingproject.org/,Not available,Extra diluent necessary,-232,Jiangsu Bioperfectus Technologies Co. Ltd - PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit - IgG - Plasma; Serum,
Jiangsu Bioperfectus Technologies Co. Ltd - PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,233,Nasopharyngeal swabs; Oropharyngeal swabs,1,PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit,Jiangsu Bioperfectus Technologies Co. Ltd,University of California,Not available,"20200313, 20200313, 20210312",Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,SC30201W,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,105,95,100,74.2,95.2,https://covidtestingproject.org/,Not available,Extra diluent necessary,-233,Jiangsu Bioperfectus Technologies Co. Ltd - PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit - IgG; IgM - Plasma; Serum,
Jiangsu Bioperfectus Technologies Co. Ltd - PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit - IgM - Plasma; Serum,IgM,Plasma; Serum,1,232,Nasopharyngeal swabs; Oropharyngeal swabs,1,PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit,Jiangsu Bioperfectus Technologies Co. Ltd,University of California,Not available,"20200313, 20200313, 20210312",Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,SC30201W,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,104,91,101,71.1,97.1,https://covidtestingproject.org/,Not available,Extra diluent necessary,-232,Jiangsu Bioperfectus Technologies Co. Ltd - PerfectPOC Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit - IgM - Plasma; Serum,
Jiangsu Medomics Medical Technologies - SARS-CoV-2 rapid IgG-IgM Viva-DiagTM Test combined antibody test kit - IgG; IgM - Whole blood,IgG; IgM,Whole blood,1,190,Oropharyngeal swabs,1,SARS-CoV-2 rapid IgG-IgM Viva-DiagTM Test combined antibody test kit,Jiangsu Medomics Medical Technologies,Ospedale Policlinico Consorziale of Bari,Asymptomatic; Moderate,Not available,Public Health,Italy,Bari,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,70,120,21,107,30,89.2,https://www.medrxiv.org/content/10.1101/2020.04.03.20052183v1,10.1101/2020.04.03.20052183,Not available,-190,Jiangsu Medomics Medical Technologies - SARS-CoV-2 rapid IgG-IgM Viva-DiagTM Test combined antibody test kit - IgG; IgM - Whole blood,
Jiangsu Medomics Medical Technologies - SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit - IgG - Plasma; Serum,IgG,Plasma; Serum,1,525,Nasopharyngeal swabs; Sputum; Respiratory specimen,1,SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit,Jiangsu Medomics Medical Technologies,First Affiliated Hospital of Guangzhou Medical University,Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,Clinical examination; Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,397,128,24,127,6,99.2,https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25727,10.1002/jmv.25727,"Note, manufacturer is among authors.",-525,Jiangsu Medomics Medical Technologies - SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit - IgG - Plasma; Serum,
Jiangsu Medomics Medical Technologies - SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,525,Nasopharyngeal swabs; Serum,1,SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit,Jiangsu Medomics Medical Technologies,First Affiliated Hospital of Guangzhou Medical University,Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,Clinical examination; Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,397,128,352,116,88.7,90.6,https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25727,10.1002/jmv.25727,"Note, manufacturer is among authors.",-525,Jiangsu Medomics Medical Technologies - SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit - IgG; IgM - Plasma; Serum,
Jiangsu Medomics Medical Technologies - SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit - IgM - Plasma; Serum,IgM,Plasma; Serum,1,525,Nasopharyngeal swabs; Sputum,1,SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit,Jiangsu Medomics Medical Technologies,First Affiliated Hospital of Guangzhou Medical University,Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,Clinical examination; Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,397,128,72,118,18.1,92.2,https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25727,10.1002/jmv.25727,"Note, manufacturer is among authors.",-525,Jiangsu Medomics Medical Technologies - SARS‐CoV‐2 rapid IgG‐IgM combined antibody test kit - IgM - Plasma; Serum,
Jiangsu Medomics medical technology Co. - A Rapid IgM-IgG Combined Antibody Test Kit for SARS-CoV-2 - IgG - Whole blood,IgG,Whole blood,1,,Upper respiratory specimen,1,A Rapid IgM-IgG Combined Antibody Test Kit for SARS-CoV-2,Jiangsu Medomics medical technology Co.,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,Not available,Not available,Not available,Not available,6,91,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,N=40,,Jiangsu Medomics medical technology Co. - A Rapid IgM-IgG Combined Antibody Test Kit for SARS-CoV-2 - IgG - Whole blood,
Jiangsu Medomics medical technology Co. - A Rapid IgM-IgG Combined Antibody Test Kit for SARS-CoV-2 - IgM - Whole blood,IgM,Whole blood,1,,Upper respiratory specimen,1,A Rapid IgM-IgG Combined Antibody Test Kit for SARS-CoV-2,Jiangsu Medomics medical technology Co.,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,Not available,Not available,Not available,Not available,24,87,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,N=40,,Jiangsu Medomics medical technology Co. - A Rapid IgM-IgG Combined Antibody Test Kit for SARS-CoV-2 - IgM - Whole blood,
"Liming Bio-Products Co., Ltd - StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test - IgG - Serum",IgG,Serum,1,256,Nasopharyngeal swabs,1,StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test,"Liming Bio-Products Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2003020,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,64.7,99,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Liming Bio-Products Co., Ltd - StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test - IgG - Serum",
"Liming Bio-Products Co., Ltd - StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,1,256,Nasopharyngeal swabs,1,StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test,"Liming Bio-Products Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2003020,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,66.7,98.1,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Liming Bio-Products Co., Ltd - StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test - IgG; IgM - Serum",
"Liming Bio-Products Co., Ltd - StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test - IgM - Serum",IgM,Serum,1,256,Nasopharyngeal swabs,1,StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test,"Liming Bio-Products Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2003020,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,32,99,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"Liming Bio-Products Co., Ltd - StrongStep SARS-CoV-2 IgM/IgG Antibody Rapid Test - IgM - Serum",
Maccura Biotechnology - SARS-CoV-2 IgM/IgG - IgG; IgM - Not available,IgG; IgM,Not available,1,143,Nasopharyngeal swabs,1,SARS-CoV-2 IgM/IgG,Maccura Biotechnology,"Institute of Laboratory Medicine, Kantonsspital Aarau AG",Not available,Not available,Hospital,Switzerland,Aarau,Symptomatic patients,Prospectively collected set,Clinical examination; Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,67,76,40,67,59.7,88.2,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0635/article-10.1515-cclm-2020-0635.xml,10.1515/cclm-2020-0635,Not available,-143,Maccura Biotechnology - SARS-CoV-2 IgM/IgG - IgG; IgM - Not available,
"MEDsan GmbH, Biological Health Solutions, Hamburg, Germany - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG - Whole blood",IgG,Whole blood,1,91,Not available,1,SARS-CoV-2 IgM/IgG Ab Rapid Test,"MEDsan GmbH, Biological Health Solutions, Hamburg, Germany",,Confirmed COVID-19 cases and asymptomatic blood donors,Not available,Hospital,Switzerland,Geneva,Not available,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,50,39,49,95.1,98,https://www.mdpi.com/2077-0383/9/8/2369/htm,10.3390/jcm9082369,Not available,-91,"MEDsan GmbH, Biological Health Solutions, Hamburg, Germany - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG - Whole blood",
Mikrogen GmbH - recomWell SARS-CoV-2 IgG ELISA - IgG - Serum,IgG,Serum,1,126,Respiratory specimen,1,recomWell SARS-CoV-2 IgG ELISA,Mikrogen GmbH,"Institut für Infektionsmedizin, Christian-Albrechts-Universität und Universitätsklinikum Schleswig-Holstein",Not available,Not available,Hospital,Germany,Kiel,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Signal/cut-off value of ≥1,Signal/cut-off value of <1,Not available,Overall,26,100,Not available,Not available,88.5,98,https://www.medrxiv.org/content/10.1101/2020.06.15.20131672v1.full.pdf,10.1101/2020.06.15.20131672,"Controls: Pre-pandemic controls

Sample collection between 4 and 60 days (median 19 days) after a positive real-time RT-PCR result

 Only  sera  from  individuals  that 70 exhibited a cycle threshold (CT) ≤ 35 (median CT 26.8) in the initial real-time RT-PCR were included.",-126,Mikrogen GmbH - recomWell SARS-CoV-2 IgG ELISA - IgG - Serum,
Mologic Ltd - SARS-CoV-2 ELISA Serology - IgG - Serum,IgG,Serum,1,834,Nasopharyngeal swabs,1,SARS-CoV-2 ELISA Serology,Mologic Ltd,"Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine",Not available,Not available,Hospital,Great Britain,London,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,270,564,238,549,88.1,97.3,https://www.medrxiv.org/content/10.1101/2020.04.29.20082099v1.full.pdf,10.1101/2020.04.29.20082099,"Note, manufacturer is among authors.

Sensitivity: Total SARS-CoV-2 positive samples ranging from day 0 - 42 post laboratory diagnosis with RT-PCR

Specificity: Total SARS-CoV-2 negative samples ranging from 2018 - 2019",-834,Mologic Ltd - SARS-CoV-2 ELISA Serology - IgG - Serum,
Multi-G B.V. - COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma) - IgG - Serum,IgG,Serum,1,256,Nasopharyngeal swabs,1,COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma),Multi-G B.V.,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,NCP20030081; NCP20030181,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,64.7,97.1,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,Multi-G B.V. - COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma) - IgG - Serum,"200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_PatientContact,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_NoPatientContact,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_WorkDuringLockdown,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_NoWorkDuringLockdown,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_CovidPatientContact,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_NoCovidPatientContact,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_CovidCoworkerContact,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorker_NoCovidCoworkerContact,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_SuspectedCovidHousehold,200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers_No_SuspectedCovidHousehold"
Multi-G B.V. - COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma) - IgG; IgM - Serum,IgG; IgM,Serum,1,256,Nasopharyngeal swabs,1,COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma),Multi-G B.V.,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,NCP20030081; NCP20030181,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,71.2,88.3,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,Multi-G B.V. - COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma) - IgG; IgM - Serum,
Multi-G B.V. - COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma) - IgM - Serum,IgM,Serum,1,256,Nasopharyngeal swabs,1,COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma),Multi-G B.V.,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,NCP20030081; NCP20030181,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,43.8,91.3,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,Multi-G B.V. - COVID-19 IgG/IgM Ab Test Cassette (Whole Blood/Serum/Plasma) - IgM - Serum,
nal von minden GmbH - NADAL® COVID-19 IgG/IgM Test - IgG - Plasma; Serum,IgG,Plasma; Serum,1,175,Not available,1,NADAL® COVID-19 IgG/IgM Test,nal von minden GmbH,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,243003N-20,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,107,68,Not available,Not available,64,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-175,nal von minden GmbH - NADAL® COVID-19 IgG/IgM Test - IgG - Plasma; Serum,"200819_Autria_UniversityHospitalKrems_hcw_poc1_blood_IgG,200819_Autria_UniversityHospitalKrems_hcw_poc1_serum_IgG"
nal von minden GmbH - NADAL® COVID-19 IgG/IgM Test - IgM - Plasma; Serum,IgM,Plasma; Serum,1,173,Not available,1,NADAL® COVID-19 IgG/IgM Test,nal von minden GmbH,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,243003N-20,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,106,67,Not available,Not available,75,99,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-173,nal von minden GmbH - NADAL® COVID-19 IgG/IgM Test - IgM - Plasma; Serum,"200819_Autria_UniversityHospitalKrems_hcw_poc1_blood_IgM,200819_Autria_UniversityHospitalKrems_hcw_poc1_serum_IgM"
NG Biotech - NG-Test IgG-IgM COVID-19 - IgG - Serum,IgG,Serum,1,293,Not available,1,NG-Test IgG-IgM COVID-19,NG Biotech,"Virology Laboratory, Angers University Hospital",Not available,Not available,Hospital,France,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,141,152,Not available,Not available,78.3,98,https://reader.elsevier.com/reader/sd/pii/S1386653220302535?token=341A1A99931901504B0EDE6F1EC192695BC491A850BE5FDF9A3467E2101C4C30CA935015148BC7A4A4F45C3916735036,10.1016/j.jcv.2020.104511,"Controls: Patients with symptoms consistent with COVID-19 but with a negative RT-PCR result, pre-pandemic controls",-293,NG Biotech - NG-Test IgG-IgM COVID-19 - IgG - Serum,
NG Biotech - NG-Test IgG-IgM COVID-19 - IgG; IgM - Serum,IgG; IgM,Serum,1,293,Not available,1,NG-Test IgG-IgM COVID-19,NG Biotech,"Virology Laboratory, Angers University Hospital",Not available,Not available,Hospital,France,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,141,152,Not available,Not available,81.8,95.3,https://reader.elsevier.com/reader/sd/pii/S1386653220302535?token=341A1A99931901504B0EDE6F1EC192695BC491A850BE5FDF9A3467E2101C4C30CA935015148BC7A4A4F45C3916735036,10.1016/j.jcv.2020.104511,"Controls: Patients with symptoms consistent with COVID-19 but with a negative RT-PCR result, pre-pandemic controls",-293,NG Biotech - NG-Test IgG-IgM COVID-19 - IgG; IgM - Serum,
NG Biotech - NG-Test IgG-IgM COVID-19 - IgM - Serum,IgM,Serum,1,293,Not available,1,NG-Test IgG-IgM COVID-19,NG Biotech,"Virology Laboratory, Angers University Hospital",Not available,Not available,Hospital,France,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,141,152,Not available,Not available,81.8,95.3,https://reader.elsevier.com/reader/sd/pii/S1386653220302535?token=341A1A99931901504B0EDE6F1EC192695BC491A850BE5FDF9A3467E2101C4C30CA935015148BC7A4A4F45C3916735036,10.1016/j.jcv.2020.104511,"Controls: Patients with symptoms consistent with COVID-19 but with a negative RT-PCR result, pre-pandemic controls",-293,NG Biotech - NG-Test IgG-IgM COVID-19 - IgM - Serum,
Not available - SARS-CoV-2 IgM Ab Rapid Test - IgM - Whole blood,IgM,Whole blood,1,91,Not available,1,SARS-CoV-2 IgM Ab Rapid Test,Not available,,Not available,Not available,Hospital,Switzerland,Geneva,Confirmed COVID-19 cases and asymptomatic blood donors,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,"Zhejian Orient-Gene Biotech Co. Ltd., Huzhou, China",Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,50,38,49,92.7,98,https://www.mdpi.com/2077-0383/9/8/2369/htm,10.3390/jcm9082369,Not available,-91,Not available - SARS-CoV-2 IgM Ab Rapid Test - IgM - Whole blood,
"NTBIO Diagnostics Inc., Surrey, BC, Canada - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG - Whole blood",IgG,Whole blood,1,91,Not reported,1,SARS-CoV-2 IgM/IgG Ab Rapid Test,"NTBIO Diagnostics Inc., Surrey, BC, Canada",,Not available,Not available,Hospital,Switzerland,Geneva,Confirmed COVID-19 cases and asymptomatic blood donors,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,41,50,36,49,87.8,98,https://www.mdpi.com/2077-0383/9/8/2369/htm,10.3390/jcm9082369,Not available,-91,"NTBIO Diagnostics Inc., Surrey, BC, Canada - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG - Whole blood",
"Orient Gene Biotech, Zhejiang, China - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",IgG; IgM,Serum,1,148,Nasopharyngeal swabs,1,COVID-19 IgG/IgM Rapid Test Cassette,"Orient Gene Biotech, Zhejiang, China","Hôpital Saint- Louis,  Paris",Not available,Not available,Hospital,France,Paris,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,106,42,99,42,93.4,100,https://jcm.asm.org/content/jcm/early/2020/06/08/JCM.01233-20.full.pdf,Not available,Not available,-148,"Orient Gene Biotech, Zhejiang, China - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Serum",
Ortho Clinical Diagnostics - VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total - IgG; IgM - Serum,IgG; IgM,Serum,1,136,Not available,1,VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total,Ortho Clinical Diagnostics,Texas Children’s Hospital,Not available,Not available,Hospital,United States of America (USA),Houston,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Blinded to reference results,Antibody,Immunoassay,Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,79,57,56,57,70.9,100,https://www.medrxiv.org/content/10.1101/2020.06.09.20126474v1.full.pdf,10.1101/2020.06.09.20126474,Not available,-136,Ortho Clinical Diagnostics - VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total - IgG; IgM - Serum,
Ortho Clinical Diagnostics - VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total - Total Ig - Serum,Total Ig,Serum,1,591,Nasopharyngeal swabs,1,VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total,Ortho Clinical Diagnostics,Public Health England,Not available,Not available,Public Health,Great Britain,London,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not available,Antibody,Chemiluminescent immunoassay (CLIA),Detection of past infection,Not available,Not available,Not available,Not available,Not available,≥1.0,<1.0,Not available,Overall,100,491,85,488,85,99.4,https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/894173/Evaluation_of_OCD_Vitros_Immunodiagnostic_Anti-SARS_CoV2_total_antibody_serology_assay.pdf,Not available,"-Breakdown of reporting days is as follows:
  early: <= 10 days
  intermediate: 11-20 days
  late: >=21 days

-For 31-40 days, sensitivity is 31/31 = 100%",-591,Ortho Clinical Diagnostics - VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total - Total Ig - Serum,"200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age<10,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age10to19,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age20to29,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age30to39,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age40to49,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age50to59,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age70to79,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age60to69,200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OrthoClinicalCLIA_Age80+,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age<10,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age10to19,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age20to29,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age30to39,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age40to49,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age50to59,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age60to69,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age70to79,200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OrthoDiagnosticsCLIA_Age80+,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_Male_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_Female_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_OtherGender_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_Age0to17_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_Age18to49_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_Age50to64_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPopAge65+_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_WhiteNonhispanic_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_BlackNonhispanic_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_Hispanic_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_AsianPacificIslanderNonHispanic_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_MultipleRaceOtherUnknown_PopAdj,200721_Georgia_CDCandGeorgiaPublicHealth_GenPop_Unadj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Male_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Female_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Age0-17_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Age18-49_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Age50-64_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Age>=65_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Male_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Female_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_White_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Black_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Hispanic_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Asian/PacificIslander_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Multiple/Other/Unknown_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_AnyChronicConditions_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_ChronicLungDisease_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_CardiovascularDisease_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_ChronicKidneyDisease_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_LiverDisease_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_DiabetesMellitus_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Autoimmune/RheumatologicCondition_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_ImmunocompromisingConditionOrTherapy_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_NeurologicCondition_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_SeasonalAllergies_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_PregnantOrPostPartum_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Contact>=1ConfirmedCase_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Care1ConfirmedCase_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Contact>=1RespiratorySymptomsUnconfirmed_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_IntlTravel_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_DomesticTravel_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_AttendWorkSchoolDaycare_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_HealthcareSetting_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_OutpatientUrgentCare_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_HospitalOrEmergDpt_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_LongTermCareAssistedLivingFacility_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_>1HealthcareSetting_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_OtherWorkplaceSetting_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Utilities/Construction/Manufacturing_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Warehouse/Shipping/ParcelDelivery_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Restaurants/Bars/Food services/Accommodation_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Retail/GroceryStores_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Transportation_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Education/ChildDayCare_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Healthcare_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_BarberShop/BeautySalon/PersonalServices_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Finance/Banking/InsuranceRealEstate/Rental/Leasing_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Professional/Scientific/TechnicalServices_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_ PublicAdministration_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_ReligiousOrganizations_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Student_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_OtherIndustry_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_RetiredUnemployed_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_NoInfoOccupation_UnAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_SingleUnit_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_MultiUnit_PopAdj,200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj"
Ortho Clinical Diagnostics Inc. - VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,1,583,Swab,1,VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG,Ortho Clinical Diagnostics Inc.,Diagnostic Support Group (DSP) at PHE Porton,Not available,Not available,Public Health,Great Britain,Not available,Convalescent COVID-19 patients and pre-pandemic negative controls,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Ratio ≥1.0,Ratio <1.0,Not available,Overall,93,490,72,488,77.4,99.6,https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/888631/Evaluation__of_OCD_Vitros_Immunodiagnostic_Anti-SARS_CoV2_serology_assay_PHE_260520.pdf,Not available,"Data reported for early/intermediate/late phases likely refer to time since hospital admission rather than symptom onset.

Controls: Negative samples; confounder + RIPL samples",-583,Ortho Clinical Diagnostics Inc. - VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 IgG - IgG - Serum,"200725_California_HoagMemorialHospitalPresbyterian_Healthcareworkers_TestAdj,200725_California_HoagMemorialHospitalPresbyterian_Healthcareworkers_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HealthcareworkersFemale_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HealthcareworkersMale_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HCWAmericanIndianorAlaskaNative_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HCWAsian_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HCWBlack_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HCWHispanicLatino_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HCWNativeHawaiianPacificIslander_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HCWWhite_UnAdj,200725_California_HoagMemorialHospitalPresbyterian_HCWOther_UnAdj,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_TestAdj_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Female_TestAdj_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Male_TestAdj_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Age15-34_TestAdj_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Age35-64_TestAdj_IgG_1 ,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Age65_TestAdj_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Asian_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Black/AfricanAmerican_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Hispanic/Latino_TestAdj_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_NativeAmerican_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_White_TestAdj_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_OtherMultiple_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_UnknownDeclined_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Female_TestAd_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Male_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Age15-34_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Age35-64_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Age65_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Female_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_Hispanic/Latino_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_White_IgG_1,200726_RhodeIsland_NewYorkBloodCenter_BloodDonors_UnknownDeclined_TestAdj_IgG_1,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Asymptomatic_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_HouseholdSymptomaticContacts_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_AvoidingPublicPlaces_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_AvoidingPublicPlaces_PopAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_AvoidingGatherings_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_AvoidingGatherings_PopAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_WorkFromHome_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_WorkFromHome_PopAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_WoreMask_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_WoreMask_PopAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_AirplaneTravel_UnAdj,201028_Connecticut_YaleSchoolOfMedicine_GenPop1_AirplaneTravel_PopAdj"
PCL Inc. - PCL COVID19 IgG/IgM Rapid Gold - IgG - Serum,IgG,Serum,1,149,Nasopharyngeal swabs; Sputum,1,PCL COVID19 IgG/IgM Rapid Gold,PCL Inc.,"Department of Laboratory Medicine, Catholic University of Daegu School of Medicine",Not available,Not available,Hospital,"Korea, Republic of (South Korea)",Daegu,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,70,79,65,78,92.9,98.7,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26060,10.1002/jmv.26060,Mean disease duration defined period from diagnosis to enrollment in this study was 23.7 days (SD 10.2).,-149,PCL Inc. - PCL COVID19 IgG/IgM Rapid Gold - IgG - Serum,
PCL Inc. - PCL COVID19 IgG/IgM Rapid Gold - IgG; IgM - Serum,IgG; IgM,Serum,1,149,Nasopharyngeal swabs; Sputum,1,PCL COVID19 IgG/IgM Rapid Gold,PCL Inc.,"Department of Laboratory Medicine, Catholic University of Daegu School of Medicine",Not available,Not available,Hospital,"Korea, Republic of (South Korea)",Daegu,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,70,79,65,76,92.9,96.2,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26060,10.1002/jmv.26060,Mean disease duration defined period from diagnosis to enrollment in this study was 23.7 days (SD 10.2).,-149,PCL Inc. - PCL COVID19 IgG/IgM Rapid Gold - IgG; IgM - Serum,"200616_Madrid_UniversidadAutónomadeMadrid_HealthWorkers,200616_Madrid_UniversidadAutónomadeMadrid_TotalPop,200616_Madrid_UniversidadAutónomadeMadrid_UniversityEmployees,200616_Madrid_UniversidadAutónomadeMadrid_IndividualsLivinginCommunities"
PCL Inc. - PCL COVID19 IgG/IgM Rapid Gold - IgM - Serum,IgM,Serum,1,149,Nasopharyngeal swabs; Sputum,1,PCL COVID19 IgG/IgM Rapid Gold,PCL Inc.,"Department of Laboratory Medicine, Catholic University of Daegu School of Medicine",Not available,Not available,Hospital,"Korea, Republic of (South Korea)",Daegu,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,70,79,46,77,65.7,97.5,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26060,10.1002/jmv.26060,Mean disease duration defined period from diagnosis to enrollment in this study was 23.7 days (SD 10.2).,-149,PCL Inc. - PCL COVID19 IgG/IgM Rapid Gold - IgM - Serum,
Phamatech - COVID19 RAPID TEST - IgG - Plasma; Serum,IgG,Plasma; Serum,1,110,Not available,1,COVID19 RAPID TEST,Phamatech,Frederick National Laboratory for Cancer Research,Not available,NCP20030239,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,26,77,86.7,96.2,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3249-a001.pdf,Not available,Not available,-110,Phamatech - COVID19 RAPID TEST - IgG - Plasma; Serum,
Phamatech - COVID19 RAPID TEST - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,110,Not available,1,COVID19 RAPID TEST,Phamatech,Frederick National Laboratory for Cancer Research,Not available,NCP20030239,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,26,75,86.7,93.8,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3249-a001.pdf,Not available,Not available,-110,Phamatech - COVID19 RAPID TEST - IgG; IgM - Plasma; Serum,200529_CoachellaValley_Desert Healthcare District_GenPop
Phamatech - COVID19 RAPID TEST - IgM - Plasma; Serum,IgM,Plasma; Serum,1,110,Not available,1,COVID19 RAPID TEST,Phamatech,Frederick National Laboratory for Cancer Research,Not available,NCP20030239,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,8,78,26.7,97.5,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3249-a001.pdf,Not available,Not available,-110,Phamatech - COVID19 RAPID TEST - IgM - Plasma; Serum,
Premier Biotech - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum,IgG,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 IgG/IgM Rapid Test Cassette,Premier Biotech,University of California,Not available,COV200300 71,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,INGM-MC42S,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,129,108,69,107,53.5,99.1,https://covidtestingproject.org/,Not available,Some band smearing,-237,Premier Biotech - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Plasma; Serum,
Premier Biotech - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 IgG/IgM Rapid Test Cassette,Premier Biotech,University of California,Not available,COV200300 71,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,INGM-MC42S,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,129,108,91,105,70.5,97.2,https://covidtestingproject.org/,Not available,Some band smearing,-237,Premier Biotech - COVID-19 IgG/IgM Rapid Test Cassette - IgG; IgM - Plasma; Serum,"200430_SantaClaraCounty_UniversityofStanford_GenPop_UnAdj,200430_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj,200430_SantaClaraCounty_UniversityofStanford_GenPop_TestAdj,200518_LosAngelesCounty_StanfordUniversity_GenPopUnweighted_TestAdj,200518_LosAngelesCounty_StanfordUniversity_GenPopCrude,200518_LosAngelesCounty_StanfordUniversity_GenPopWeighted_NoTestAdj,200518_LosAngelesCounty_StanfordUniversity_Female,200518_LosAngelesCounty_StanfordUniversity_Male,200518_LosAngelesCounty_StanfordUniversity_18-34yrs,200518_LosAngelesCounty_StanfordUniversity_35-54yrs,200518_LosAngelesCounty_StanfordUniversity_>=55yrs,200518_LosAngelesCounty_StanfordUniversity_Hispanic,200518_LosAngelesCounty_StanfordUniversity_White,200518_LosAngelesCounty_StanfordUniversity_Black,200518_LosAngelesCounty_StanfordUniversity_OtherEthnicity,200518_LosAngelesCounty_StanfordUniversity_Income<$50000,200518_LosAngelesCounty_StanfordUniversity_Income$50000to$99999,200518_LosAngelesCounty_StanfordUniversity_Income>$100000,200518_LosAngelesCounty_StanfordUniversity_MissingIncomeData,200518_LosAngelesCounty_StanfordUniversity_GenPopWeighted_TestAdj"
Premier Biotech - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum,IgM,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,COVID-19 IgG/IgM Rapid Test Cassette,Premier Biotech,University of California,Not available,COV200300 71,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,INGM-MC42S,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,129,108,89,106,69,98.1,https://covidtestingproject.org/,Not available,Some band smearing,-237,Premier Biotech - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Plasma; Serum,
PRIMA Lab S.A. - PRIMA COVID-19 IgG/IgM Rapid Test - IgG - Serum,IgG,Serum,1,256,Nasopharyngeal swabs,1,PRIMA COVID-19 IgG/IgM Rapid Test,PRIMA Lab S.A.,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,E01349; E01350,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,71.2,90.3,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,PRIMA Lab S.A. - PRIMA COVID-19 IgG/IgM Rapid Test - IgG - Serum,
PRIMA Lab S.A. - PRIMA COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,IgG; IgM,Serum,1,256,Nasopharyngeal swabs,1,PRIMA COVID-19 IgG/IgM Rapid Test,PRIMA Lab S.A.,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,E01349; E01350,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,79.1,85.4,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,PRIMA Lab S.A. - PRIMA COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,"200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj,200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_Females,200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_Male(andother),200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_HCW,200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_Smokers,200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_Hypertension,200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_OutbreakStartTestAdj,200531_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_OutbreakEndTestAdj,200704_Milan_SantagostinoMedicalCenter_HCWs,200704_Milan_SantagostinoMedicalCenter_HCWs+Family,200704_Milan_SantagostinoMedicalCenter_FamilyMembers,200704_Milan_SantagostinoMedicalCenter_FamilyMembersYoung,200704_Milan_SantagostinoMedicalCenter_FamilyMembersMiddleAge,200704_Milan_SantagostinoMedicalCenter_FamilyMembersOld"
PRIMA Lab S.A. - PRIMA COVID-19 IgG/IgM Rapid Test - IgM - Serum,IgM,Serum,1,256,Nasopharyngeal swabs,1,PRIMA COVID-19 IgG/IgM Rapid Test,PRIMA Lab S.A.,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,E01349; E01350,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,56.2,93.2,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,PRIMA Lab S.A. - PRIMA COVID-19 IgG/IgM Rapid Test - IgM - Serum,
Prometheus Bio Inc. - 2019-nCOV IgG/IgM Test Cassette (Whole blood/Serum/Plasma) - IgG; IgM - Serum,IgG; IgM,Serum,1,25,Nasopharyngeal swabs; Oropharyngeal swabs; Sputum,1,2019-nCOV IgG/IgM Test Cassette (Whole blood/Serum/Plasma),Prometheus Bio Inc.,Department of Medical Microbiology and Infection Control,Not available,Not available,Hospital,Netherlands,Rotterdam,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,20,5,4,5,20,100,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30305-0/pdf,10.1016/j.cmi.2020.05.028,Not available,-25,Prometheus Bio Inc. - 2019-nCOV IgG/IgM Test Cassette (Whole blood/Serum/Plasma) - IgG; IgM - Serum,
"Qingdao Hightop Biotech Co., Ltd - Hightop COVID-19 IgM/IgG Ab Rapid Test Kit - IgG - Serum",IgG,Serum,1,228,Respiratory specimen,1,Hightop COVID-19 IgM/IgG Ab Rapid Test Kit,"Qingdao Hightop Biotech Co., Ltd",Royal Melbourne Hospital and Victorian Infectious Diseases Reference Laboratory,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Duplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,136,92,80,92,58.8,100,https://www.health.gov.au/sites/default/files/documents/2020/06/post-market-validation-of-serological-assays-for-covid-19-updated-report_0.pdf,Not available,"Controls: Patients  with  respiratory  viral  infections, patients  with  other  acute  infections, pre-pandemic controls",-228,"Qingdao Hightop Biotech Co., Ltd - Hightop COVID-19 IgM/IgG Ab Rapid Test Kit - IgG - Serum",
"Qingdao Hightop Biotech Co., Ltd - Hightop COVID-19 IgM/IgG Ab Rapid Test Kit - IgG; IgM - Serum",IgG; IgM,Serum,1,228,Respiratory specimen,1,Hightop COVID-19 IgM/IgG Ab Rapid Test Kit,"Qingdao Hightop Biotech Co., Ltd",Royal Melbourne Hospital and Victorian Infectious Diseases Reference Laboratory,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Duplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,136,92,83,92,61,100,https://www.health.gov.au/sites/default/files/documents/2020/06/post-market-validation-of-serological-assays-for-covid-19-updated-report_0.pdf,Not available,"Controls: Patients  with  respiratory  viral  infections, patients  with  other  acute  infections, pre-pandemic controls",-228,"Qingdao Hightop Biotech Co., Ltd - Hightop COVID-19 IgM/IgG Ab Rapid Test Kit - IgG; IgM - Serum",
"Qingdao Hightop Biotech Co., Ltd - Hightop COVID-19 IgM/IgG Ab Rapid Test Kit - IgM - Serum",IgM,Serum,1,228,Respiratory specimen,1,Hightop COVID-19 IgM/IgG Ab Rapid Test Kit,"Qingdao Hightop Biotech Co., Ltd",Royal Melbourne Hospital and Victorian Infectious Diseases Reference Laboratory,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Duplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,136,92,53,92,39,100,https://www.health.gov.au/sites/default/files/documents/2020/06/post-market-validation-of-serological-assays-for-covid-19-updated-report_0.pdf,Not available,"Controls: Patients  with  respiratory  viral  infections, patients  with  other  acute  infections, pre-pandemic controls",-228,"Qingdao Hightop Biotech Co., Ltd - Hightop COVID-19 IgM/IgG Ab Rapid Test Kit - IgM - Serum",
RayBiotech - Novel Coronavirus IgG antibody test kit (colloidal gold method) - IgG - Whole blood,IgG,Whole blood,1,49,Upper respiratory specimen,1,Novel Coronavirus IgG antibody test kit (colloidal gold method),RayBiotech,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,9,79,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,RayBiotech - Novel Coronavirus IgG antibody test kit (colloidal gold method) - IgG - Whole blood,
RayBiotech - Novel Coronavirus IgM antibody test kit (colloidal gold method) - IgM - Whole blood,IgM,Whole blood,1,,Upper respiratory specimen,1,Novel Coronavirus IgM antibody test kit (colloidal gold method),RayBiotech,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,Not available,Not available,Not available,Not available,27,68,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,N=30,,RayBiotech - Novel Coronavirus IgM antibody test kit (colloidal gold method) - IgM - Whole blood,
Roche - Elecsys Anti‐SARS‐CoV‐2 - IgG; IgM - Serum,IgG; IgM,Serum,1,565,Pharyngeal swabs,1,Elecsys Anti‐SARS‐CoV‐2,Roche,Diagnostic Support Group (DSP) at PHE Porton,Not available,49025901,Public Health,Great Britain,Not available,Confirmed COVID-19 patients,Not available,RT-PCR,No replicates,Not available,Antibody,Electrochemiluminescence immunoassay (ECLIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,93,472,78,472,83.9,100,https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/886159/PHE_Evaluation_of_Roche_Elecsys_anti_SARS_CoV_2.pdf,Not available,Not available,-565,Roche - Elecsys Anti‐SARS‐CoV‐2 - IgG; IgM - Serum,"200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020,200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020,200729_London_WhittingtonHealthNHSTrust_Overall,200729_London_WhittingtonHealthNHSTrust_1,200729_London_WhittingtonHealthNHSTrust_2,200729_London_WhittingtonHealthNHSTrust_3,200729_London_WhittingtonHealthNHSTrust_4,200729_London_WhittingtonHealthNHSTrust_5,200729_London_WhittingtonHealthNHSTrust_Overall_Covidwardcpap,200729_London_WhittingtonHealthNHSTrust_Overall_Covidwardnocpap,200729_London_WhittingtonHealthNHSTrust_Overall_Noncovidward,200729_London_WhittingtonHealthNHSTrust_Overall_OR,200729_London_WhittingtonHealthNHSTrust_Overall_Noncovidwardother,200729_London_WhittingtonHealthNHSTrust_Overall_ICU,200618_Japan_IwatePrefecturalCentralHospital_HealthCareWorkersRocheTest_IgG/IgM,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_unadjusted,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_TestAdj,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_age18_34,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_age35_49,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_age50_65,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_age65+,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_sex_male,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_sex_female,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_comorb_hypert,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_comorb_DM2,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_comorb_obesity,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_occu_police,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_occu_manager,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_occu_maint,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_occu_HCW,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_occu_other,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_geo_guad,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_geo_mty,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_geo_juarez,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_geo_other,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_BMI_under,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_BMI_normal,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_BMI_over,201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_BMI_obesity"
Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Plasma; Serum,Total Ig,Plasma; Serum,1,174,Not available,1,Elecsys Anti‐SARS‐CoV‐2,Roche,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Electrochemiluminescence immunoassay (ECLIA),Detection of current infection; Detection of past infection,09203095190,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,107,67,Not available,Not available,73,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-174,Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Plasma; Serum,"200607_Jordan_KingHusseinCancerCentre_BloodDonors,200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall"
Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Serum,Total Ig,Serum,1,126,Respiratory specimen,3,Elecsys Anti‐SARS‐CoV‐2,Roche,"Institut für Infektionsmedizin, Christian-Albrechts-Universität und Universitätsklinikum Schleswig-Holstein",Not available,Not available,Hospital,Germany,Kiel,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Electrochemiluminescence immunoassay (ECLIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Signal/cut-off value of ≥1,Signal/cut-off value of <1,Not available,Overall,26,100,Not available,Not available,88.5,99,https://www.medrxiv.org/content/10.1101/2020.06.15.20131672v1.full.pdf,10.1101/2020.06.15.20131672,"Controls: Pre-pandemic controls

Sample collection between 4 and 60 days (median 19 days) after a positive real-time RT-PCR result

 Only  sera  from  individuals  that 70 exhibited a cycle threshold (CT) ≤ 35 (median CT 26.8) in the initial real-time RT-PCR were included.",-126,Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Serum,"200717_Switzerland_UniversityofLausanne_Contacts_ECLIAAssay,200717_Switzerland_UniversityofLausanne_GenPop_ECLIAAssay"
Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Serum,Total Ig,Serum,2,110,Not available,3,Elecsys Anti‐SARS‐CoV‐2,Roche,PathCare N1 Reference Laboratory,Not available,Not available,Private Laboratory,South Africa,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Electrochemiluminescence immunoassay (ECLIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,≥1.0,<1.0,Not available,Overall,56,54,44,54,78.6,100,Not available,Not available,"Controls: Pre-pandemic controls, EQA material",-110,Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Serum,
Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Serum,Total Ig,Serum,3,92,not reported,3,Elecsys Anti‐SARS‐CoV‐2,Roche,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,ECLIA,Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,42,50,30,50,71.4,100,https://jcm.asm.org/content/jcm/early/2020/07/10/JCM.01361-20.full.pdf,10.1128/JCM.01361-20,"Sensitivity available for multiple groups according to time since symptom onset, but categories do not match ours",-92,Roche - Elecsys Anti‐SARS‐CoV‐2 - Total Ig - Serum,
"Roche Diagnostics, Basel, Switzerland - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA; IgG; IgM - Not available",IgA; IgG; IgM,Not available,1,228,Not available,1,"Anti-SARS-CoV-2 ELISA (IgA) (manual, automated)","Roche Diagnostics, Basel, Switzerland",,Not available,Not available,Hospital,United States of America (USA),Not available,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,54,174,35,174,64.8,100,https://watermark.silverchair.com/jfaa125.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAArcwggKzBgkqhkiG9w0BBwagggKkMIICoAIBADCCApkGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMoAjn6ByoYAii6DHfAgEQgIICaqFGrRO85bZRx4JxGgbqHiXgsKx7Kdpj8YnLdbKbn_2t6ic,https://doi.org/10.1093/jalm/jfaa125,Not available,-228,"Roche Diagnostics, Basel, Switzerland - Anti-SARS-CoV-2 ELISA (IgA) (manual, automated) - IgA; IgG; IgM - Not available",
"Shanghai Kehua Bio-engineering Co., Ltd - Diagnostic kit for SARS-CoV-2 IgM/IgG Antibody (Colloidal Gold) - IgG; IgM - Plasma; Serum; Whole blood",IgG; IgM,Plasma; Serum; Whole blood,1,407,Nasopharyngeal swabs,1,Diagnostic kit for SARS-CoV-2 IgM/IgG Antibody (Colloidal Gold),"Shanghai Kehua Bio-engineering Co., Ltd","UOC Microbiologia, AUSL della Romagna, Pievesestina di Cesena",Asymptomatic; Mild; Moderate; Severe; Critical,Not available,Hospital,Italy,Not available,Confirmed COVID-19 patients,Retrospective set,Clinical examination; Epidemiologic criteria; RT-PCR,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,R-423-25-C-CE,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,135,272,92,269,68.1,98.9,Not available,Not available,Control: PCR negative asymptomatic or symptomatic patients,-407,"Shanghai Kehua Bio-engineering Co., Ltd - Diagnostic kit for SARS-CoV-2 IgM/IgG Antibody (Colloidal Gold) - IgG; IgM - Plasma; Serum; Whole blood",
Shanghai LiangRun Biomedicine Technology Co. Ltd - Diagnostic Kit for IgM/IgG Antibody of SARS-CoV-2 (Collodial Gold /Lateral Flow) - IgG - Serum,IgG,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,1,Diagnostic Kit for IgM/IgG Antibody of SARS-CoV-2 (Collodial Gold /Lateral Flow),Shanghai LiangRun Biomedicine Technology Co. Ltd,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,6,25,26.1,100,Not available,Not available,Not available,-48,Shanghai LiangRun Biomedicine Technology Co. Ltd - Diagnostic Kit for IgM/IgG Antibody of SARS-CoV-2 (Collodial Gold /Lateral Flow) - IgG - Serum,
Shanghai LiangRun Biomedicine Technology Co. Ltd - Diagnostic Kit for IgM/IgG Antibody of SARS-CoV-2 (Collodial Gold /Lateral Flow) - IgM - Serum,IgM,Serum,1,48,Nasopharyngeal swabs; Oropharyngeal swabs,1,Diagnostic Kit for IgM/IgG Antibody of SARS-CoV-2 (Collodial Gold /Lateral Flow),Shanghai LiangRun Biomedicine Technology Co. Ltd,RIVM,Mild; Moderate; Severe,Not available,Public Health,Netherlands,Bilthoven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,23,25,1,25,4.3,100,Not available,Not available,Not available,-48,Shanghai LiangRun Biomedicine Technology Co. Ltd - Diagnostic Kit for IgM/IgG Antibody of SARS-CoV-2 (Collodial Gold /Lateral Flow) - IgM - Serum,
"Shanghai Outdo Biotech Co., Ltd - Novel Coronavirus (SARS-CoV-2) Antibody (IgM / IgG) Test (Colloidal Gold) - IgG; IgM - Serum",IgG; IgM,Serum,1,150,Nasopharyngeal swabs; Oropharyngeal swabs,1,Novel Coronavirus (SARS-CoV-2) Antibody (IgM / IgG) Test (Colloidal Gold),"Shanghai Outdo Biotech Co., Ltd","Taizhou Hospital, Wenzhou Medical University",Severe,20200101,Hospital,China,Linhai,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,97,53,69,51,71.1,96.2,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191168/pdf/ajtr0012-1348.pdf,Not available,Not available,-150,"Shanghai Outdo Biotech Co., Ltd - Novel Coronavirus (SARS-CoV-2) Antibody (IgM / IgG) Test (Colloidal Gold) - IgG; IgM - Serum",
Shenzhen Tisenc Medical Devices Company - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,IgG,Serum,1,404,Nasopharyngeal swabs; Oropharyngeal swabs,1,2019-nCoV IgG/IgM Antibody Detection Kit,Shenzhen Tisenc Medical Devices Company,"Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA",Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,12,392,10,389,83.3,99.2,https://www.medrxiv.org/content/10.1101/2020.05.05.20092551v1.full.pdf,10.1101/2020.05.05.20092551.t,Analysis on an ACCRE 6 system,-404,Shenzhen Tisenc Medical Devices Company - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,
Shenzhen Tisenc Medical Devices Company - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,IgM,Serum,1,404,Nasopharyngeal swabs; Oropharyngeal swabs,1,2019-nCoV IgG/IgM Antibody Detection Kit,Shenzhen Tisenc Medical Devices Company,"Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA",Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,12,392,1,392,8.3,100,https://www.medrxiv.org/content/10.1101/2020.05.05.20092551v1.full.pdf,10.1101/2020.05.05.20092551.t,Analysis on an ACCRE 6 system,-404,Shenzhen Tisenc Medical Devices Company - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,
Shenzhen Yahuilong Biotechnology Co Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,IgG,Serum,1,412,Nasopharyngeal swabs; Oropharyngeal swabs,1,2019-nCoV IgG/IgM Antibody Detection Kit,Shenzhen Yahuilong Biotechnology Co Ltd,"Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA",Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,12,400,11,395,91.7,98.8,https://www.medrxiv.org/content/10.1101/2020.05.05.20092551v1.full.pdf,10.1101/2020.05.05.20092551.t,"Analysis on a Yahuilong iFlash 3000-H System

Cut-off value:10 AU/mL",-412,Shenzhen Yahuilong Biotechnology Co Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,"200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_Total_IgG,200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_nonCOVIDpatients_IgG,200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_Otherdiseasepatients_IgG,200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_Medicalstaff_IgG"
Shenzhen Yahuilong Biotechnology Co Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,IgM,Serum,1,412,Nasopharyngeal swabs; Oropharyngeal swabs,1,2019-nCoV IgG/IgM Antibody Detection Kit,Shenzhen Yahuilong Biotechnology Co Ltd,"Department of Laboratory Medicine, General Hospital of Southern Theatre Command of PLA",Not available,Not available,Hospital,China,Guangzhou,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,12,400,4,399,33.3,99.8,https://www.medrxiv.org/content/10.1101/2020.05.05.20092551v1.full.pdf,10.1101/2020.05.05.20092551.t,"Analysis on a Yahuilong iFlash 3000-H System

Cut-off value:10 AU/mL",-412,Shenzhen Yahuilong Biotechnology Co Ltd - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,"200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_Total_IgM,200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_nonCOVIDpatients_IgM,200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_Otherdiseasepatients_IgM,200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_Medicalstaff_IgM"
Shenzhen Yhlo Biotech Co. Ltd - iFlash-SARS-CoV-2 IgG - IgG - Serum,IgG,Serum,1,56,Nasopharyngeal swabs; Oropharyngeal swabs,1,iFlash-SARS-CoV-2 IgG,Shenzhen Yhlo Biotech Co. Ltd,The First Affiliated Hospital of University of Science and Technology of China,Severe,Not available,Hospital,China,Hefei,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,16,40,16,0,100,0,https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25930,10.1002/jmv.25930,"The cutoff value for a positive result was 10, and samples with values greater than or equal to10 AU/mL were considered positive for SARS‐CoV‐2 infection.",-56,Shenzhen Yhlo Biotech Co. Ltd - iFlash-SARS-CoV-2 IgG - IgG - Serum,
Shenzhen Yhlo Biotech Co. Ltd - iFlash-SARS-CoV-2 IgM - IgM - Serum,IgM,Serum,1,56,Nasopharyngeal swabs; Oropharyngeal swabs,1,iFlash-SARS-CoV-2 IgM,Shenzhen Yhlo Biotech Co. Ltd,The First Affiliated Hospital of University of Science and Technology of China,Severe,Not available,Hospital,China,Hefei,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,16,40,15,6,93.8,15,https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25930,10.1002/jmv.25930,"The cutoff value for a positive result was 10, and samples with values greater than or equal to10 AU/mL were considered positive for SARS‐CoV‐2 infection.",-56,Shenzhen Yhlo Biotech Co. Ltd - iFlash-SARS-CoV-2 IgM - IgM - Serum,
Shenzhen Yhlo Biotech Co. Ltd - Not available - IgG - Serum,IgG,Serum,1,65,Not reported,1,Not available,Shenzhen Yhlo Biotech Co. Ltd,,Not available,Not available,Hospital,China,Jinhua,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,CLIA,Detection of current infection; Detection of past infection,Not available,Not available,Not available,10,AU/ml,Not available,Not available,Not available,Overall,15,50,13,50,86.7,100,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.23466,10.1002/jcla.23466,Not available,-65,Shenzhen Yhlo Biotech Co. Ltd - Not available - IgG - Serum,
Shenzhen Yhlo Biotech Co. Ltd - Not available - IgM - Serum,IgM,Serum,1,65,not reported,1,Not available,Shenzhen Yhlo Biotech Co. Ltd,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,CLIA,Detection of current infection; Detection of past infection,Not available,Not available,Not available,10,AU/ml,Not available,Not available,Not available,Overall,15,50,9,50,60,100,https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcla.23466,10.1002/jcla.23466,Not available,-65,Shenzhen Yhlo Biotech Co. Ltd - Not available - IgM - Serum,
Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM and IgG chemiluminescence immunoassay - IgG - Serum,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM and IgG chemiluminescence immunoassay - IgG - Serumo,IgG,Serum,1,79,not reported,1,SARS-CoV-2 IgM and IgG chemiluminescence immunoassay,Shenzhen Yhlo Biotech Co. Ltd,,Not available,Not available,Hospital,Canada,Not available,Not available,Retrospective set,RT-PCR,Not available,Not available,Antibody,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,53,19,53,73.1,100,https://www.medrxiv.org/content/10.1101/2020.07.16.20155796v1.full.pdf,Not available,Not available,-79,Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM and IgG chemiluminescence immunoassay - IgG - Serum,"200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_AgeLess30,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_Age30to39,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_Age40to49,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_Age50to59,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_Age60to69,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_Age70orMore,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_Female,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG_Male,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_AgeLess30,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_Age30to39,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_Age40to49,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_Age50to59,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_Age60to69,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_Age70ormore,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_Female,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG_Male,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Age30orless,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Age30to39,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Age40to49,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Age50to59,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Age60to69,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Age70tomore,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Male,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG_Female,200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG+only,200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG+,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_popadj,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_popunadj,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_age<10,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_age10-17,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_age18-65,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_age18-65_popadj,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_age65,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_centerdistrict,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_centerdistrict_popadj,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_eastdistrict,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_eastdistrict_popadj,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_southdistrict,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_1cohabitant,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_2cohabitants,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_3cohabitants,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_3cohabitants_popadj,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_female,200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_male,200820_Hubei_NanjingUniversity_hcw_IgG"
Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM and IgG chemiluminescence immunoassay - IgM - Serum,IgM,Serum,1,79,Oropharyngeal swabs; Sputum,1,SARS-CoV-2 IgM and IgG chemiluminescence immunoassay,Shenzhen Yhlo Biotech Co. Ltd,,Not available,Not available,Hospital,Japan,Tokyo,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,chemiluminescence immunoassay,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,53,8,52,30.8,98.1,https://www.medrxiv.org/content/10.1101/2020.07.16.20155796v1.full.pdf,https://doi.org/10.1101/2020.07.16.20155796,Not available,-79,Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM and IgG chemiluminescence immunoassay - IgM - Serum,"200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_AgeLess30,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_Age30to39,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_Age40to49,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_Age50to59,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_Age60to69,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_Age70orMore,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_Female,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgM_Male,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_AgeLess30,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_Age30to39,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_Age40to49,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_Age50to59,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_Age60to69,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_Age70ormore,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_Female,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgM_Male,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Age30orless,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Age30to39,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Age40to49,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Age50to59,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Age60to69,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Age70tomore,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Female,200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgM_Male,200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgM+,200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgM+only,200820_Hubei_NanjingUniversity_hcw_IgM"
Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgG - Serum,IgG,Serum,1,60,Oropharyngeal swabs; Sputum,2,SARS-CoV-2 IgM/IgG CLIA kits,Shenzhen Yhlo Biotech Co. Ltd,Xixi Hospital of Hangzhou,Not available,Not available,Hospital,China,Hangzhou,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Duplicates,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,10,arbitrary units (AU) / mL,Not available,Not available,Not available,Overall,27,33,24,30,88.9,90.9,https://www.ijidonline.com/article/S1201-9712(20)30198-3/pdf,10.1016/j.ijid.2020.03.065,"The median duration from first symptoms
to serological testing was 16 days (IQR 9–20 days).",-60,Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgG - Serum,
Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgG - Serum,IgG,Serum,2,736,Nasopharyngeal swabs,2,SARS-CoV-2 IgM/IgG CLIA kits,Shenzhen Yhlo Biotech Co. Ltd,"Department of Laboratory Medicine, Shengjing Hospital of China Medical University",Moderate; Severe,Not available,Hospital,China,Shenyang,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,3,733,3,726,100,99,https://www.medrxiv.org/content/10.1101/2020.03.04.20030916v2.full.pdf,10.1101/2020.03.04.20030916,Not available,-736,Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgG - Serum,"200602_Wuhan_SunYat-senUniversity_HCW_IgG,200602_Wuhan_SunYat-senUniversity_nurses_IgG,200602_Wuhan_SunYat-senUniversity_doctors_IgG"
Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgM - Serum,IgM,Serum,1,60,Oropharyngeal swabs; Sputum,2,SARS-CoV-2 IgM/IgG CLIA kits,Shenzhen Yhlo Biotech Co. Ltd,Xixi Hospital of Hangzhou,Not available,Not available,Hospital,China,Hangzhou,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Duplicates,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,10,arbitrary units (AU) / mL,Not available,Not available,Not available,Overall,27,33,13,33,48.1,100,https://www.ijidonline.com/article/S1201-9712(20)30198-3/pdf,10.1016/j.ijid.2020.03.065,"The median duration from first symptoms
to serological testing was 16 days (IQR 9–20 days).",-60,Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgM - Serum,
Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgM - Serum,IgM,Serum,2,736,Nasopharyngeal swabs,2,SARS-CoV-2 IgM/IgG CLIA kits,Shenzhen Yhlo Biotech Co. Ltd,"Department of Laboratory Medicine, Shengjing Hospital of China Medical University",Moderate; Severe,Not available,Hospital,China,Shenyang,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,3,733,3,722,100,98.5,https://www.medrxiv.org/content/10.1101/2020.03.04.20030916v2.full.pdf,10.1101/2020.03.04.20030916,Not available,-736,Shenzhen Yhlo Biotech Co. Ltd - SARS-CoV-2 IgM/IgG CLIA kits - IgM - Serum,"200602_Wuhan_SunYat-senUniversity_HCW_IgM,200602_Wuhan_SunYat-senUniversity_doctors_IgM,200602_Wuhan_SunYat-senUniversity_nurses_IgM"
Siemens - Atellica® IM SARS-CoV-2 Total (COV2T) - Total Ig - Serum,Total Ig,Serum,1,599,Not available,1,Atellica® IM SARS-CoV-2 Total (COV2T),Siemens,,Not available,Not available,Public Health,Great Britain,Porton Down,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Chemilumienscent immunoassay,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,100,499,86,499,86,100,https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/894176/Evaluation_of_Siemens_Atellica-IM_anti_SARS_CoV_2_Total.pdf,Not available,Not available,-599,Siemens - Atellica® IM SARS-CoV-2 Total (COV2T) - Total Ig - Serum,
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Plasma; Serum",IgG,Plasma; Serum,1,579,Not available,2,MAGLUMI 2019-nCoV IgG (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,130219015M,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,176,403,Not available,Not available,73,99,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-579,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Plasma; Serum","200617_Italy_D.CotugnoHospital_HCW_IgG,200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_DIPC-HCW,200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_BAME,200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_Caucasian,200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_Males,200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_Females,200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW,200811_Belgium_universitairesSaint-Luc_IgM,200813_Foggia_UniversityofFoggia_IgGonly"
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Plasma; Serum",IgG,Plasma; Serum,2,175,Not available,2,MAGLUMI 2019-nCoV IgG (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,130219015M,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,107,68,Not available,Not available,64,100,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-175,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Plasma; Serum",
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Serum",IgG,Serum,1,322,Not available,3,MAGLUMI 2019-nCoV IgG (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",Guangzhou Eighth People's Hospital,Mild; Moderate; Severe,Not available,Hospital,China,Guangzhou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Blinded to reference results,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,>9677 relative light unit (RLU),<9677 relative light unit (RLU),Not available,Overall,192,130,179,129,93.2,99.2,https://www.medrxiv.org/content/10.1101/2020.05.22.20102525v1.full.pdf,10.1101/2020.05.22.20102525,"Controls: COVID-19 suspects excluded from COVID-19 infection

Interval between symptom onset to admission: 5±3 days",-322,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Serum","200629_SaoPaulo_UniversidadedeSaoPaulo_IgG+/IgM-,200717_Switzerland_UniversityofLausanne_Contacts_SnibeAssay,200717_Switzerland_UniversityofLausanne_GenPop_SnibeAssay,200729_Fuenlabrada_HospitalUniversitariodeFuenlabrada_IgG"
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Serum",IgG,Serum,2,198,Not available,3,MAGLUMI 2019-nCoV IgG (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,126,72,67,72,53.2,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,"Control: Pre-pandemic controls

Cut-off value: 1.0 AU/mL",-198,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgG - Serum",
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgM - Serum",IgM,Serum,1,322,Not available,1,MAGLUMI 2019-nCoV IgG (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",Guangzhou Eighth People's Hospital,Mild; Moderate; Severe,Not available,Hospital,China,Guangzhou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Blinded to reference results,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,> 5000 relative light unit (RLU),< 5000 relative light unit (RLU),Not available,Overall,192,130,157,129,81.8,99.2,https://www.medrxiv.org/content/10.1101/2020.05.22.20102525v1.full.pdf,10.1101/2020.05.22.20102525,"Controls: COVID-19 suspects excluded from COVID-19 infection

Interval between symptom onset to admission: 5±3 days",-322,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgG (CLIA) - IgM - Serum","200629_SaoPaulo_UniversidadedeSaoPaulo_IgM+/IgG-,200729_Fuenlabrada_HospitalUniversitariodeFuenlabrada_IgM"
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgM (CLIA) - IgM - Plasma; Serum",IgM,Plasma; Serum,1,579,Not available,2,MAGLUMI 2019-nCoV IgM (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,130219015M6,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,177,402,Not available,Not available,71,98,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-579,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgM (CLIA) - IgM - Plasma; Serum","200508_Bari_IstitutoTumoriGPaolo_HCW_IgM,200508_Bari_IstitutoTumoriGPaolo_HCW_IgG,200617_Italy_D.CotugnoHospital_HCW_IgM,200811_Belgium_universitairesSaint-Luc_IgG"
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgM (CLIA) - IgM - Plasma; Serum",IgM,Plasma; Serum,2,175,Not available,2,MAGLUMI 2019-nCoV IgM (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)","Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection; Detection of past infection,130219016M,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,108,67,Not available,Not available,60,99,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-175,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgM (CLIA) - IgM - Plasma; Serum",
"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgM (CLIA) - IgM - Serum",IgM,Serum,1,198,Not available,1,MAGLUMI 2019-nCoV IgM (CLIA),"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd)",Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Chemiluminescence immunoassay (CLIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,126,72,74,72,58.7,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,"Control: Pre-pandemic controls

Cut-off value: 1.0 AU/mL",-198,"Snibe Co., Ltd (Shenzhen New Industries Biomedical Engineering Co., Ltd) - MAGLUMI 2019-nCoV IgM (CLIA) - IgM - Serum",
"Sugentech, Inc. - SGTi-flex COVID-19 IgM/IgG (manual) - IgG; IgM - Plasma; Serum; Whole blood",IgG; IgM,Plasma; Serum; Whole blood,1,157,Nasopharyngeal swabs,1,SGTi-flex COVID-19 IgM/IgG (manual),"Sugentech, Inc.",,Not available,Not available,Hospital,France,Paris,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Lateral flow immunoassay,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,20,137,15,110,75,80.3,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392071/pdf/main.pdf,https://doi.org/10.1016/j.jinf.2020.07.032,Not available,-157,"Sugentech, Inc. - SGTi-flex COVID-19 IgM/IgG (manual) - IgG; IgM - Plasma; Serum; Whole blood",200520_England_RutherfordHealth_HCW_IgM&IgG
"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG - Plasma; Serum",IgG,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,SARS-CoV-2 IgM/IgG Ab Rapid Test,"Sure Bio-Tech (USA) Co., Ltd",University of California,Not available,COV125200 3B,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,VC012103,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,129,108,73,108,56.6,100,https://covidtestingproject.org/,Not available,Not available,-237,"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG - Plasma; Serum",
"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,SARS-CoV-2 IgM/IgG Ab Rapid Test,"Sure Bio-Tech (USA) Co., Ltd",University of California,Not available,COV125200 3B,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,VC012103,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,129,108,74,108,57.4,100,https://covidtestingproject.org/,Not available,Not available,-237,"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG; IgM - Plasma; Serum",
"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG; IgM - Plasma; Serum; Whole blood",IgG; IgM,Plasma; Serum; Whole blood,1,50,Nasopharyngeal swabs; Oropharyngeal swabs,1,SARS-CoV-2 IgM/IgG Ab Rapid Test,"Sure Bio-Tech (USA) Co., Ltd",National Reference Center for Emerging Antibiotic Resistance,Not available,Not available,Public Health,Switzerland,Fribourg,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,VC012103,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,28,22,24,22,85.7,100,Not available,Not available,Not available,-50,"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgG; IgM - Plasma; Serum; Whole blood",
"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgM - Plasma; Serum",IgM,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,SARS-CoV-2 IgM/IgG Ab Rapid Test,"Sure Bio-Tech (USA) Co., Ltd",University of California,Not available,COV125200 3B,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,VC012103,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,129,108,62,108,48.1,100,https://covidtestingproject.org/,Not available,Not available,-237,"Sure Bio-Tech (USA) Co., Ltd - SARS-CoV-2 IgM/IgG Ab Rapid Test - IgM - Plasma; Serum",
SureScreen Diagnostics - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Whole blood,IgG,Whole blood,1,49,Upper respiratory specimen,1,COVID-19 IgG/IgM Rapid Test Cassette,SureScreen Diagnostics,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,4,100,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,SureScreen Diagnostics - COVID-19 IgG/IgM Rapid Test Cassette - IgG - Whole blood,
SureScreen Diagnostics - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Whole blood,IgM,Whole blood,1,49,Upper respiratory specimen,1,COVID-19 IgG/IgM Rapid Test Cassette,SureScreen Diagnostics,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,30,85,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,SureScreen Diagnostics - COVID-19 IgG/IgM Rapid Test Cassette - IgM - Whole blood,
"Tangshan Yingnuote Biotechnology Enterprise Co., Ltd. - Colloidal Gold Immunochromatography Assay (CGIA) kit - IgG; IgM - Serum",IgG; IgM,Serum,1,188,Oropharyngeal swabs,1,Colloidal Gold Immunochromatography Assay (CGIA) kit,"Tangshan Yingnuote Biotechnology Enterprise Co., Ltd.","Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not available,Not available,Hospital,China,Wuhan,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,126,62,110,62,87.3,100,https://www.ajkd.org/action/showPdf?pii=S0272-6386%2820%2930786-1,10.1053/j.ajkd.2020.06.008,Not available,-188,"Tangshan Yingnuote Biotechnology Enterprise Co., Ltd. - Colloidal Gold Immunochromatography Assay (CGIA) kit - IgG; IgM - Serum","200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandIgM,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Male,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Female,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_COVIDinFamily,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_CurrentSmoker,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_DiabeticNephropathy,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Hypertensiveinducedkidneyfailure,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Glomerulonephritis,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_PolycysticKidneyDisease,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_LupusNephritis,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_OtherCausesKidneyFailure,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Hemodialysis,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Hemoperfusion,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Hemodiafiltration,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_CVD,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_DiabetesMellitus,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_COPD,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_Cancer,200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandorIgM"
TECHNOGENETICS S.r.l - 2019-nCoV IgM Antibody Diagnostic Kit (Colloidal gold) - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,415,Plasma; Serum,1,2019-nCoV IgM Antibody Diagnostic Kit (Colloidal gold),TECHNOGENETICS S.r.l,"Dipartimento di Medicina Molecolare e Traslazionale
Università degli Studi di Brescia
SMeL Microbiologia e Virologia
ASST Spedali Civili",Not available,00484,Hospital,Italy,Brescia,Confirmed COVID-19 patients,Retrospective set,Immunoassay,No replicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Not available,CVRT2500,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,120,295,119,290,99.2,98.3,Not available,Not available,Controls: Pre-pandemic controls,-415,TECHNOGENETICS S.r.l - 2019-nCoV IgM Antibody Diagnostic Kit (Colloidal gold) - IgG; IgM - Plasma; Serum,
TESTSEALABS - SARS-COV-2-IgG/IgM Test Cassette - IgG - Plasma; Serum,IgG,Plasma; Serum,1,110,Not available,1,SARS-COV-2-IgG/IgM Test Cassette,TESTSEALABS,Frederick National Laboratory for Cancer Research,Not available,20200320,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,12,75,40,93.8,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3277-a001.pdf,Not available,Not available,-110,TESTSEALABS - SARS-COV-2-IgG/IgM Test Cassette - IgG - Plasma; Serum,
TESTSEALABS - SARS-COV-2-IgG/IgM Test Cassette - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,110,Not available,1,SARS-COV-2-IgG/IgM Test Cassette,TESTSEALABS,Frederick National Laboratory for Cancer Research,Not available,20200320,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,25,74,83.3,92.5,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3277-a001.pdf,Not available,Not available,-110,TESTSEALABS - SARS-COV-2-IgG/IgM Test Cassette - IgG; IgM - Plasma; Serum,
TESTSEALABS - SARS-COV-2-IgG/IgM Test Cassette - IgM - Plasma; Serum,IgM,Plasma; Serum,1,110,Not available,1,SARS-COV-2-IgG/IgM Test Cassette,TESTSEALABS,Frederick National Laboratory for Cancer Research,Not available,20200320,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,80,22,79,73.3,98.8,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3277-a001.pdf,Not available,Not available,-110,TESTSEALABS - SARS-COV-2-IgG/IgM Test Cassette - IgM - Plasma; Serum,
The University of Puerto Rico - CovIgG-Assay kit - IgG - Plasma,IgG,Plasma,1,116,Not available,1,CovIgG-Assay kit,The University of Puerto Rico,University of Puerto Rico-Medical Sciences Campus,Not available,Not available,Not available,Puerto Rico,San Juan,Symptomatic patients,Retrospective set,RT-PCR,Duplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of past infection,Not available,Not available,Not available,Not available,A492 ie 492 nm,0.312,Not available,Not available,Overall,49,67,48,67,98,100,https://www.biorxiv.org/content/10.1101/2020.06.11.146332v1.full.pdf,10.1101/2020.06.11.146332,"Not 100% sure if this is really a commercial assay but it is undergoing EUA approval https://prsciencetrust.org/the-covigg-assay-kit/
***also I think I maybe originally said this was peer-reviewed but it is a pre-print***",-116,The University of Puerto Rico - CovIgG-Assay kit - IgG - Plasma,
"Tianjin Beroni Biotechnology Co., Ltd. - SARS-COV-2 IgG/IgM Antibody Detection Kit - IgG - Plasma; Serum",IgG,Plasma; Serum,1,100,Not available,1,SARS-COV-2 IgG/IgM Antibody Detection Kit,"Tianjin Beroni Biotechnology Co., Ltd.",Frederick National Laboratory for Cancer Research,Not available,20200405,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,9,70,30,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3251-a001.pdf,Not available,Not available,-100,"Tianjin Beroni Biotechnology Co., Ltd. - SARS-COV-2 IgG/IgM Antibody Detection Kit - IgG - Plasma; Serum",
"Tianjin Beroni Biotechnology Co., Ltd. - SARS-COV-2 IgG/IgM Antibody Detection Kit - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,100,Not available,1,SARS-COV-2 IgG/IgM Antibody Detection Kit,"Tianjin Beroni Biotechnology Co., Ltd.",Frederick National Laboratory for Cancer Research,Not available,20200405,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,27,70,90,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3251-a001.pdf,Not available,Not available,-100,"Tianjin Beroni Biotechnology Co., Ltd. - SARS-COV-2 IgG/IgM Antibody Detection Kit - IgG; IgM - Plasma; Serum",
"Tianjin Beroni Biotechnology Co., Ltd. - SARS-COV-2 IgG/IgM Antibody Detection Kit - IgM - Plasma; Serum",IgM,Plasma; Serum,1,100,Not available,1,SARS-COV-2 IgG/IgM Antibody Detection Kit,"Tianjin Beroni Biotechnology Co., Ltd.",Frederick National Laboratory for Cancer Research,Not available,20200405,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,25,70,83.3,100,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3251-a001.pdf,Not available,Not available,-100,"Tianjin Beroni Biotechnology Co., Ltd. - SARS-COV-2 IgG/IgM Antibody Detection Kit - IgM - Plasma; Serum",
UCP Biosciences - Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette - IgG - Plasma; Serum,IgG,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette,UCP Biosciences,University of California,Not available,"SMP202003 12, SMP202003 13",Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,U-CoV-102,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,107,73,105,56.2,98.1,https://covidtestingproject.org/,Not available,Extra diluent necessary,-237,UCP Biosciences - Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette - IgG - Plasma; Serum,
UCP Biosciences - Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette - IgG; IgM - Plasma; Serum,IgG; IgM,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette,UCP Biosciences,University of California,Not available,"SMP202003 12, SMP202003 13",Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,U-CoV-102,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,107,80,105,61.5,98.1,https://covidtestingproject.org/,Not available,Extra diluent necessary,-237,UCP Biosciences - Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette - IgG; IgM - Plasma; Serum,
UCP Biosciences - Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette - IgM - Plasma; Serum,IgM,Plasma; Serum,1,237,Nasopharyngeal swabs; Oropharyngeal swabs,1,Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette,UCP Biosciences,University of California,Not available,"SMP202003 12, SMP202003 13",Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,U-CoV-102,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,130,107,79,105,60.8,98.1,https://covidtestingproject.org/,Not available,Extra diluent necessary,-237,UCP Biosciences - Coronavirus IgG/IgM Antibody (COVID-19) Test Cassette - IgM - Plasma; Serum,
"UNscience Biotechnology Co., Ltd. - COVID-19 IgG/IgM Rapid Test Kit - IgG - Plasma",IgG,Plasma,1,58,Plasma,1,COVID-19 IgG/IgM Rapid Test Kit,"UNscience Biotechnology Co., Ltd.",Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,86.7,95,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,"UNscience Biotechnology Co., Ltd. - COVID-19 IgG/IgM Rapid Test Kit - IgG - Plasma",
"UNscience Biotechnology Co., Ltd. - COVID-19 IgG/IgM Rapid Test Kit - IgM - Plasma",IgM,Plasma,1,58,Plasma,1,COVID-19 IgG/IgM Rapid Test Kit,"UNscience Biotechnology Co., Ltd.",Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,80,65,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,"UNscience Biotechnology Co., Ltd. - COVID-19 IgG/IgM Rapid Test Kit - IgM - Plasma",
Vircell S.L. - COVID-19 ELISA IgG - IgG - Plasma; Serum,IgG,Plasma; Serum,1,174,Not available,2,COVID-19 ELISA IgG,Vircell S.L.,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,G1032,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,110,64,Not available,Not available,74,97,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-174,Vircell S.L. - COVID-19 ELISA IgG - IgG - Plasma; Serum,200826_Croatia_UniversityofZagreb_HCWsIgG
Vircell S.L. - COVID-19 ELISA IgG - IgG - Plasma; Serum,IgG,Plasma; Serum,2,57,Not available,2,COVID-19 ELISA IgG,Vircell S.L.,"Institute for Medical Virology, University Hospital, Goethe University",Moderate; Severe,Not available,Hospital,Germany,Frankfurt,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Ratio >0.6,Ratio <0.4,Not available,Overall,33,24,28,20,84.8,83.3,https://www.biorxiv.org/content/biorxiv/early/2020/05/10/2020.05.08.085506.full.pdf,10.1101/2020.05.08.085506,Control: samples of individuals with selected PCR- or serologically-confirmed infections,-57,Vircell S.L. - COVID-19 ELISA IgG - IgG - Plasma; Serum,
Vircell S.L. - COVID-19 ELISA IgM+IgA - IgA; IgM - Plasma; Serum,IgA; IgM,Plasma; Serum,1,162,Not available,1,COVID-19 ELISA IgM+IgA,Vircell S.L.,"Institute of Microbiology, Lausanne University Hospital",Not available,Not available,Hospital,Switzerland,Lausanne,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection; Detection of past infection,MA1032,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,106,56,Not available,Not available,91,46,https://www.medrxiv.org/content/10.1101/2020.07.09.20149864v1.full.pdf,10.1101/2020.07.09.20149864,Controls: Pre-pandemic controls,-162,Vircell S.L. - COVID-19 ELISA IgM+IgA - IgA; IgM - Plasma; Serum,"200826_Croatia_UniversityofZagreb_HCWsIgMIgA,200826_Croatia_UniversityofZagreb_Healthcare,200826_Croatia_UniversityofZagreb_Admin,200826_Croatia_UniversityofZagreb_InfectiousDiseaseWard,200826_Croatia_UniversityofZagreb_Asymptomatic"
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Plasma; Serum",IgG,Plasma; Serum,1,220,Nasopharyngeal swabs; Oropharyngeal swabs,1,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd",University of California,Not available,E2003002,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,VID35-08- 011,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,121,99,77,95,63.6,96,https://covidtestingproject.org/,Not available,Some band smearing,-220,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Plasma; Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Serum",IgG,Serum,1,229,Respiratory specimen,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd",Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Symptomatic patients,Not available,RT-PCR,Duplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,71,Not available,51.8,98.9,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-229,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Serum",IgG,Serum,2,256,Nasopharyngeal swabs,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,E2003031,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,62.8,99,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Serum; Whole blood",IgG,Serum; Whole blood,1,60,Nasopharyngeal swabs,1,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd","Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo",Not available,Not available,Not available,Italy,Pavia,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,30,24,30,80,100,https://onlinelibrary.wiley.com/doi/10.1002/jmv.25800,10.1002/jmv.25800,"Serum samples were obtained at a median 7 days (interquartile range, 4‐11) after the first COVID‐19 positive result.",-60,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG - Serum; Whole blood",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,220,Nasopharyngeal swabs; Oropharyngeal swabs,1,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd",University of California,Not available,E2003002,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,VID35-08- 011,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,121,99,79,94,65.3,94.9,https://covidtestingproject.org/,Not available,Some band smearing,-220,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Plasma; Serum","200823_Bergamo_HospitalPapaGiovanniXXIII_Female,200823_Bergamo_HospitalPapaGiovanniXXIII_Male,200823_Bergamo_HospitalPapaGiovanniXXIII_<28,200823_Bergamo_HospitalPapaGiovanniXXIII_28-47,200823_Bergamo_HospitalPapaGiovanniXXIII_>47,200823_Bergamo_HospitalPapaGiovanniXXIII_UlcerativeColitis,200823_Bergamo_HospitalPapaGiovanniXXIII_CrohnsDisease,200823_Bergamo_HospitalPapaGiovanniXXIII_Adalimumab,200823_Bergamo_HospitalPapaGiovanniXXIII_Infliximab,200823_Bergamo_HospitalPapaGiovanniXXIII_Golimumab,200823_Bergamo_HospitalPapaGiovanniXXIII_Vedolizumab,200823_Bergamo_HospitalPapaGiovanniXXIII_Ustekinumab,200823_Bergamo_HospitalPapaGiovanniXXIII_Overall"
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,1,229,Respiratory specimen,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd",Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,Duplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,71,Not available,51.8,97.8,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-229,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum",IgG; IgM,Serum,2,256,Nasopharyngeal swabs,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven,",Not available,E2003031,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,65.4,99,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum; Whole blood",IgG; IgM,Serum; Whole blood,1,60,Nasopharyngeal swabs,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd","Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo",Not available,Not available,Public Health,Italy,Pavia,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,30,25,20,83.3,66.7,https://onlinelibrary.wiley.com/doi/10.1002/jmv.25800,10.1002/jmv.25800,"Serum samples were obtained at a median 7 days (interquartile range, 4‐11) after the first COVID‐19 positive result",-60,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum; Whole blood","200426_Guilan_GuilanUniversity_GenPop_Asymptomatic_UnAdj,200426_Guilan_GuilanUniversity_GenPop_UnAdj,200426_Guilan_GuilanUniversity_Males_UnAdj,200426_Guilan_GuilanUniversity_Females_UnAdj,200426_Guilan_GuilanUniversity_Age<5_UnAdj,200426_Guilan_GuilanUniversity_Age5-18_UnAdj,200426_Guilan_GuilanUniversity_Age18-60_UnAdj,200426_Guilan_GuilanUniversity_Age>60_UnAdj,200426_Guilan_GuilanUniversity_Employee_UnAdj,200426_Guilan_GuilanUniversity_Housekeeper_UnAdj,200426_Guilan_GuilanUniversity_Student_UnAdj,200426_Guilan_GuilanUniversity_Unemployed_UnAdj,200426_Guilan_GuilanUniversity_Farmer_UnAdj,200426_Guilan_GuilanUniversity_Salesman_UnAdj,200426_Guilan_GuilanUniversity_Driver_UnAdj,200426_Guilan_GuilanUniversity_HCW_UnAdj,200426_Guilan_GuilanUniversity_Worker_UnAdj,200426_Guilan_GuilanUniversity_County_Rasht_UnAdj,200426_Guilan_GuilanUniversity_County_Anzali_UnAdj,200426_Guilan_GuilanUniversity_County_Astara_UnAdj,200426_Guilan_GuilanUniversity_County_Lahijan_UnAdj,200426_Guilan_GuilanUniversity_County_Rudbar_UnAdj,200426_Guilan_GuilanUniversity_Village_UnAdj,200426_Guilan_GuilanUniversity_Town_UnAdj,200426_Guilan_GuilanUniversity_GenPop_PopAdj,200426_Guilan_GuilanUniversity_GenPop_PopTestAdj,200426_Guilan_GuilanUniversity_GenPop_IgG_Unadj,200426_Guilan_GuilanUniversity_GenPop_IgG_PopAdj,200426_Guilan_GuilanUniversity_GenPop_IgG_PopTestAdj,200426_Guilan_GuilanUniversity_GenPop_IgM_Unadj,200426_Guilan_GuilanUniversity_GenPop_IgM_PopAdj,200426_Guilan_GuilanUniversity_GenPop_IgM_PopTestAdj,200426_Guilan_GuilanUniversity_GenPop_IgG&IgM_Unadj,200426_Guilan_GuilanUniversity_GenPop_IgG&IgM_PopAdj,200426_Guilan_GuilanUniversity_GenPop_IgG&IgM_PopTestAdj,200426_Guilan_GuilanUniversity_Males_PopAdj,200426_Guilan_GuilanUniversity_Females_PopAdj,200426_Guilan_GuilanUniversity_Age<5_PopAdj,200426_Guilan_GuilanUniversity_Age5-18_PopAdj,200426_Guilan_GuilanUniversity_Age18-60_PopAdj,200426_Guilan_GuilanUniversity_Age>60_PopAdj,200426_Guilan_GuilanUniversity_Employee_PopAdj,200426_Guilan_GuilanUniversity_Housekeeper_PopAdj,200426_Guilan_GuilanUniversity_Student_PopAdj,200426_Guilan_GuilanUniversity_Unemployed_PopAdj,200426_Guilan_GuilanUniversity_Farmer_PopAdj,200426_Guilan_GuilanUniversity_Salesman_PopAdj,200426_Guilan_GuilanUniversity_HCW_PopAdj,200426_Guilan_GuilanUniversity_Driver_PopAdj,200426_Guilan_GuilanUniversity_Worker_PopAdj,200426_Guilan_GuilanUniversity_County_Rasht_PopAdj,200426_Guilan_GuilanUniversity_County_Anzali_PopAdj,200426_Guilan_GuilanUniversity_County_Astara_PopAdj,200426_Guilan_GuilanUniversity_County_Lahijan_PopAdj,200426_Guilan_GuilanUniversity_County_Rudbar_PopAdj,200426_Guilan_GuilanUniversity_Village_PopAdj,200426_Guilan_GuilanUniversity_Town_PopAdj"
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum; Whole blood",IgG; IgM,Serum; Whole blood,2,50,Nasopharyngeal swabs,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd","Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo",Not available,Not available,Public Health,Italy,Pavia,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,12,7,11,18.4,91.7,https://onlinelibrary.wiley.com/doi/10.1002/jmv.25800,10.1002/jmv.25800,"To estimate the sensitivity, LFA with IgG and/or IgM bands (including weak signals) were considered as positive results.",-50,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgG; IgM - Serum; Whole blood",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Plasma; Serum",IgM,Plasma; Serum,1,220,Nasopharyngeal swabs; Oropharyngeal swabs,1,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd",University of California,Not available,E2003002,Not available,United States of America (USA),San Francisco,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Interpretation by two independent readers,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,VID35-08- 011,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,121,99,79,94,65.3,94.9,https://covidtestingproject.org/,Not available,Some band smearing,-220,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Plasma; Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Serum",IgM,Serum,1,229,Respiratory specimen,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd",Clinical Trials Research Laboratory - Royal Melbourne Hospital,Not available,Not available,Hospital,Australia,Melbourne,Confirmed COVID-19 patients,Not available,RT-PCR,Duplicates,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,137,92,71,Not available,51.8,97.8,https://www.health.gov.au/sites/default/files/documents/2020/05/post-market-validation-of-three-serological-assays-for-covid-19-final-report.pdf,Not available,Controls: Other non-COVID-19 infections; pre-pandemic controls,-229,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Serum",IgM,Serum,2,256,Nasopharyngeal swabs,2,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd","Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,E2003031,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,65.4,100,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Serum",
"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Serum; Whole blood",IgM,Serum; Whole blood,1,60,Nasopharyngeal swabs,1,VivaDiag COVID-19 IgM/IgG Rapid Test,"VivaChek Biotech (Hangzhou) Co., Ltd","Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo",Not available,Not available,Not available,Italy,Pavia,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,30,25,30,83.3,100,https://onlinelibrary.wiley.com/doi/10.1002/jmv.25800,10.1002/jmv.25800,"Serum samples were obtained at a median 7 days (interquartile range, 4‐11) after the first COVID‐19 positive result.",-60,"VivaChek Biotech (Hangzhou) Co., Ltd - VivaDiag COVID-19 IgM/IgG Rapid Test - IgM - Serum; Whole blood",
"W.H.P.M, Inc. - Covisure Covid-19 IgM/IgG Rapid Test - IgG - Plasma; Serum",IgG,Plasma; Serum,1,100,Not available,1,Covisure Covid-19 IgM/IgG Rapid Test,"W.H.P.M, Inc.",Frederick National Laboratory for Cancer Research,Not available,P0406203922,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,21,68,70,97.1,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3267-a001.pdf,Not available,Not available,-100,"W.H.P.M, Inc. - Covisure Covid-19 IgM/IgG Rapid Test - IgG - Plasma; Serum",
"W.H.P.M, Inc. - Covisure Covid-19 IgM/IgG Rapid Test - IgG; IgM - Plasma; Serum",IgG; IgM,Plasma; Serum,1,100,Not available,1,Covisure Covid-19 IgM/IgG Rapid Test,"W.H.P.M, Inc.",Frederick National Laboratory for Cancer Research,Not available,P0406203922,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,23,68,76.7,97.1,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3267-a001.pdf,Not available,Not available,-100,"W.H.P.M, Inc. - Covisure Covid-19 IgM/IgG Rapid Test - IgG; IgM - Plasma; Serum",
"W.H.P.M, Inc. - Covisure Covid-19 IgM/IgG Rapid Test - IgM - Plasma; Serum",IgM,Plasma; Serum,1,100,Not available,1,Covisure Covid-19 IgM/IgG Rapid Test,"W.H.P.M, Inc.",Frederick National Laboratory for Cancer Research,Not available,P0406203922,Public Health,United States of America (USA),Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,30,70,23,68,76.7,97.1,https://www.accessdata.fda.gov/cdrh_docs/presentations/maf/maf3267-a001.pdf,Not available,Not available,-100,"W.H.P.M, Inc. - Covisure Covid-19 IgM/IgG Rapid Test - IgM - Plasma; Serum",
"Wadsworth Center, New York State Department of Health - New York SARS-CoV Microsphere Immunoassay for Antibody Detection - Total Ig - Serum",Total Ig,Serum,1,370,Nasopharyngeal swabs,1,New York SARS-CoV Microsphere Immunoassay for Antibody Detection,"Wadsworth Center, New York State Department of Health","Department of Pathology and Laboratory Medicine, Weill Cornell Medicine",Not available,Not available,Hospital,United States of America (USA),New York,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Microsphere immunoassay (MIA),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Index value ≥ 1.78,Not available,Not available,Overall,114,256,69,Not available,60.5,99.2,https://reader.elsevier.com/reader/sd/pii/S0009898120302680?token=71A28DA0252D168AED57399149A4E40B0E5F035E8C6BD2CFC9F35D4737A3A1A64A35EAEDCD2CD84C974C941DECC01472,10.1016/j.cca.2020.06.004,Controls: Pre-pandemic controls,-370,"Wadsworth Center, New York State Department of Health - New York SARS-CoV Microsphere Immunoassay for Antibody Detection - Total Ig - Serum","200617_NewYork_StateUniversityofNewYork_GeneralPopUnadj,200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj,200617_NewYork_StateUniversityofNewYork_MaleTestAdj,200617_NewYork_StateUniversityofNewYork_FemaleTestAdj,200617_NewYork_StateUniversityofNewYork_HispanicTestAdj,200617_NewYork_StateUniversityofNewYork_WhiteTestAdj,200617_NewYork_StateUniversityofNewYork_BlackTestAdj,200617_NewYork_StateUniversityofNewYork_AsianTestAdj,200617_NewYork_StateUniversityofNewYork_Age18-34TestAdj,200617_NewYork_StateUniversityofNewYork_Age35-44TestAdj,200617_NewYork_StateUniversityofNewYork_Age45-54TestAdj,200617_NewYork_StateUniversityofNewYork_Age55+TestAdj,200617_NewYork_StateUniversityofNewYork_NYCTestAdj,200617_NewYork_StateUniversityofNewYork_RocklandWestchesterTestAdj,200617_NewYork_StateUniversityofNewYork_LongIslandTestAdj,200617_NewYork_StateUniversityofNewYork_RestofNYSTestAdj,200617_NewYork_StateUniversityofNewYork_OtherEthnicitiesTestAdj"
"Wantai Bio- logical Pharmacy Enterprise Co., Ltd., China - Wantai SARS-CoV-2 Ab ELISA - IgG - Plasma",IgG,Plasma,1,333,Not available,1,Wantai SARS-CoV-2 Ab ELISA,"Wantai Bio- logical Pharmacy Enterprise Co., Ltd., China",,Not available,Not available,Public Health,Netherlands,Rotterdam,Asymptomatic individuals,Not available,Immunoassay,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,187,146,186,145,99.5,99.3,https://www.nature.com/articles/s41467-020-17317-y.pdf,10.1038/s41467-020-17317-y,Not available,-333,"Wantai Bio- logical Pharmacy Enterprise Co., Ltd., China - Wantai SARS-CoV-2 Ab ELISA - IgG - Plasma",
"Wuhan UNscience Biotechnology Co., Ltd - COVID-19 IgG/IgM Rapid Test - IgG - Whole blood",IgG,Whole blood,1,,Upper respiratory specimen,1,COVID-19 IgG/IgM Rapid Test,"Wuhan UNscience Biotechnology Co., Ltd","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,Not available,Not available,Not available,Not available,0,67,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,N=15,,"Wuhan UNscience Biotechnology Co., Ltd - COVID-19 IgG/IgM Rapid Test - IgG - Whole blood",
"Wuhan UNscience Biotechnology Co., Ltd - COVID-19 IgG/IgM Rapid Test - IgM - Whole blood",IgM,Whole blood,1,,Upper respiratory specimen,1,COVID-19 IgG/IgM Rapid Test,"Wuhan UNscience Biotechnology Co., Ltd","Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,Not available,Not available,Not available,Not available,0,75,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,N=15,,"Wuhan UNscience Biotechnology Co., Ltd - COVID-19 IgG/IgM Rapid Test - IgM - Whole blood",
"Xiamen Biotime Biotechnology Co., Ltd - SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit - IgG - Serum",IgG,Serum,1,112,Serum,1,SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit,"Xiamen Biotime Biotechnology Co., Ltd","Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,32,80,23,78,71.9,97.5,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,Days of sickness: 3 to 16 days,-112,"Xiamen Biotime Biotechnology Co., Ltd - SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit - IgG - Serum",
"Xiamen Biotime Biotechnology Co., Ltd - SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit - IgM - Serum",IgM,Serum,1,112,Serum,1,SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit,"Xiamen Biotime Biotechnology Co., Ltd","Helsinki University Hospital Laboratory, Finland",Mild; Moderate; Severe,Not available,Hospital,Finland,Not available,Confirmed COVID-19 patients,Not available,Microneutralization test (MNT),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,32,80,26,71,81.2,88.8,https://www.medrxiv.org/content/10.1101/2020.05.18.20101618v1.full.pdf,10.1101/2020.05.18.20101618,Days of sickness: 3 to 16 days,-112,"Xiamen Biotime Biotechnology Co., Ltd - SARS-CoV-2 IgG/IgM Rapid Qualitative Test Kit - IgM - Serum",
"Xiamen InnoDx Biotech Co., Ltd. - CMIA-Ab - Total Ig - Plasma",Total Ig,Plasma,1,380,Not available,1,CMIA-Ab,"Xiamen InnoDx Biotech Co., Ltd.",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangzhou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,300,77,298,96.2,99.3,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-380,"Xiamen InnoDx Biotech Co., Ltd. - CMIA-Ab - Total Ig - Plasma",
"Xiamen InnoDx Biotech Co., Ltd. - CMIA-IgM - IgM - Plasma",IgM,Plasma,1,380,Not available,1,CMIA-IgM,"Xiamen InnoDx Biotech Co., Ltd.",The Key Laboratory of Clinical In Vitro Diagnostic Techniques of Zhejiang Province,Not available,Not available,Hospital,China,Hangzhou,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Chemiluminescence immunoassay (CLIA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,80,300,69,298,86.2,99.3,https://www.medrxiv.org/content/10.1101/2020.03.23.20041707v1.full.pdf,10.1101/2020.03.23.20041707,Not available,-380,"Xiamen InnoDx Biotech Co., Ltd. - CMIA-IgM - IgM - Plasma",
Xiamen Wantai Kairui Biotechnology - Not available - Total Ig - Serum,Total Ig,Serum,1,375,Nasopharyngeal swabs,1,Not available,Xiamen Wantai Kairui Biotechnology,The First People’s Hospital of Jingmen,Not available,Not available,Hospital,China,Jingmen,Symptomatic patients,Retrospective set,RT-PCR,No replicates,Not available,Antibody,Chemiluminescent microparticle immunoassay (CMIA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Signal-to-cut off ratio ≥1.0,Signal-to-cut off ratio <1.0,Not available,Overall,141,234,135,231,95.7,98.7,https://www.sciencedirect.com/science/article/pii/S0166093420301713?via%3Dihub,10.1016/j.jviromet.2020.113919,Not available,-375,Xiamen Wantai Kairui Biotechnology - Not available - Total Ig - Serum,"200727_FaroeIslands_TheFaroeseHospitalSystem_Overall_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedMales_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedFemales_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge0-9Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge10-19Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge20-29Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge30-39Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge40-49Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge50-59Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge60-69Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge70-79Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge80-89Yr_UnAdj,200727_FaroeIslands_TheFaroeseHospitalSystem_DetailedAge90+Yr_UnAdj,200727_FaroeIslandsStreymoy_TheFaroeseHospitalSystem_Overall_UnAdj,200727_FaroeIslandsEysturoy_TheFaroeseHospitalSystem_Overall_UnAdj,200727_FaroeIslandsNorðoyggjar_TheFaroeseHospitalSystem_Overall_UnAdj,200727_FaroeIslandsVágar_TheFaroeseHospitalSystem_Overall_UnAdj,200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj"
Zentech SA - QuickZen COVID-19 IgM / IgG - IgG - Serum,IgG,Serum,1,200,Not available,1,QuickZen COVID-19 IgM / IgG,Zentech SA,Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,63,72,49.2,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,Zentech SA - QuickZen COVID-19 IgM / IgG - IgG - Serum,
Zentech SA - QuickZen COVID-19 IgM / IgG - IgG; IgM - Serum,IgG; IgM,Serum,1,200,Not available,1,QuickZen COVID-19 IgM / IgG,Zentech SA,Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,91,72,71.1,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,Zentech SA - QuickZen COVID-19 IgM / IgG - IgG; IgM - Serum,
Zentech SA - QuickZen COVID-19 IgM / IgG - IgM - Serum,IgM,Serum,1,200,Not available,1,QuickZen COVID-19 IgM / IgG,Zentech SA,Laboratoire Hospitalier Universitaire de Bruxelles - Universitair Laboratorium Brussel (LHUB-ULB); Microbiology Department of Cliniques Universitaires Saint Luc-UCLouvain (CUSL),Not available,Not available,Hospital,Belgium,Brussels,Confirmed COVID-19 patients,Retrospective set,Computed Tomography (CT); RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,128,72,88,72,68.8,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198434/pdf/main.pdf,10.1016/j.jcv.2020.104413,Control: Pre-pandemic controls,-200,Zentech SA - QuickZen COVID-19 IgM / IgG - IgM - Serum,
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG - Serum,IgG,Serum,1,256,Nasopharyngeal swabs,2,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2003318,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,68,93.2,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG - Serum,"200520_Marbella_HospitalCostadelSol_HCW_IgG,200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_IgG,200811_Stockholm_UppsalaUniversity_Tensta_IgG,200805_Stockholm_UppsalaUniversity_CaregiversOverallIgGOnly,200805_Stockholm_UppsalaUniversity_CaregiversNoSymptoms_IgG,200805_Stockholm_UppsalaUniversity_CaregiversNoSymptoms1/2Mos_IgG,200805_Stockholm_UppsalaUniversity_CaregiversNoSymptomsMonth_IgG,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteA_IgG,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteC_IgG,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteD_IgG,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteE_IgG,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteF_IgG,200810_Spain_CostadelSolHospital_HCW_IgG"
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG - Serum,IgG,Serum,2,99,Plasma; Serum; Not available,2,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,"Department of Viroscience, Erasmus Medical Centre",Not available,2003260,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,90,9,Not available,Not available,91.6,100,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-99,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG - Serum,
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG - Serum; Whole blood,IgG,Serum; Whole blood,1,153,Not available,1,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,Uppsala University Hospital,Not available,2003242,Hospital,Sweden,Uppsala,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,GCCOV-402,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,29,124,27,123,93.1,99.2,https://www.tandfonline.com/doi/full/10.1080/20008686.2020.1754538#aHR0cHM6Ly93d3cudGFuZGZvbmxpbmUuY29tL2RvaS9wZGYvMTAuMTA4MC8yMDAwODY4Ni4yMDIwLjE3NTQ1Mzg/bmVlZEFjY2Vzcz10cnVlQEBAMA==,10.1080/20008686.2020.1754538,Not available,-153,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG - Serum; Whole blood,"200527_Varna_MedicalDiagnosticLaboratory_IgG,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_PoC,200706_Spain_InstituteofHealthCarlosIII_Females_PoC,200706_Spain_InstituteofHealthCarlosIII_Males_PoC,200706_Spain_InstituteofHealthCarlosIII_0–19_PoC,200706_Spain_InstituteofHealthCarlosIII_20–34_PoC,200706_Spain_InstituteofHealthCarlosIII_35–49_PoC,200706_Spain_InstituteofHealthCarlosIII_50–64_PoC,200706_Spain_InstituteofHealthCarlosIII_≥65_PoC,200706_Spain_InstituteofHealthCarlosIII_Telecommuting_PoC,200706_Spain_InstituteofHealthCarlosIII_Retail_PoC,200706_Spain_InstituteofHealthCarlosIII_Transport_PoC,200706_Spain_InstituteofHealthCarlosIII_PublicSafety_PoC,200706_Spain_InstituteofHealthCarlosIII_Cleaning_PoC,200706_Spain_InstituteofHealthCarlosIII_Health care_PoC,200706_Spain_InstituteofHealthCarlosIII_Nursinghomeworker_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_NationalitySpanish_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_NationalityOther_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Activeworker_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Unemployed_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Student_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Retired_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_DisabilityLeave_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseWork_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_UnpaidSocialWork_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_OtherOccupation_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof1_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof2_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof3to5_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_HouseHoldof6ormore_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income<5thpercentile_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income5thto24thpercentile_PoC ,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income25thto49thpercentile_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income50thto74thpercentile_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income75thto94thpercentile_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_Income95th+percentile_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize100000+_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize20000to99999_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize5000to19999_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_CitySize<5000_PoC,200706_Spain_InstituteofHealthCarlosIII_NoContactConfirmedCase_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedHousehold_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedFriend_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedCoWorker_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedHouseStaff_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactConfimedClient_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_NoContactSymptomaticCase_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticHousehold_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticFriend_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticCoWorker_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticHouseStaff_PoC,200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ContactSymptomaticClient_PoC,200706_Spain_InstituteofHealthCarlosIII_Homecaregiver_Poc,200706_Spain_InstituteofHealthCarlosIII_OccupationSectorOther_PoC ,200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T2"
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,IgG; IgM,Serum,1,228,Nasopharyngeal swabs; Oropharyngeal swabs; Sputum,3,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,Department of Medical Microbiology and Infection Control,Not available,Not available,Hospital,Netherlands,Rotterdam,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,99,129,43,126,43.4,97.7,https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30305-0/pdf,10.1016/j.cmi.2020.05.028,Median time from symptom onset to sample collection: 7 days (IQR 4-14 days),-228,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,"200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM,200527_Varna_MedicalDiagnosticLaboratory_Male ,200527_Varna_MedicalDiagnosticLaboratory_Female,200527_Varna_MedicalDiagnosticLaboratory_IgG+IgM,200527_Varna_MedicalDiagnosticLaboratory_Age21-30,200527_Varna_MedicalDiagnosticLaboratory_Age31-40,200527_Varna_MedicalDiagnosticLaboratory_Age41-50,200527_Varna_MedicalDiagnosticLaboratory_Age51-60,200527_Varna_MedicalDiagnosticLaboratory_Age61-70,200527_Varna_MedicalDiagnosticLaboratory_Age3-20,200527_Varna_MedicalDiagnosticLaboratory_Age71-92,200520_Marbella_HospitalCostadelSol_HCW_IgG+IgM,200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive,200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive,200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_IgMANDIgG,200811_Stockholm_UppsalaUniversity_Tensta_IgGANDIgM,200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM,200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGANDIgM,200805_Stockholm_UppsalaUniversity_CaregiversContactCase,200805_Stockholm_UppsalaUniversity_CaregiversNoContactCase,200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgGIgM_T2,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteA_Overall,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteA_IgG&IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteC_IgG&IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteD_Overall,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteC_Overall,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteD_IgG&IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteE_Overall,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteE_IgG&IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteF_Overall,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteF_IgG&IgM,200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM,200810_Spain_CostadelSolHospital_HCW_IgGANDIgM"
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,IgG; IgM,Serum,2,256,Nasopharyngeal swabs,3,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2003318,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,76.5,91.3,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,IgG; IgM,Serum,3,195,Serum,3,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,Viroscience Erasmus MC,Mild; Moderate; Severe,2003260,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,96,99,87,89,90.6,89.9,Not available,Not available,Each sample was tested by one test and interpreted by two operators in parallel from Erasmus MC.,-195,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgG; IgM - Serum,
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum,IgM,Serum,1,256,Nasopharyngeal swabs,3,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,"Clinical department of Laboratory Medicine, University Hospitals Leuven",Not available,2003318,Hospital,Belgium,Leuven,Confirmed COVID-19 patients,Retrospective set,RT-PCR,No replicates,Not blinded to reference results,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,153,103,Not available,Not available,72.5,95.1,https://www.sciencedirect.com/science/article/pii/S1198743X20303001,10.1016/j.cmi.2020.05.023,"Controls: Pre-pandemic controls

Median time between onset of symptoms and admission to the hospital: 7 days",-256,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum,"200520_Marbella_HospitalCostadelSol_HCW_IgM,200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_IgM,200811_Stockholm_UppsalaUniversity_Tensta_IgM,200805_Stockholm_UppsalaUniversity_CaregiversOverallIgMOnly,200805_Stockholm_UppsalaUniversity_CaregiversNoSymptoms_IgM,200805_Stockholm_UppsalaUniversity_CaregiversNoSymptomsMonth_IgM,200805_Stockholm_UppsalaUniversity_CaregiversNoSymptoms1/2Mos_IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteA_IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteC_IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteD_IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteE_IgM,200804_Tuscany_ArezzoHospital_HealthcareWorkers_SiteF_IgM,200810_Spain_CostadelSolHospital_HCW_IgM"
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum,IgM,Serum,2,195,Serum,3,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,Viroscience Erasmus MC,Mild; Moderate; Severe,2003260,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,96,99,80,90,83.3,90.9,Not available,Not available,Each sample was tested by one test and interpreted by two operators in parallel from Erasmus MC.,-195,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum,
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum,IgM,Serum,3,99,Plasma; Serum; Not available,3,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,"Department of Viroscience, Erasmus Medical Centre",Not available,2003260,Hospital,Netherlands,Rotterdam,Confirmed COVID-19 patients,Retrospective set,Plaque-reduction neutralization test (PRNT50),Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,90,9,Not available,Not available,89.4,100,https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v2.full.pdf,10.1101/2020.04.23.20077156,"Controls: Persons exposed to a human coronaviruses (HCoV-229E,  NL63  or  OC43), SARS, MERS, or with a range of other respiratory  viruses.",-99,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum,
Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum; Whole blood,IgM,Serum; Whole blood,1,153,Not available,1,COVID-19 IgG/IgM Rapid Test,Zhejiang Orient Gene Biotech,Uppsala University Hospital,Not available,2003242,Hospital,Sweden,Uppsala,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,GCCOV-402,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,29,124,20,124,69,100,https://www.tandfonline.com/doi/full/10.1080/20008686.2020.1754538#aHR0cHM6Ly93d3cudGFuZGZvbmxpbmUuY29tL2RvaS9wZGYvMTAuMTA4MC8yMDAwODY4Ni4yMDIwLjE3NTQ1Mzg/bmVlZEFjY2Vzcz10cnVlQEBAMA==,10.1080/20008686.2020.1754538,Not available,-153,Zhejiang Orient Gene Biotech - COVID-19 IgG/IgM Rapid Test - IgM - Serum; Whole blood,"200527_Varna_MedicalDiagnosticLaboratory_IgM,200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgM_T2"
Zhuhai Encode Medical Engineering Co. - SARS-CoV-2 IgG/IgM Rapid Test - IgG - Whole blood,IgG,Whole blood,1,49,Upper respiratory specimen,1,SARS-CoV-2 IgG/IgM Rapid Test,Zhuhai Encode Medical Engineering Co.,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,13,100,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,Zhuhai Encode Medical Engineering Co. - SARS-CoV-2 IgG/IgM Rapid Test - IgG - Whole blood,
Zhuhai Encode Medical Engineering Co. - SARS-CoV-2 IgG/IgM Rapid Test - IgM - Whole blood,IgM,Whole blood,1,49,Upper respiratory specimen,1,SARS-CoV-2 IgG/IgM Rapid Test,Zhuhai Encode Medical Engineering Co.,"Norwegian Organization for Quality Improvement of Laboratory Examinations, Haraldsplass Deaconess Hospital",Not available,Not available,Hospital,Norway,Bergen,Symptomatic patients,Prospectively collected set,RT-PCR,No replicates,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,26,23,Not available,Not available,22,96,https://www.degruyter.com/view/journals/cclm/ahead-of-print/article-10.1515-cclm-2020-0628/article-10.1515-cclm-2020-0628.xml,10.1515/cclm-2020-0628,"Median number of days since onset of symptoms: 8 (range 2–34)

Thirteen had <7 days since onset of symptoms, six had 7–13 days, and four had 14+ days.",-49,Zhuhai Encode Medical Engineering Co. - SARS-CoV-2 IgG/IgM Rapid Test - IgM - Whole blood,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,IgG,Serum,1,314,Nasopharyngeal swabs,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,General Hospital of the Central Theater Command of the People’s Liberation Army (PLA),Not available,Not available,Hospital,China,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Triplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,214,100,150,100,70.1,100,https://jcm.asm.org/content/jcm/early/2020/03/27/JCM.00461-20.full.pdf,10.1128/jcm.00461-20,"A median of 15 d.p.o. (range, 0–55 days)",-314,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,"200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG_adj,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_doctors_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_nurses_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_lab_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_midwives_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_radiographers_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_medstudents_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_assistingnurses_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_paramedics_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_other_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_admin_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_nonfrontline_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Geriatrics_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Endocrinology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Derm_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_frontline_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_noncovid19ward_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pedpsych_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_OBGYN_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Radiology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hematology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_covid19ward_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Emergency_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Anesthesiology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Surgery_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Gastroenterology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Nephrology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pulmonology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurosurgery_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Cardiology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ICU_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_VascularSurgery_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NuclearMedicine_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ID_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Opthalmology _IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Oncology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PlasticSurgery_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalGenetics_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Psychiatry_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Orthopedics_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pediatrics_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalPharmacology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartSurgery_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Rheumatology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pathology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Otolaryngologist_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Urology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalBiochemistry_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ForensicPathology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SocialMedicine_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalMicrobiology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalImmunology_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ThoracicSurgery_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_51-100contacts_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContact_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household=>3contacts_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HouseholdLivingAlone_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_11-50contacts_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PsychiatricSocialInstitution_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household2contacts_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContactPartTime_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_<10contacts_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>100contacts_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NoPatientContact_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SomaticHospital_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Asthma_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>15units_alcohol_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartDisease_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_FormerSmoker_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_DiabetesMellitus_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_COPD_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Allergies_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CurrentSmoker_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NeverSmoker_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hypertension_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CompromisedImmunity _IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_KidneyDisease_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_1-7units_alcohol_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_8-14units_alcohol_IgG,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_0units_alcohol_IgG,200824_Wuhan_WuhanUniversity_IgG_T1,200824_Wuhan_WuhanUniversity_IgG_T2,200725_Wuhan_WuhanInstituteofVirology_IgG_ELISA_AllParticipants,200725_Wuhan_WuhanInstituteofVirology_IgG_ELISA_Closecontactgroup,200725_Wuhan_WuhanInstituteofVirology_IgG_ELISA_Nonclosecontactgroup,200725_Wuhan_WuhanInstituteofVirology_IgG_ELISA_Noncontactgroup"
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,IgG,Serum,2,358,Pharyngeal swabs,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,General Hospital of Central Theater Command of PLA,Not available,Not available,Hospital,China,Wuhan,Symptomatic patients,Prospectively collected set,Clinical examination; RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,238,120,168,118,70.6,98.3,https://www.medrxiv.org/content/10.1101/2020.03.06.20031856v1.full.pdf,10.1101/2020.03.06.20031856,Not available,-358,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,IgG,Serum,3,84,Nasopharyngeal swabs; Oropharyngeal swabs,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,"Tongji Medical College, Huazhong University of Science and Technology",Not available,20200308,Hospital,China,Wuhan,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,24,60,17,57,70.8,95,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188146/pdf/ciaa461.pdf,10.1093/cid/ciaa461,Diagnostic value of serological IgM and IgG antibodies for suspected COVID-19 pneumonia patients was evaluated in 24 patients with negative nucleic acid tests.,-84,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,IgG,Serum,4,98,Not available,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,Wuhan Jinyintan Hospital,Not available,2020010108,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,WHO Interim Guidance,Duplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,63,35,52,35,82.5,100,https://www.medrxiv.org/content/10.1101/2020.02.27.20028787v1.full.pdf+html,10.1101/2020.02.27.20028787,Not available,-98,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG - Serum,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum,IgG; IgM,Serum,1,314,Nasopharyngeal swabs,3,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,General Hospital of the Central Theater Command of the People’s Liberation Army (PLA),Not available,Not available,Hospital,China,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Triplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,214,100,172,100,80.4,100,https://jcm.asm.org/content/jcm/early/2020/03/27/JCM.00461-20.full.pdf,10.1128/jcm.00461-20,"A median of 15 d.p.o. (range, 0–55 days)",-314,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum,"200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG_ANDOR_IgM_adj,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_doctors_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_doctors_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_nurses_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_nurses_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_lab_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_radiographers_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_assistingnurses_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_radiographers_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_paramedics_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_paramedics_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_admin_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_lab_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_admin_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_medstudents_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_medstudents_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_other_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_midwives_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_midwives_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_other_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_assistingnurses_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_noncovid19ward_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hematology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Endocrinology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_noncovid19ward_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_covid19ward_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hematology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Geriatrics_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Anesthesiology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Radiology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_nonfrontline_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Endocrinology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Geriatrics_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Derm_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_frontline_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_OBGYN_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Anesthesiology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Emergency_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_covid19ward_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pedpsych_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pedpsych_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Radiology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_OBGYN_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_frontline_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Derm_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_nonfrontline_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Gastroenterology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NuclearMedicine_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ICU_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_VascularSurgery_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Oncology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Gastroenterology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurosurgery_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_VascularSurgery_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ICU_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pulmonology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Nephrology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Surgery_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Surgery_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ID_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Nephrology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ID_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pulmonology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Opthalmology _IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NuclearMedicine_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurosurgery_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Cardiology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Cardiology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Opthalmology _IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Psychiatry_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pathology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pediatrics_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Urology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Orthopedics_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pediatrics_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Rheumatology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Urology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Orthopedics_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Psychiatry_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pathology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Rheumatology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Otolaryngologist_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalBiochemistry_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalBiochemistry_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartSurgery_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Oncology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartSurgery_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalGenetics_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalGenetics_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PlasticSurgery_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalPharmacology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PlasticSurgery_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Otolaryngologist_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalPharmacology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalMicrobiology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalImmunology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ForensicPathology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalImmunology_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ForensicPathology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SocialMedicine_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ThoracicSurgery_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalMicrobiology_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ThoracicSurgery_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SocialMedicine_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PsychiatricSocialInstitution_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household2contacts_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_11-50contacts_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NoPatientContact_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household=>3contacts_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HouseholdLivingAlone_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_<10contacts_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_51-100contacts_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HouseholdLivingAlone_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SomaticHospital_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_11-50contacts_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContactPartTime_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PsychiatricSocialInstitution_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContact_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household=>3contacts_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_<10contacts_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NoPatientContact_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContactPartTime_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContact_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_51-100contacts_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>100contacts_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>100contacts_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SomaticHospital_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household2contacts_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hypertension_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_8-14units_alcohol_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_COPD_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Allergies_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>15units_alcohol_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartDisease_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_FormerSmoker_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hypertension_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_FormerSmoker_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CurrentSmoker_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CurrentSmoker_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NeverSmoker_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Asthma_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Asthma_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartDisease_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Allergies_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CompromisedImmunity _IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_8-14units_alcohol_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_KidneyDisease_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_KidneyDisease_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>15units_alcohol_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CompromisedImmunity _IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_COPD_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NeverSmoker_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_DiabetesMellitus_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_DiabetesMellitus_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_1-7units_alcohol_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_0units_alcohol_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_0units_alcohol_IgG_AND_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_1-7units_alcohol_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_Female_hcw_IgG_ANDOR_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_Male_hcw_IgG_ANDOR_IgM"
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum,IgG; IgM,Serum,2,358,Pharyngeal swabs,3,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,General Hospital of Central Theater Command of PLA,Not available,Not available,Hospital,China,Wuhan,Symptomatic patients,Prospectively collected set,Clinical examination; RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,"Shuoshi, Shanghai, China",Not available,Not available,Not available,Not available,Not available,Overall,238,120,194,116,81.5,96.7,https://www.medrxiv.org/content/10.1101/2020.03.06.20031856v1.full.pdf,10.1101/2020.03.06.20031856,Not available,-358,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum,IgG; IgM,Serum,3,98,Not available,3,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,Wuhan Jinyintan Hospital,Not available,2020010108,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,WHO Interim Guidance,Duplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,63,35,55,35,87.3,100,https://www.medrxiv.org/content/10.1101/2020.02.27.20028787v1.full.pdf+html,10.1101/2020.02.27.20028787,Not available,-98,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgG; IgM - Serum,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,IgM,Serum,1,314,Nasopharyngeal swabs,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,General Hospital of the Central Theater Command of the People’s Liberation Army (PLA),Not available,Not available,Hospital,China,Not available,Confirmed COVID-19 patients,Retrospective set,RT-PCR,Triplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,214,100,146,100,68.2,100,https://jcm.asm.org/content/jcm/early/2020/03/27/JCM.00461-20.full.pdf,10.1128/jcm.00461-20,"A median of 15 d.p.o. (range, 0–55 days)",-314,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,"200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgM_adj,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_doctors_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_nurses_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_medstudents_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_other_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_admin_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_assistingnurses_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_lab_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_radiographers_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_midwives_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_paramedics_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Radiology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Geriatrics_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_frontline_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pedpsych_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_OBGYN_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_covid19ward_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Anesthesiology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_noncovid19ward_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_nonfrontline_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Endocrinology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Emergency_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Derm_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Neurosurgery_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Gastroenterology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NuclearMedicine_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Surgery_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Nephrology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hematology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Cardiology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pulmonology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_VascularSurgery_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ID_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Opthalmology _IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ICU_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Rheumatology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalPharmacology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartSurgery_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalBiochemistry_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pediatrics_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Psychiatry_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Pathology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Otolaryngologist_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Oncology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Orthopedics_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PlasticSurgery_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Urology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalImmunology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ThoracicSurgery_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SocialMedicine_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalMicrobiology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ForensicPathology_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_ClinicalGenetics_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_51-100contacts_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>100contacts_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PsychiatricSocialInstitution_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household=>3contacts_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NoPatientContact_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_SomaticHospital_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_11-50contacts_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HouseholdLivingAlone_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContactPartTime_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_PatientContact_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_<10contacts_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Household2contacts_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_DiabetesMellitus_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_KidneyDisease_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Hypertension_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_>15units_alcohol_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_FormerSmoker_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_COPD_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CurrentSmoker_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_CompromisedImmunity _IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_NeverSmoker_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Allergies_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_Asthma_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_HeartDisease_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_8-14units_alcohol_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_1-7units_alcohol_IgM,200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_0units_alcohol_IgM,200824_Wuhan_WuhanUniversity_IgM_T1,200824_Wuhan_WuhanUniversity_IgM_T2,200725_Wuhan_WuhanInstituteofVirology_IgM_ELISA_AllParticipants,200725_Wuhan_WuhanInstituteofVirology_IgM_ELISA_Closecontacts,200725_Wuhan_WuhanInstituteofVirology_IgM_ELISA_Nonclosecontacts,200725_Wuhan_WuhanInstituteofVirology_IgM_ELISA_Noncontactgroup"
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,IgM,Serum,2,358,Pharyngeal swabs,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,General Hospital of Central Theater Command of PLA,Not available,Not available,Hospital,China,Wuhan,Symptomatic patients,Prospectively collected set,Clinical examination; RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,238,120,167,117,70.2,97.5,https://www.medrxiv.org/content/10.1101/2020.03.06.20031856v1.full.pdf,10.1101/2020.03.06.20031856,Not available,-358,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,IgM,Serum,3,84,Nasopharyngeal swabs; Oropharyngeal swabs,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,"Tongji Medical College, Huazhong University of Science and Technology",Not available,20200308,Hospital,China,Wuhan,Symptomatic patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,24,60,21,60,87.5,100,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188146/pdf/ciaa461.pdf,10.1093/cid/ciaa461,Diagnostic value of serological IgM and IgG antibodies for suspected COVID-19 pneumonia patients was evaluated in 24 patients with negative nucleic acid tests.,-84,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,
Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,IgM,Serum,4,98,Not available,4,2019-nCoV IgG/IgM Antibody Detection Kit,Zhuhai Livzon Diagnostics Inc,Wuhan Jinyintan Hospital,Not available,2020010108,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,WHO Interim Guidance,Duplicates,Not available,Antibody,Enzyme-linked immunosorbent assay (ELISA),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,63,35,28,35,44.4,100,https://www.medrxiv.org/content/10.1101/2020.02.27.20028787v1.full.pdf+html,10.1101/2020.02.27.20028787,Not available,-98,Zhuhai Livzon Diagnostics Inc - 2019-nCoV IgG/IgM Antibody Detection Kit - IgM - Serum,
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG - Plasma,IgG,Plasma,1,58,Plasma,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,86.7,100,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG - Plasma,
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG - Plasma; Serum; Whole blood,IgG,Plasma; Serum; Whole blood,1,108,Respiratory specimen,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Zhongnan Hospital of Wuhan University,Not available,Not available,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,86,22,47,13,54.7,59.1,https://www.medrxiv.org/content/10.1101/2020.03.13.20035428v1,10.1101/2020.03.13.20035428,Not available,-108,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG - Plasma; Serum; Whole blood,
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG - Serum,IgG,Serum,1,126,Not available,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Wuhan Jinyintan Hospital,Not available,2001010220,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,WHO Interim Guidance,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,91,35,74,35,81.3,100,https://www.medrxiv.org/content/10.1101/2020.02.27.20028787v1.full.pdf+html,10.1101/2020.02.27.20028787,Not available,-126,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG - Serum,
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG; IgM - Plasma; Serum; Whole blood,IgG; IgM,Plasma; Serum; Whole blood,1,108,Respiratory specimen,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Zhongnan Hospital of Wuhan University,Not available,Not available,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,86,22,59,14,68.6,63.6,https://www.medrxiv.org/content/10.1101/2020.03.13.20035428v1,10.1101/2020.03.13.20035428,Not available,-108,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG; IgM - Plasma; Serum; Whole blood,"200625_Denmark_GeneralPopTestAdj,200625_Denmark_GeneralPopTestUnadj_IgGIgM,200625_Denmark_females,200625_Denmark_males,200625_Denmark_genpop_capitalregion,200625_Denmark_genpop_capitalregion_testadj,200625_Denmark_genpop_SouthDkZealand,200625_Denmark_genpop_SouthDkZealand_testadj,200625_Denmark_genpop_CentralDKNorthDK,200625_Denmark_genpop_CentralDKNorthDK_testadj,200625_Denmark_GeneralPopTestUnadj_IgM,200625_Denmark_GeneralPopTestUnadj_IgG,200625_Denmark_17-29,200625_Denmark_30-39,200625_Denmark_40-49,200625_Denmark_50-59,200625_Denmark_60-69"
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG; IgM - Serum,IgG; IgM,Serum,1,126,Not available,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Wuhan Jinyintan Hospital,Not available,2001010220,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,WHO Interim Guidance,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,91,35,75,35,82.4,100,https://www.medrxiv.org/content/10.1101/2020.02.27.20028787v1.full.pdf+html,10.1101/2020.02.27.20028787,Not available,-126,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgG; IgM - Serum,
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgM - Plasma,IgM,Plasma,1,58,Plasma,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Montpellier University Hospital,Not available,Not available,Hospital,France,Montpellier,Confirmed COVID-19 patients,Prospectively collected set,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,38,20,Not available,Not available,80,95,https://www.medrxiv.org/content/10.1101/2020.05.04.20090027v1.full.pdf,10.1101/2020.05.04.20090027,"Cases: PCR-confirmed cases as well as suspected COVID-19
           Early days of infection, N: 9
           Intermediate days of infection, N: 14
           Late days of infection, N: 15

Controls: Stored samples from before the pandemic",-58,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgM - Plasma,
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgM - Plasma; Serum; Whole blood,IgM,Plasma; Serum; Whole blood,1,108,Respiratory specimen,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Zhongnan Hospital of Wuhan University,Not available,Not available,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,RT-PCR,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Detection of current infection; Detection of past infection,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,86,22,48,8,55.8,36.4,https://www.medrxiv.org/content/10.1101/2020.03.13.20035428v1,10.1101/2020.03.13.20035428,Not available,-108,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgM - Plasma; Serum; Whole blood,
Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgM - Serum,IgM,Serum,1,126,Not available,1,Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow),Zhuhai Livzon Diagnostics Inc,Wuhan Jinyintan Hospital,Not available,2001010220,Hospital,China,Wuhan,Confirmed COVID-19 patients,Not available,WHO Interim Guidance,Not available,Not available,Antibody,Rapid diagnostic test (RDT),Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Not available,Overall,91,35,52,35,57.1,100,https://www.medrxiv.org/content/10.1101/2020.02.27.20028787v1.full.pdf+html,10.1101/2020.02.27.20028787,Not available,-126,Zhuhai Livzon Diagnostics Inc - Diagnostic Kit for IgM / IgG Antibody to Coronavirus (SARS-CoV-2) (Lateral Flow) - IgM - Serum,